Skip to main content

Full text of "The chemist and druggist [electronic resource]"

See other formats




I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I 

The  UK's  best-selling  toothpaste*  with  stripes! 

1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 

i  i  i  i  i 




20  July  1996 

I  i  I  i  I 

3,000  pharmacies 
may  go  if  RPM  lost 

Malone  go-ahead  for 
season  ticket  sales 

Sex  attack  pharmacist 
struck  off  Register 

Update:  performance- 
enhancing  drugs  in  sport 

Keeping  a 
brief  on 

eye  care  SK> 

Pharmacists'  biggest 
fears  are  revealed 

Sunderland  TV  star 
Ortis  looks  for  'lurve' 

Online  at 


When  your  customers 

Household  chemicals 

Detergent  hands 

are  itching  to  scratch, 

d  I  X 

I  v 

/  V 

Plant  allergy 

Insect  bites 

you've  no  better  way 

( ) 


Nickel  allergy 

to  relieve  them. 


WO -[5  HIVING  ^ 

HC45  Hydrocortisone  Cream  quickly  soothes  itchy,  inflamed, 
irritated  skin  to  provide  the  fast  relief  your  customers  need.  In  fact 
there's  no  better  recommendation  you  can  make. 

Trusted  relief  from  everyday  skin  irritations 

containing  HYDROCORTISONE  ACETATE  BP  1%  w/w.  Uses:  For  the  relief  of  mild  to  moderate 
eczema,  irritant  and  allergic  contact  dermatitis  and  insect  bite  reactions.  Dosage  &  Administration: 
Apply  sparingly  to  a  small  area,  once  or  twice  a  day,  for  a  maximum  of  seven  days.  Contra-indi cations, 
Warnings  etc:  Hc45  should  not  be  used  on  the  eyes  or  face,  the  ano-gemtal  area  or  on  broken  or 

infected  skin,  including  lmpeogo,  cold  sores,  acne  or  athletes  foot.  The  product  should  not  be  used 
in  pregnancy  or  in  children  under  10  years  without  medical  advice.  Packaging  Quantity:  Tube 
containing  15g.  RSP:  £2.65.  Legal  Category:  P.  Product  Licence  Number:  PL  0327/0039. 
Product  Licence  Holder:   Crookes  Healthcare  Ltd.,  Nottingham      ^^^k  CROOKES 
NG2  3AA  Date  of  Preparation:  June  1996.  ^^^F  HEALTHCARE 



ongratulations  to  the  Community  Pharmacy 
Action  Group  lor  its  hard-hitting,  albeit  bleak 
reading,  report  on  the  impact  of  abolishing 
Resale  Price  Maintenance. 
Although   it    confirms   the   worst    fears  of 
pharmacists  (see  Business  News,  p96),  it  states 
the  pharmacy  case  effectively,  while  stressing  the 
pharmacy's  importance  in  the  community. 

Of  course,  there  may  be  those,  both  within  and 
without  the  profession,  who  see  mass  pharmacy 
closure  as  for  the  common  good.  And  it  is  also 
disappointing  to  see  other  health  professionals 
backing  Asda's  stance,  but  it's  hard  to  see  how 
there  can  be  any  long-term  gain.  The  ultimate  effect 
of  job  losses,  increased  GP  burden  and  dissatisfied 
patients  will  be  a  hard  one  to  bear  for  a 
Government  which  introduced  a  Patient's  Charter 
and  for  GPs  already  burdened  by  overwor  k. 

It  is  patients  to  whom  the  Office  of  Fair  Trading 
must  look  when  considering  RPM's  fate,  so  it  is 
good  news  that  the  Patients'  Association  has  also 
come  out  battling  in  the  pharmacy  comer  (p78). 

Guy  Howland,  the  organisation's  chief  executive,  is 
a  fervent  pharmacy  supporter.  He  believes  the 
profession's  accessibility  is  key  to  its  patient 
popularity  and  stresses  that  that  must  be  maintained. 
He  points  out  that  the  supermarkets  who  are  trying 
to  change  pharmacy  aim  to  "make  a  fast  buck,  rather 
than  having  anything  to  do  with  patients". 

In  contrast,  he  feels  the  local  pharmacy  could  be 
expanded  to  offer  more  services  for  patients  to 
supplement  those  on  offer  from  the  surgery. 

His  response  is  one  of  the  positive  spin-offs  from 
the  whole  RPM  debate.  Support  such  as  this, 
backed  by  the  Deloitte  &  Touche  (TAG  report,  will 
have  a  long  shelf-life  and  may  be  used  in  the  future 
to  help  pharmacy  reach  its  potential  -  hopefully 
with  the  RPM  debate  settled  in  the  profession's 


Editor  Patrick  <  rrice, 

Assistant  Editor  Maria 
Murray,  MRPharmS 
News  Editor  Marianne  Mac  Donald,  MRPharmS 
Technical  Editor  Fawz  Faihan,  MRPharmS 
Beauty  Editor  Joanne  Webb 
Business  Editor  Guy  L'Aimable,  BA 
Contributing  Editor  A< Incline  de  Mont,  MRPharmS 
Reporter  ( lharles  <  lladwin  MRPharmS 

Art  Editor  Tony  Lamb 

Production  Editor  Vanessa Townsend,  BA 

Price  List  Colin  Simpson  (Controller) 
I  tarren  Lai  Kin,  Maria  Locke 

Advertisement  Manager  .lull. in  de  lirnxelles 
Assistant  Advertisement  Manager  Doug  Mytton 
Display  Advertisement  Executives 

Martin  <  lalder-Smith,  Nick  Fishet 

Production  Jenny  I  latl 
Publisher  Ron  Salmon,  FRPharmS 
Publishing  Director  Roger  Murphy 
<0  Miller  Freeman  pic.  [996 

Chemist  &  Diuyiiisl  mcorporatinij  Retail 
Ohwiir.l  ^  I'Imiiii.ii  v  Hpij.ili: 

Published  Saturdays  hy 

Mi  Her  Freeman  Professional  I  td 

Sovereign  Way,  Timlnirlqe.  Kent  TN9  1RW 

telephone  01732  364422 

Telex  95132  Milt  RE  G 

Fax:  01732  361534 

E-Mail:  tlieiiidrii(),(?ilnt|ih.imiacy com 
Internet  site 

Imp  //www  y  i  urn/ 

Subscriptions  Home  £115  per  annum 
Overseas  &  Eire  t'ltj1.  pel  annum 
including  postage 
£2  40  pei  copy  (postage  extial 

Circulation  and  subscription  Royal 
Sovereign  House,  Beresford  Street 
London  SI  I86BQ  hi  0181  855  //// 

Refunds  on  cancelled  subscriptions  will 
only  In'  provided  at  the  publisher's 
discretion,  unless  specifically 
guaranteed  within  the  terms  ot 
subscription  offer 

The  editorial  photos  used  are  courtesy 
of  the  suppliers  whose  products  they 

\fl  Miller  Freeman 




VOLUME  247  No  6044     136th  YEAR  OF  PUBLICATION    ISSN  0009-3033 


Report  commissioned  by  the  Community  Pharmacy  Action 
Group  spells  out  the  clangers  if  Resale  Price  Maintenance  is  lost 

Oxygen  services  to  be  devolved  to  local  level  77 

I  )e]  lartment  of  Health  to  devolve  oxygen  services  by  October  1 

Pre-papent  certificates  to  be  sold  through  pharmacies  77 

Regulations  to  be  amended  to  allow  sale  directly  to  patients 

From  Practice  to  People  84 

Show  how  yon  work  in  practice  and  win  a  prize! 

Update:  the  dope  hope  in  sport 

Drugs  in  sport,  pharmacy  needle  exchange 
schemes,  plus  Research  Digest 


care  90 

Trends  and  changes  in  the  eye  care  market 

Counterpart  assistant  training  94 

There  is  si  ill  time  to  register  staff! 

Nurse  prescribing  regarded  as  an  opportunity  by  many  96 

( Haxo  survey  reveals  threats  and  opportunities  for  pharmacists 

Co-op  Health  Care  continues  to  expand  96 

Five  pharmacies  acquired  in  North  Midlands  and  North  West 

Dental  relief  aid  deliver}'  to  Bihac  in  Bosnia 

A  pharmacist  helps  to  deliver  essential  dental  supplies 





Cambridge  Counterpart 


Topical  Reflections 


Business  News 


Prescription  Specialities 


Classified  Advertisements 




Business  Link 


Practice  to  People 


About  People 


CHEMIST  k  DRI GGIST  20  JULY  1996 



000  pharmacies  could  go  if  RPM  lost 

Over  3,000  community  pharma- 
cies could  face  closure  if  Resale 
Price  Maintenance  is  lost,  reveals 
a  report  commissioned  by  the 
Community  Pharmacy  Action 
( rroup. 

"Our  concern,"  says  CPAG 
spokesperson  and  director  of  the 
National  Pharmaceutical  Associ- 
ation Tim  Astill,  "is  that  the 
removal  of  RPM  would  force  the 
closure  of  many  small  pharma- 
cies and  reduce  the  services  pro- 
vided by  others,  resulting  in  a 
threat  to  public  healthcare." 

The  'In  defence  of  community 
pharmacy'  study  by  management 
consultant  Deloitte  &  Touche 
shows  that  the  public  would 
have  access  to  fewer  pharmacies 
and  would  be  forced  to  travel  fur- 
ther to  get  pharmaceutical 
advice,  with  the1  proportions  of 
vulnerable  groups,  such  as  the 
elderly  and  those  with  young 
families,  higher  in  the  areas  most 
at  risk.  There  would  also  be  a 
reduced  range  of  over  the 
counter  medicines  available  and 
job  losses  would  be  incurred. 

The  <  >ftk  e  of  F  ur  Tr  riding  last 

investigated  RPM  in  1970  and  is 
to  decide  by  the  autumn  if  there 
is  any  material  change  thai 
would  allow  its  demise.  The 
report  divulges  that  there  is 
change,  but  it  strengthens  the 
case  for  RPM  retention,  as  phar- 
macists are  now  more  reliant  on 
branded  medicines. 

In  11)70,  the  average  small 
pharmacy  derived  7  per  cent  of 
turnover  from  medicine  sales 
and  10  per  cent,  from  NHS  dis- 
pensing, with  the  margins  on  the 
latter  at  around  26  per  cent.  Now 
NHS  dispensing  accounts  for  70 
per  cent  of  turnover,  with  mar- 
gins down  to  16  per  cent,  while 
OTCs  are  responsible  for  15-16 
per  cent  of  turnover,  around  45 
per  cent  of  the  profit. 

The  upshot  of  losing  RPM 
would  be  a  saving  of  S180  mil- 
lion, plus  another  in 00, 000  saved 
in  policing. 

"Without  RPM,"  says  Mr  Astill, 
"there  might  be  a  short-term 
gain,  but  there  will  certainly  be  a 
long-term  loss."  And  91  per  cent 
of  pharmacists  surveyed  by 
<ilaxo  Wellcome  believe  their 

Numark  is 
tackling  the 
head-on  with  a 
pharmacy  advice 
campaign.  Terry 
Morris,  Numark's 
director,  sees  the 
campaign  as  a 
complement  to  the 
Resale  Price 
defence:  "Numark 
totally  supports 

the  retention  of  RPM  and  what  we  want  from  this  campaign  is  for  the 
consumer  to  ask  the  question:  when  did  a  supermarket  shelf  last 
advise  me  not  to  buy  something?"  Numark's  900  shareholder 
pharmacies  will  highlight  the  advisory  role  of  trained  pharmacy  staff 
and  compare  that  with  what's  on  offer  in  an  ordinary  supermarket  via 
posters  and  shelf  cards,  which  ask  a  series  of  advice-related 
questions  and  issues  the  challenge:  Try  asking  your  supermarket  shelf 
these  questions' 

business  viability  will  be  threat- 
ened (Business  News,  p96). 

Supermarket  chain  Asda,  at 
the  forefront  of  the  fight  to  abol- 
ish RPM,  comments:  "We  are 
well  aware  of  the  services  that 
community  pharmacies  deliver 

The  impact  on  healthcare  of  abolishing  Resale  Price  Maintenance 

•  Up  to  3,055  pharmacies 
would  be  at  risk  of  closure:  one- 
quarter  of  Britain's  total. 

•  Up  to  8.2  million  people 
whose  pharmacy  is  at  risk  of  clo- 
sure could  be  affected. 

•  Additional  travel  costs  of 
between  S4.4  million  and  SI 5.9m 
would  be  incurred  by  people 
affected  by  the  closure  of  their 
local  pharmacy. 

•  If  a  tenth  of  those  who  treat 

themselves  with  pharmacy- 
bought  medicines  were  to  visit  a 
GP  instead,  the  annual  cost  to 
the  NHS  could  be  more  than  S4.7 

#  The  range  of  non-prescrip- 
tion medicines  available  would 
be  cut:  the  average  pharmacy 
carries  700  OTC  lines,  while 
supermarkets  cany  70. 

•  Between  800  and  3,000  jobs 
could  be  lost  if  pharmacies  close, 

not  including  any  pharmacists. 

•  The  benefits  of  RPM  would 
be  a  saving  of  SI 80m  if  prices 
were  cut  across  the  board  (6p 
per  person  per  week  ),  but  super- 
markets are  more  likely  to  offer 
seasonal  reductions  on  adver- 
tised products  rather  than 
wholesale  discounting. 

•  The  cost  of  administering 
RPM,  around  S100,000  annually, 
would  also  be  saved. 

to  the  local  community,  but  we 
do  not  believe  that  RPM  supports 
local  pharmacies." 

Asda  says  that  GPs  and  nurses 
back  its  stance  on  RPM.  In  an 
Asda  mailing  to  30,000  GPs,  some 
7,500  replies  agreed  that  RPM 
results  in  artificially  high  prices 
for  "common  healthcare  prod- 
ucts". Only  40  replies  disagreed. 

But  backing  for  RPM  comes 
from  an  even  more  powerful 
source,  the  Patients'  Associa- 
tion. "With  RPM  loss  there  will  be 
a  trade-off,"  says  chief  executive 
Guy  Howland.  "Lowering  prices 
will  undoubtedly  cause  some 
exist  ing  pharmacies  to  close  and 
reduce  choice.  The  public  like 
the  access  they  currently  get 
from  pharmacies  and  we  need  to 
keep  that  available." 

The  OFT  has  been  sent  a  copy 
of  the  Deloitte  &  Touche  report. 

Pharmacists  to  be  more  clinical  with  methadone? 

Pharmacy  Group 

MPs  disappear  from  Westminster 
for  their  three-month  summer 
break  on  July  20,  with  no  sign  of  a 
long-awaited  Pharmacy  Group 
being  established  to  promote  the 
interests  of  the  sector. 

Tory  MP  Sir  Malcolm  Thornton 
and  Labour's  Alan  Keen  said  last 
year  that  they  planned  to  set  up  a 
group  to  lobby  on  behalf  of  phar- 
macies and  vowed  to  launch  the 
body  early  this  year. 

But  Sir  Malcolm  admits  he  has 
dropped  out  because  of  a  lack  of 
time.  "Unfortunately,  I  ran  up 
against  the  buffers,"  he  says. 

Mr  Keen's  office  says  the  group 
has  yet  to  be  set  up,  but  insists 
that  the  MP  for  Feltham  still 
intends  it  to  go  ahead. 

Pharmacists'  potential  to  adopt  a 
more  clinical  role  in  managing 
methadone  patients  is  to  be 
investigated  by  South  Humber- 
side's  pharmacist-run  Freelance 
Needle  Exchange. 

Community  pharmacist  Dr 
Rod  Tucker,  director  of  the  Free- 
lance Group  and  devisor  of  the 
study,  says:  "The  overall  objec- 
tive ( if  the  project  is  to  determine 
whether  or  not  pharmacists  can 
play  a  greater  role  in  the  clinical 
management  of  opiate-depen- 
dent individuals." 

South  I  lumber  Health  Author- 
ity is  paying  SI  per  addict  per  day 
for  pharmacists  to  supervise  the 
methadone  consumption  of  30 
patients  over  13  weeks,  plus  an 
additional  S750  for  evaluation.  A 
clinical  audit,  sheet  will  be  main- 
tained   and    clients    will  be 

assessed  using  an  opiate  with- 
drawal scale  to  titrate  the 
methadone  dose.  An  initial  three- 
day  assessment  by  the  referral 
agency  scores  various  signs  and 
symptoms,  such  as  sweating,  agi- 
tation and  mydriasis,  to  establish 
the  degree  of  withdrawal.  The 
dose  is  titrated  upwards  until 
symptoms  are  under  control. 

Thereafter,  the  pharmacist  con- 
tinues daily  monitoring  of  the 
patient  using  the  same  scale.  A 
change  in  the  patient's  drug-tak- 
ing habit,  such  as  taking  addi- 
tional opiates,  can  also  be  indi- 
cated by  changes  in  routine  or 

Every  fortnight  during  the  pro- 
ject, the  withdrawal  scales  are 
scored  and  given  to  the  prescrib- 
ing agency  responsible  for  the 
overall  management  of  the  client. 

From  Practice  to  People - 
deadline  imminent 

You've  got  less  than  two  weeks 
to  enter  the  Glaxo  Well- 
come/C&D  community  phar- 
macy award,  From  Practice  to 
People  (see  page  84). 

The  award  will  be  granted  to 
three  community  pharmacists 
who  show  how  they  are  forging 
links  with  other  health  profes- 
sionals to  benefit  patients, 
other  primary  care  workers  and 
their  business.  Closing  date  for 
entries  is  July  31, 1996,  and  win- 
ning entries  will  be  announced 
on  November  9. 

Winners  will  be  offered  the 
chance  to  attend  one  of  the 
major  1997  conferences  or 
choose  from  a  range  of  manage- 
ment courses. 




Oxygen  to  be  devolved  on  October  1 

The  I  'epartmenl  oi  Health  is  to 
devolve  oxygen  services  i<>  local 
level  by  <  ictobei  1 

The  Pharmaceutical  Services 
Negotiating  Committee,  winch 
has  opposed  the  move,  will  write 
to  local  pharmaceutical  commit- 
tees with  a  model  for  local  nego- 
tiations as  soon  as  it  receives 
mure  detailed  guidelines. 

The  NHS  Executive  expects 
agreements  wit  h  heall  h  auttv  »ri- 
ties  in  I"'  made  by  January  1, 
l!i!)7  ( 'ontractors  should  carry 
on  as  before  unlil  they  receive 
further  advice  from  then  LP( 's. 
The  number  of  oxygen  head  sets 
is  to  lir  reduced,  but  contractors 

who  have  to  give  up  head  sels 

will  be  paid  compensation. 
PSN< '  warns  dial  monej  is  only 
available  f<  a  this  financial  year. 
Remuneration  The  hull  and 
PSNC  are  poised  on  the  brink  of 
a  remuneration  settlement  foi 
l!)!)ii/!i7.  PSNC  has  been 
pr< mused  an  i  iffei  I  iefi  »r< 1  the  end 
ol  the  month,  aftei  ii  met  with 
health  minister  Gerald  Malone. 
This  followed  PSNC's  rejection 

oi  the  Moll's  last  offei  of  3  per 
cent  in  May  (C&D  May  25,  p712). 

PSNC  chairman  Wally  Dove 
says  thai  the  offei  w  ill  m  it  be  put 
to  contractors.  Providing  an 
agreement  is  reached  then 
PSNC  will  discuss  the  distribu- 
tion of  the  global  sum  at  its  Sep- 
tember meeting  and  the  new 
si  ruct  ure  sin  mill  be  in  ]  ilace  by 
t  ictobei  1 

Director  The  first  advertise- 
ment for  the  new  position  of 

duei  lor  w  ill  be  placed  Ihls  week 

iii  the  PSNC  News  and  pharma- 
ceutical piess 

MPs  The  PSNC  wants  to  thank 
tin isc  pharmacists  who  wr< ite  to 
their  MPs  to  raise  awareness  of 
pharmacy  remuneration  It  also 
wants  io  encourage  LP( 's  to  con- 
tinue inviting  MPs  to  \  isii  phar- 
macies, so  thai  they  gel  a  bettei 
understanding    ol  community 

phai  ma<  V  issues 
Control  of  Entry  Most  of  the 
comments  made  by  PSNC  over 
the  draft  guide  concei  ning  ( 'on- 
trol  ol  Entry  regulations  have 
been  acce] ited  I iy  the  DoH  and 

will  be  inc<  »rj » >rate<  I  into  the  sec- 
ond draft. 

Taxation  advice  Advice  will  be 
senl  to  LP< 's  setting  oul  the  lax 
implications  for  allow  ances  paid 
foi  members  attending  LPC 

Primary  care  The  I  lull  has  indi- 
i  ated  that  the  NHS  Executive 
would  welcome  further  position 
papeis  from  PSN(  ■  on  the  health 
minister's  paper  'Primary  care: 
the  future'.  PSNC  will  place 
emphasis  on  the  need  for  non- 
global  sum  money  to  be  made 
available  for  local  initiatives. 
Pilot  trials  PSNC  has  been  in 
discussion  with  the  DoH  over 
pilot  trials  in  1996/97.  Il  is  stress- 
in;;  thai  pharmacists  should 
receive  then  share  of  any  money 
saved  m  icpeai  dispensing 

GP  co-operatives  PSN(  is  con 
cerned  that  there  has  been  no 
national  approach  by  local  med- 
ical councils  to  the  pharmacy 
pi  c  pfessii  m  ovei  the  setting  up  i  >l 
GP  co-operatives  to  provide 
emergency  oul  of  hours  medical 

services.  PSNC  secretary  Steph- 
en Axon  is  against  health  author- 
ities extending  existing  phar- 
macy rota  hours  to  beyond  those 
of  surgeries 

NAIIAT  PSNC  wants  to  create  a 
dialogue  with  the  National  Asso- 
ciation of  Health  Authorities  and 
Trusts  over  developing  pharma- 
ceutical services.  It  is  hoped  that 
money  other  than  the  global  sum 
will  be  made  available  fi ir  such 

Conference  The  third  confer- 
ence organised  jointly  with  the 
Royal  Pharmaceutical  Society 
and  the  Pharmaceutical  Advisers 

(  JrOlip  W  ill  be  held  al  the  Mello- 

pole  Hotel,  Birmingham,  on 
Novembei  7.  The  theme  will  be 
'Pharmacists  as  partners  in 

LPC  Conference  PSNC  has 
received  comments  from 
LPCs  about  the  March  confer- 
ence. The  Committee  will  be 
looking  at  making  the  working 
group  sessions  more  interactive, 
ami  will  be  targeting  MPs  more 
lor  the  dinner. 

New  research  suggests  that  hairy  men  are  more  intelligent.  More  details  can  be  found  on  p80 

Sale  of  season  tickets  receives  go-ahead 

Pharmacists  are  to  be  allowed  to 
officially  sell  prescription  pie 
payment  certificates.  The  health 
minister,  Gerald  Malone,  an- 
nounced in  a  written  answer  lasl 
week  that  the  Gi ivei iinient  "pro 
poses  to  amend  cm  rent  regula- 
tions later  this  yeai  to  allow  com- 
munity pharmacists  who  wish  to 
do  so  lo  sell  prescription  pie 
payment  certificates  directly  to 
Al    present,    patients  must 

apply  directly  to  then  health 
authority,  but  m  some  areas 
pharmacists  have  been  supply- 
ing certificates  with  the  tacit 
approval  of  the  1 IA 

"We  have  been  making  repre 
sentations  lor  some  time  foi  a 
change  in  the  regulations,"  says 
Pharmaceutical  Services  Negoti- 
ating Committee  assistant  secre- 
tary Mike  Kins*.  "Now  we  will  he 
discussing  details  with  the  Nils 
Execul  ive." 

A  Department  of  Health  spokes- 
man says  Ihe  changes  should  be 
made  bcli  n  e  next  April  and  discus- 
sions a i e  in  progress  with  relevant 
bodies.  One  of  the  DoH's  main  con- 
cerns is  Ihe  security  ol  the  certifi- 
cates held  in  pharmacies 

The  National  Asthma  Cam 
paign  has  been  lobbying  lor  a 
greatei  awareness  of  'season 
tickets',  which  Mr  Malone  says 
will  be  further  publicised  after 
I  he  n 'gulat  ions  are  changed. 

certification  and  reward 

Medicines  counter  assistants 
are  m  iw  completing  ( 'hem  ist  & 
Dnifjgist's  ( 'am bridge  <  ounler- 
part  course  and  certification  is 
under  way. 

The  College  of  Pharmacy 
Practice  hopes  to  have  its  cer- 
tificates of  accreditation 
printed  by  Ihe  end  of  July.  < '&D 
will  then  begin  a  search  of  its 
computer  records  to  find  out 
which  assistants  have  success- 
fully passed  all  modules  in  the 
previous  lour  weeks;  their 
pharmacist  will  then  get  a  letter 
lo  sign  and  rel  urn  confirming 
joint  c  ompletion  ol'  all  case 
studies  and  that  each  assis- 
tant's customer  communica- 
tion skills  are  satisfactory. 
Within  one  month  of  receipt  of 
that  letter  from  ihe  pharmacist 

the  assistant  should  receive  a 

CPP  certificate  of  accredita- 

Each  month,  (  \Ki>  will  give 
bottles  ol'  champagne  lo  a  suc- 
cessfully-accredited assistant 
and  their  pharmacist  -  one  PIN 
will  be  draw  n  from  a  batch  ol' 

Al  Ihe  end  of  this  year,  one 
accredited  assistant  will  win  a 
weekend  holiday  lor  two  by 
prize  draw,  courtesy  ol'  White- 
hall Laboratories, 
•  Registration  form  and  fur- 
ther information  on  page  9 1. 




Pharmac  ists  should  be  given  an 
expanded  role  in  the  primary 
care  arena,  according  to  the 
Patients'  Association. 

Guy  Howland,  PA  chief  execu- 
tive, says  the  Association  is  in  the 
process  of  writing  a  paper  on  the 
future  of  pharmacy,  which  will 
place  pharmacists  at  the  fore- 
front of  primary  care.  "Our  whole 
thrust  is  that  we  want  to  see  a 
role  switch  from  dispensing  to 

A  veteran  pharmacist  who 
bought  more  than  £11,000  of 
drugs  from  the  hack  of  an  un- 
licensed wholesaler's  car  was 
or  dered  to  be  struck  off  the  Reg- 
ister this  week. 

John  Aloysius  Judge,  56,  super- 
intendent pharmacist  at  Snow- 
drop Pharmacy,  Canterbury, 
admitted  purchasing  unlicensed 
drugs,  but  claimed  he  had  been 
unaware  that  I  hey  were  unli- 
censed at  the  time. 

His  supplier  -  Pierre  Schaffer 
of  Palm  Bay,  Margate  -  has 
already  been  responsible  for  the 
striking  off  of  1 1  other  pharma- 
cists, with  four  more  yet  to 
appear  before  the  Statutory 
Committee  ol  Ihe  Royal  Pharma 
ceutical  Society. 

Society  inspectors  visited  Mr 
Judge's  pharmacy  in  October, 
1993,  where  they  discovered  22 

A  pharmacist  who  terrorised  a 
young  woman  by  breaking  into 
her  flat  and  asking  for  sex  was 
struck  off  the  Register  by  a  disci- 
plinary panel  this  week. 

Rajinder  Singh  Atwal,  25,  who 
was  studying  at  Manchester  Infir- 
mary at  the  time,  was  jailed  for 
four  years  by  Manchester  Crown 
Court  in  May  last  year,  after 
being  convicted  of  burglary  with 
intent  to  commit  rape.  He  gradu- 
ated from  John  Moore  University 
in  Liverpool  just  a  year  before 
forcing  his  way  into  the  25-year- 
old  woman's  flat  and  threatening 
to  sin  >ot  her  if  she  didn't  have  sex 
with  him. 

The  Statutory  Committee  of  the 
Royal  Pharmaceutical  Society  was 
told  Mr  Atwal  had  been  out  drink- 
ing on  the  night  of  the  offence,  cel- 
ebrating the  successful  presenta- 
tion of  a  paper  on  ast  hma  and  a  job 
offer  with  Lloyds  Chemists. 

undertaking  consultations,  ad- 
vising, prescribing  and  supple- 
menting the  work  of  the  doctor 
and  nurse,"  says  Mr  Howland. 

He  believes  that  pharmacists' 
skills  can  be  put  to  better  use.  "If 
we  do  not  utilise  the  skills  in  pri- 
mary care  more  effectively,  then 
primary  care  as  we  know  it  will 
not  survive.  Let's  get  pharmacists 
to  solve  the  primary  care  crisis." 

He  feels  that  there  should  be  a 

consignments  of  products  from 
Mr  Schaffer,  worth  SI  1,301. 

Josselyn  Hill,  solicitor  to  the 
Society,  told  the  hearing  that  Mr 
Judge,  who  had  been  practising 
for  32  years,  bought  medicine 
from  the  back  of  Mr  Schaffer's 
car  and  received  handwritten 
invoices,  although  not  all  of  the 
products  were  unlicensed. 

Mr  Judge  of  Petham,  Canter- 
bury, who  admitted  misconduct, 
said  he  had  trusted  Mr  Schaffer 
and  assumed  his  supplies  were 

Mr  Judge  said  he  had  been  told 
by  Mr  Schaffer  that  he  would  be 
supplied  at  "much  keener"  prices 
because  he  had  taken  care  of  Mr 
Schaffer  when  he  suffered  a  dia- 
betes attack  in  the  pharmacy. 

In  a  letter  to  the  Society,  Mr 
Judge,  who  sold  the  pharmacy  in 
February  this  year  but  continued 

Detective  sergeant  Steve  Mc- 
Gahey  told  the  hearing  the  victim 
had  gone  to  bed  at  1.45am  on  the 
night  of  June  24,  1994.  At  around 
3.30am,  Mr  Atwal  approached 
the  entrance  to  the  block  and 
began  talking  to  two  residents 
who  believed  he  knew  somebody 
and  let  him  in.  "He  forced  the 
front  door  of  her  flat  and  went  to 
her  bedroom.  She  awoke  and 
saw  him  standing  close  to  her 

Mr  McGahey  said  the  victim  - 
who  did  not  know  Mr  Atwal  - 
asked  him  how  he  got  inside  her 
home.  He  showed  her  a  bunch  of 
keys  and  claimed  he  had  believed 
a  girl  called  Leigh  lived  there. 

"He  then  asked  her  if  she 
would  consent  to  making  love 
with  him  and  said  she  would 
have  no  choice  in  the  matter 
because  he  would  shoot  her.  She 
was    absolutely    terrified  and 

re-think  on  training  so  that  all 
health  professionals  share  a  core 
base,  and  pharmacists  will  be 
allowed  to  develop  their  diagnos- 
tic and  prescribing  skills. 

The  report  is  expected  in  Octo- 
ber, but  the  PA  is  keen  to  collate 
pharmacist  evidence  on  how 
progress  can  be  made.  Informa- 
tion should  be  sent  to:  The 
Patients'  Association,  8  Guilford 
Street,  London  WC1N  IDT 

to  work  as  a  locum,  said:  "With 
the  benefit  of  hindsight,  I  accept 
my  actions  were  at  best  naive 
and  at  worst  stupid." 

In  mitigation,  David  Reissmer 
told  the  Committee  that  Mr 
Schaffer  was  a  trickster  who  had 
possibly  put  on  his  "hypoglae- 
cemic  attack"  to  gain  Mr  Judge's 
sympathy  and  confidence. 

"It  was  not  more  than  ig- 
norance in  that  he  did  not  know- 
some  of  the  drugs  were  un- 
licensed, although  he  accepts 
today  that  he  should  have  done." 

(fiving  the  Committee's  deci- 
sion, chairman  Gary  Flather  QC 
said  Mr  Judge  is  one  of  the 
longest-serving  pharmacists  to 
have  been  caught  out  in  the 
'Schaffer  affair'.  He  told  Mr 
Judge  that  the  Committee  would 
not  entertain  any  application  for 
restoration  for  nine  months. 

started  shouting  'rape'  loudly." 

Mr  Atwal  then  panicked  and 
ran  from  the  flat.  However,  he 
was  unable  to  find  the  way  out 
and  he  smashed  a  window. 
Bleeding  profusely,  he  then 
banged  on  another  resident's 
door  claiming  he  had  been 
mugged.  He  was  taken  to  hospi- 
tal but  was  later  arrested  after 
the  woman  called  the  police. 

Mr  Atwal,  who  is  now  serving 
his  prison  sentence,  broke  down 
in  tears  as  he  told  the  Committee 
he  could  make  no  excuse  for  his 
behaviour.  He  said  he  committed 
the  offence  "in  a  drunken  haze". 
Committee  chairman  Gary 
Flather  QC  said  the  Committee 
had  no  option  but  to  strike  him 
off  because  of  the  conviction  but 
added  that  the  Society  would 
entertain  an  application  for 
restoration  in  1998  -  he  is  due  for 
release  in  Dec  ember  next  year. 

WCPPE  goes  on-line 

The  Welsh  Centre  for  Post-gradu- 
ate Pharmaceutical  Education 
can  now  be  accessed  on  the 

Aimed  mainly  at  pharmacists  I 
living  in  Wales,  the  site  offers  an 
index  of  literature  for  community 
pharmacists,  a  calendar  of  Welsh  I 
pharmacy  events  and  articles 
published  or  presented  by  the 
WCPPE's  staff. 

This  will  soon  be  expanded  to 
offer  a  distance  learning  pack 
ordering  system  or  allow  reserva- 
tion at  a  WCPPE  evening  course, 
with   plans   to   put   computer-  I 
assisted  learning  material  onto  H 
the  Net .  The  WCPPE's  home  page 
address  is 
html.  Its  e-mail  address  is  at:  I 
•  Boots  has  also  set  up  an  Inter- 
net site  (Website  address:  www.  I  offering  advice  on 
common  ailments,  pharmacy  ser- 
vices and  a  vitamin  database. 

More  Sun  E45 
recalls  for  Crookes 

Hot  on  the  heels  of  last  month's 
recall  of  seven  batches  of  Sun  I 
E45  Sun  Block  Cream,  Crookes 
Healthcare  is  now  recalling  all 
remaining  stock  of  Sun  E45  Fac- 
tors 8  and  15. 

Stock  should  be  returned  to 
wholesalers  or  Crookes'  territory 
managers.  Full  refunds  will  be 
given,  with  replacement  stock 
available  from  July  29.  Pharma- 
cists with  any  queries  should  tele-  I 
phone  0115  968  8711. 

MCA  cuts  waiting 
time  for  assessment 

The  Medicines  Control  Agency  is 
maintaining  its  status  as  the 
fastest  authority  in  the  world  for  I 
1 1 ii  ■  assessment  i  'I  new  di  ngs 

The  MCA's  sixth  annual  report  I 
and  accounts  for  1995/96  shows  I 
that  the  Agency  has  cut  the  mean  H 
assessment  time  to  51  days  for 
applications  containing  new  ac- 
tive substances.  Application  fees 
have    also    been    reduced  by 
4  per  cent. 

Slimming  pills  stay 

The  Department  of  Health  has 
rejected  calls  for  a  ban  on  slim- 
ming pills,  such  as  dexenflu- 
ramine,  fenfluramine  and  maxin- 
dol,  arguing  that  the  drugs  can  be 
useful  in  the  treatment  of  obe- 
sity. However,  health  minister 
Gerald  Malone  has  asked  for 
tighter  prescribing  guidelines. 

Schaffer  affair  rolls  on  and  on 

Striking  off  follows  sex  attack 



Over  80  per  cent  of 
elderly  on  repeats 

( Iver  so  per  cciii  of  eldei  ly  patients 
are  on  repeal  prescriptions,  bui  a 
quarter  are  inconvenienced  by  hav- 
ing in  make  a  return  trip  in  the 
pharmacy  because  of  'owings'. 

According  to  a  survey  by  Help 
the  Aged,  the  mosl  popular  service 
Offered  by  pharmacies  is  home 
delivery,  used  by  lo  pei  cenl  of  the 
over-70s.  Around  a  third  of  those 
surveyed  in  England  and  Wales  said 
they  were  nol  completely  satisfied 
with  their  current  means  of  receiv- 
ing repeals 

"The  efforl  of  visiting  GPs  and 
having  to  keep  visiting  pharma- 
cies adds  up  In  a  .ureal  deal  of 
time  an  inconvenience,"  says 
Help  the  Aged's  head  of  public 
affairs,  Mervyn  Kohler. 

The  report  also  reveals  thai 

71    per  cenl    of  people  o\el  60 

suller  from  ai  leasl  one  long- 
standing illness.  half  1 1  (nil 
rheumatism  oi  arthritis,  a  third 
from  hypertension,  and  respira- 
tory illness  or  heart  disease 
afflicts  one-quat  ter. 

SHS  hits  the  road 

If  you  feel  ignorant  about  coeliac 
disease  or  have  patients  who 
would  like  lo  know  more,  then 
Scientific  Hospital  Supplies  has 
the  answer. 

In  a  series  of  SHS  autumn  sem- 
inars, aimed  specifically  at  phar- 
macists and  their  customers,  a 
gastro-enterologist  will  reveal 
the  latest  advances  in  research, 

w  hile  a  Iu\  ela  home  ec(  inoiuisl 
will  demonstrate  gluten-free 

The  seminar  dales  are  Septem 
ber  5  (Dundee),  ( ictober  18  (Nor- 
wich) and  Novembei  28  (South- 
aiuplon  )  Kurt  her  inloi  mat  i<  m  is 
available  from  the  Juvela  adv  ice 
line  on  0151  228  1992. 

( loeliac  disease  affects  one  per- 
son m  every  2,500  in  the  UK. 

CPPE  workshop  on 
patient  counselling 

The  ari  of  patient  counselling 

collies  under  the  microscope  in 

the  ('cnirc  foi  Pharmacy  Post- 
graduate   Education's  autumn 

W '  irkshl  )|  i  series 

The  counselling  skills  series 
will  run  from  September  lo 
December,  with  the  help  of  local 
( TITO  i  utors  and  presental  i<  >ns  I >y 
qualified  counsellors 

Topics  lo  be  explored  iik  hide 
the  need  for  counselling  and  the 
additional  skills  required, 

The  ( !PPE's  workshop  pro 
gramme  in  spring  will  locus  on 
medicines  management,  which 
will  he  selected  on  a  local  basis. 

A  fair  day's 
pay  ,„  but 
only  for  some 

I  make  no  apology  for  quoting 
from  the  front  page  of  the 
Guardian  (Thursday,  July  11): 
"There  can  be  very  few  people 
here  or  anywhere  else  who 
have  sacrificed  more  in  pay 
restraint  than  members  of  this 
House,"  Alf  Morris,  Labour.  I 
beg  to  differ.  In  case  Mr  Morris 
is  unaware  of  pharmacy's 
current  problems,  there  is  one 
profession  which  has  not  only 
sacrificed  but  has  been 
sacrificed  on  the  altar  of 
Treasury  frugality. 

Community  pharmacy  is 
rapidly  approaching  a  crisis  of 
recruitment  that  is  purely  a 
function  of  the  dissatisfaction 
of  pharmacists  at  the  salaries 
currently  being  offered.  Our 
pay  is  an  insult  to  any 
profession  and  would  be 
laughable  if  it  was  not  so 
serious.  Job  seekers  are 
voting  with  their  feet  and 
employers  are  now  resorting 
to  overseas  recruitment  in 
order  to  fill  the  gap  left  by  our 
own  graduates  who  are 
seeking  employment 

I  do  not  expect  that  the 
Department  of  Health  will  pay 
any  more  attention  to  the 
current  situation  than  it  has  to 
reasoned  argument  in  the 
past.  However,  before  the 
service  is  starved  of  the  vital 
new  blood  it  needs  to  develop 
its  own  'New  Age',  perhaps 
Mr  Morris  and  his  like-minded 
parliamentarians  should  be 
reminded  of  pharmacy's 
parallels.  Having  enjoyed  the 
luxury  of  voting  for  their  own 
fair  pay  rise,  might  they  now 
pressurise  the  DoH  into 
similarly  granting  community 
pharmacy's  reasonable 

Playing  piggy 
in  the  middle 

The  saga  of  melatonin  has 
moved  on  since  I  last  made 
light  of  a  situation  that  could 
now  find  retailers  as  piggy  in 
the  middle  of  a  serious 
confrontation  between  the 
Medicines  Control  Agency  and 
healthfood  manufacturers. 
The  MCA  considers  that 
melatonin  is  a  hormone  which 


has  a  physiological  function 
and  is  therefore  "medicinal  in 
function".  On  this  basis,  it  has 
classified  it  as  a  medicine  and 
has  warned  manufacturers 
and  retailers  alike  that  it 
should  not  be  sold  until  a 
product  licence  is  granted. 
However,  some  manufacturers 
-  and  Pharma  Notd  in 
particular  -  dispute  this 
classification  and  claim  that, 
since  melatonin  is  naturally 
present  in  many  fresh  foods,  it 
is  a  food  supplement. 

Who  is  right  in  law  may 
eventually  have  to  be  decided 
by  the  courts.  What  is  clear  is 
that  many  products, 
melatonin  included,  are 
presently  marketed  under  the 
guise  of  'food  supplements' 
when  their  use  is  obviously 

Wild  third  party  curative 
claims  are  made,  often  in  the 
pages  of  the  popular  press,  for 
products  which  rarely  live  up 
to  the  expectations  of  their 
desperate  purchasers. 
However,  they  do  achieve  a 
very  lucrative  return  for  their 
producers  without  the 
inconvenience  of  having  to  go 
through  the  process  of 
obtaining  a  product  licence! 

I  hope  that  this  court  case 
may  clarify  the  medicinal 
status  of  'food  supplements', 

but  even  if  it  is  non-definitive, 
the  resulting  publicity  may 
attract  sufficient  political  will 
to  tackle  a  real  legislative 
problem  that  at  the  moment 
allows  the  mavericks  of  a 
mainly  responsible  industry  to 
exploit  the  gullibility  of  a  lay 
public  desperate  for  that 
'miracle  cure'. 

A  change 
for  the  better 
at  Glaxo? 

Glaxo's  agency  scheme  was 
introduced  in  order  to  bring 
this  giant  of  the 
pharmaceutical  industry 
closer  to  its  customers.  The 
result,  for  me  at  least,  has 
been  a  complete  disaster,  with 
poorer  discounts,  more 
paperwork  and  non-existent 
presentation.  Every  purchase 
of  a  Glaxo  product  costs  me 
money,  so  I  just  hope  that  the 
rumour  of  a  change  in  the 
agency  scheme  is  true  (C&D 
July  13,  p62). 

So  far,  Glaxo  has 
disdainfully  ignored  all  pleas 
for  fair  play  and  has  continued 
to  actively  discriminate 
against  the  small 
independents.  If  you  are  a 
multiple  chain  of  pharmacies, 
many  goodies  will  flow  out  of 
Brentford,  but,  for  me,  the 
company  remains  an 
expensive  luxury  for  whom  it 
is  more  important  to  persuade 
local  medical  practices  to 
adopt  new  asthma  delivery 
systems  than  it  is  to  service 
the  local  pharmacy. 

I  would  prefer  that  the 
agency  scheme  was  scrapped 
altogether,  but  the  rumoured 
change  is  far  more  likely.  If 
that  is  true,  then  perhaps  this 
time  my  welfare  will  be 
protected  by  Glaxo  -  and  not 





Salmeterol  receives 
IOC  approval 

Serevent  (salmeterol)  has  be- 
come the  first  long-acting  bron- 
chodilator  to  be  approved  by  the 
International  Olympic  Commit- 
tee, a  decision  that  will  be  wel- 
comed by  asthmatic  athletes 
c  ompeting  in  this  year's  games  in 

The  drug  was  approved  follow- 
ing evidence  that  it  did  nol 
enhance  sporting  performance.  It 
is  expected  to  benefit  athletes  on 
short-acting  bronchodilators  who 
do  not  want  the  risk  of  break- 
through symptoms  and  conse- 
quent compromised  performance. 

The  use  of  the  drug  is  permitt- 
ed by  inhaler  only  and  the  ath- 
letes must  declare  that  they 
intend  to  take  it  by  writing  to  the 
relevant  medical  authority  prior 
to  competition. 

Bayer  launches  new 
versatile  lancets 

Bayer  has  launched  a  new  type  of 
lancet  designed  to  fit  any  finger- 
pricking  device  for  which  lancets 
are  prescribable. 

Baylet  lancets  (200-pack,  basic 
NHS  price  S6.08),  which  are  25 
gauge  for  pain-free  penetration, 
can  now  be  dispensed  against  any 
prescription  for  blood  glucose 
monitoring  lancets. 

The  new  lancets  solve  the  prob- 
lem for  the  phar  macist  of  trying 
to  match  the  appropriate  product 
with  the  finger-pricking  device 
the  patient  is  using. 
Bayer  Diagnostics  UK  Ltd.  Tel: 
01256  29181. 

Sporanox  now  available 
as  an  oral  solution 

Sporanox  is  now  available  as  an 
oral  solution  containing  lOmg 
per  ml  of  itraconazole. 

The  liquid  has  improved  ab- 
sorption and  enhanced  bioavail- 
ability compared  to  the  capsules 
and  is  indicated  for  oral  and/or 
oesophageal  candidosis  in  HIV 
positive  and  other  immunocom- 
promised patients.  The  dose  is 
200mg  ( 20ml)  daily  to  be  taken  as 
a  single  dose  or  divided  into  two 
doses  for  one  week.  Treatment 
should  be  continued  for  another 
week  if  there  is  no  initial 

For  resistant  cases,  200-400mg 
should  be  given  daily  in  one  or 
two  intakes  for  two  weeks.  If 
there  is  no  response  after  that 
period,  treatment  should  be 
extended  for  another  two  weeks. 

Sporanox  liquid  is  recom- 
mended to  be  taken  without  food 
for  maximum  absorption.  The 
liquid  should  be  swished  around 
the  mouth  before  swallowing. 
The  mouth  must  not  be  rinsed 
after  swallowing. 

Sporanox  liquid  (NHS  price 
£52.28)  comes  in  150ml  bottles 
and  is  accompanied  by  a  measur- 
ing cup. 

Janssen-Cilag  has  also  launch- 
ed 60-capsule  packs  of  Sporanox 
lOOmg  (in  addition  to  existing 
packs  of  four  and  15)  for  patients 
needing  long-term  maintenance 
therapy,  such  as  those  with  AIDS 
or  prolonged  neutropenia.  The 
NHS  price  of  the  new  packs  is 

Janssen-Cilag  Ltd.  Tel:  01494 

Videx  given  first-line  indication  for  HIV 

Videx  (didanosine,  DDI)  has 
received  approval  for  use  as  a 
first-line  adjuvant  therapy  in  HIV 

The  close  is  125mg  eveiy  12 
hours  for  an  adult  under  (iOkg 
and  200mg  eveiy  12  hours  for 
adults  of  60kg  and  over. 

The  approval  was  reached 
through  a  mutual  recognition 
procedure  across  15  European 
countries  and  is  now  awaiting 
the  final  seal  from  the  Medicines 
Control  Agency,  which  is  ex- 
pected in  the  next  few  weeks. 

Bristol-Myers  Squibb  is  cur- 

rently evaluating  once  daily 
administration  of  Videx  and  new 

Preliminary  results  of  a  US 
study  presented  at  last  week's 
international  conference  on 
AIDS  in  Vancouver  found  that 
combination  therapy  of  didano- 
sine and  stavudine  (D4T)  may 
have  potent  antiviral  effects  and 
that  suppression  of  viral  load  is 
sustained  for  at  least  one  year. 
The  combination  was  also  found 
to  be  well  tolerated. 
Bristol-Myers  Squibb.  Tel:  0181 
572  7422. 

Seroxat  (paroxetine)  has  been 
granted  a  licence  for  use  in  the 
prevention  of  relapse  of  panic 
disorder.  The  standard  dose 
(40mg  daily)  for  panic  attacks 
should  be  used.  Paroxetine  is  the 
only  antidepressant  in  the  UK  to 
be  licensed  for  both  treatment 
and  prevention  of  relapse  of  the 

SmithKline  Beecham 
Pharmaceuticals.  Tel:  01707 

Glamin  infusion  solution 

Pharmacia  &  Upjohn  has 
launched  Glamin,  an  amino  acid 
infusion  solution  containing 
supplemental  glutamine.  It  is 
available  in  500ml  bottles  at  an 
NHS  basic  price  of  £26.38. 
Pharmacia  &  Upjohn  Ltd.  Tel: 
01908  661101. 

Wellcome  interest 

Zovirax  Cream  2g  tube  (POM)  is 
now  being  distributed  by  Glaxo 
Wellcome  UK,  but  the  OTC  packs 
of  the  tube  and  the  pump  will 
continue  to  be  available  from 
Warner-Lambert  Consumer 
Healthcare.  Dermal  cream  30g,  on 
the  other  hand,  will  no  longer  be 
distributed  by  Warner-Lambert 
but  by  Glaxo  Wellcome  only. 
Glaxo  Wellcome  UK  Ltd.  Tel: 
01270  508030. 

Kefadini  singles 

All  Kefadim  (ceftazidime)  vials 
are  now  supplied  in  single  units. 
The  new  NHS  basic  prices  are 
500mg/10ml,  £4.95;  1g/20ml,  £9.90, 
2g/50ml  and  2g/100ml,  £19.80. 
Eli  Lilly  &  Co  Ltd.  Tel:  01256 


ooster  for  MMR  introduced 

From  October,  all  pre-school 
children  will  be  offered  a  booster 
dose  of  the  measles,  mumps  and 
rubella  (MMR)  vaccine. 

The  second  dose  will  be  avail- 
able to  children  just  before  they 
start,  school,  alongside  boosters 
of  the  diphtheria,  tetanus  and 
polio  vaccines.  It  is  expected  to 
increase  the  protection  of  the 
first  MMR  given  at  12-15  months 
and  prevent  the  build-up  of  a 
large  number  of  children  suscep- 
tible to  measles. 

To  ensure  no  child  is  over- 
looked, the  Department  of 
Health  is  also  organising  a  catch- 
up programme.  This  means  that 

all  children  who  were  too  young 
to  be  immunised  in  the  1994 
measles/rubella  campaign,  but 
who  have  already  had  their  pre- 
school boosters  by  the  time  the 
MMR  second  close  conies  in,  will 
be  offered  it. 

The  catch-up  programme  will 
usually  be  run  by  general  practi- 
tioners and  call-up  of  children 
will  be  by  health  authority/Trust 
Child  Health  System  computer 
unless  it  is  initiated  by  the  GPs 

The  DoH  will  be  supporting  the 
new  campaign  with  publicity 
material  for  the  public  and 
healthcare  professionals. 

Hairy  chest  -  a  sign  of  intelligence? 

Hairy  men  should  bare  all  and  be 
proud.  After  all,  it  is  a  sign  of 
intelligence,  according  to  a  study 
presented  at  last  week's  Con- 
gress of  the  Association  of  Euro- 
pean Psychiatrists  in  London. 

The  study,  conducted  by  Dr 
Aikarakudy  Alias,  of  the  Chester 
Mental  Health  Centre  in  Illinois, 
found  a  link  between  body  hair, 
intelligence  and  academic  ach- 
ievement in  men. 

He  found  that  45  per  cent  of 
medical  students  in  America 
were  'very  hairy'  compared  to 
less  than  10  per  cent  among  the 
general  male  population.  In 
India,  medical  students  and  engi- 

neering students  were  found  to 
have  more  body  hair  than  manual 
labourers  and  to  achieve  better 
results  in  their  degrees  than 
'smoother'  colleagues. 

Menil.eisol  MENSA  also  had  a 
tendency  to  thick  body  hair, 
while  some  of  the  most  intelli- 
gent men  appeared  to  have  haiiy 
backs  as  well  as  chests. 

Dihydrotestosterone,  a  variant 
of  testosterone  that  is  associated 
with  male  sexual  characteristics 
and  mental  faculties,  is  thought 
to  be  responsible  for  the  link. 

However,  one  famous  excep- 
tion is  Albert  Einstein,  who  had 
no  body  hair  at  all. 




Mycil  Gold  Clotrimazole  contains  1% 
clotrimazole,  one  of  the  most  effective  athletes 
foot  treatments  available. 

And  with  your  customers'  confidence  in 
the  Mycil  brand  name,  your  recommendation 
will  be  reassuring  as  well  as  effective. 

So  next  time  you're  looking  tor  a 
treatment  that's  effective  in  more  ways  than  one, 
remember  Mycil  Gold. 

It'll  soon  show  athlete's  toot  a  clean 
p. nr  of  heels. 


HHHj^HHHHjjSMUaHHfl  Clotrimazole  1  % 

There's  no  better  recommendation 
for  persistent  athlete's  foot 

Product  Information:  Mycil  Gold  Clotrimazole 

Topical  antifungal  cream  containing  l%  clol  azoic,  Use:  Broad-spectrum  antifungal  cream 

I"1  the  treatment  ol  athlete's  foot  and  other  fungal  infei  tions  mm  h  .is  dhobic  h.  h,  intertrigo, 
fungal  nappy  rash  and  ringworm.  Contra-indications:  hypersensitivity  to  any  ol  the 
ingredients    Precautions:  I  lo  no!  use  in  or  near  eyes    Not  recommended  foi   use  in 

pregnancy  and  lactation  Dosage:  Apply  to  the  affected  area  think  and  evenly  2-3  times  daily 
Side-effects:    Karely,   mild    transient   burning  or   irritation   after  applying  the  cream 
Packaging  quantities:     20g  tube.  P  (in  box)  RSP:  £2.99.  PL:   10622/000-1  Licence 
Holder:  Dominion  Pharm.i  lid    Haslemere,  Surrey  GU27  l|l  ^fl^CROOKES 
Manufactured  by:  I  I  le.ilth.  .in  I  id    Alton  Hants  CiU.W  XJR    ^ftU0f  H 15  A I  ,T1 1(  'A  K  K 


with  Forehead-C 

Foreheatl-C  is  a  new 
forehead-sized  cooling 
sheet,  said  to  soothe 
headaches  and  relieve 
fever  in  babies  and  young 
children.  The  active 
ingredient  is  super- 
hydrated  aloe  vera  which 
has  a  cooling  effect  when 
placed  on  the  forehead.  A 
packet  of  three  sheets 
retails  at  £1.99. 

According  to  Lina 
Trading,  advantages  of 
the  products  are  that  it  is 
easy  to  apply,  it  provides 
instant  comfort;  aloe  vera 
is  good  for  the  skin;  and 
the  sheet  contains  very 
little  menthol  (its  vapours 
can  irritate  the  eyes). 

Lina  Trading  is 
supporting  the  launch 
with  a  £60,000  television 
advertising  campaign 
within  London  and  the 
Home  Counties  area  for  a 
one-month  period  during 

The  television 
advertisement  will 
feature  a  Freefone 
number  which  viewers 
can  use  to  obtain 
information  about  the 
nearest  stockist. 
Mothercare  will  be 
stocking  the  product 
during  the  campaign  and 
Lina  is  currently 
recruiting  pharmacies 
within  the  area  to  do 

Lina  Trading  Ltd.  Tel:  0171 
629  4144. 

Complete  ad 
knocks  juggling 

'Are  you  still  juggling 
with  a  multi-bottle 
system?'  is  the  catchline 
for  Allergan  Complete's 
£250,000  national 
consumer  campaign. 

The  month-long 
campaign  includes  full- 
page,  colour 
advertisements  in 
national  newspaper 
magazines,  including  the 

Mail  on  Sunday's 
Night  and  Day, 
the  Sunday  Times 
magazine,  and  the 
magazine.  The 
Even  in y  Sta  ndard 's 
ES  magazine  is  also 
being  included  to  give 
extra  emphasis  in  the 
London  area. 
Allergan  group 

Colgate's  added  value  Plax  packs 

Colgate-Palm<  ilive 
is  running  an 
added  value 
consumer  offer  on 
Colgate  Plax 

An  eye-catching 
neck  collar  on 
500ml  slock  will 
carry  a  money-off 
coupon  towards 
the  purchase  of  a 
Colgate  Total 
prompting  consumers  to 
stock  up  across  the 
Colgate  range,  and  at  the 
same  time  encouraging 
them  to  change  their 
toothbrush  regularly.  The 
offer  runs  for  two  months 
and  returns  on  the  250ml 
bottles  from  mid- 
September  for  a  further 
two  months. 

The  collar  also  features 
the  'Plax  Worx'  message 
from  the  high-profile 
poster  campaign,  which 
will  be  back  for  a  second 
burst  during  August.  The 
campaign  is  part  of  a  S 1 
million  spend  behind 
Colgate  Plax  this  year. 
Colgate-Palmolive  Ltd. 
Tel:  01 483  302222. 

Blisteze  and  Blistex  give  lips  the  kiss  of  life 

I  >cniln  Hi  is  suppi  ii  ling  its 
cold  sore  brands  - 
Blisteze  and  Blistex  - 
with  a  national 
promotional  campaign 
starting  in  September. 

Nearly  ,S2  million  is 
being  invested  in  the 
campaign,  which  is  set  to 
run  dining  the  winter 
months  and  feature  on 
cinema  screens,  in  the 
press  and  at  point  of 

The  campaign  for 
Blisteze  targets  15-24- 
year-< >lds  with  its 
'Blisteze  -  it's  the  cream' 
cinema  commercial.  The 
30-second  advert  will  be 
seen  on  1,,S()I)  cinema 

screens  from  October  to 
March  next  year,  hitting 
over  50  per  cent  of  the 
target  audience. 
Advert  ising  with  a 
similar  theme  will  appear 
in  teen  magazines  from 
September,  backed  by 
POS  shelf  wobblers. 

Similar  campaign 
support  for  Blistex 
includes  cinema  and 
press  advertising  based 
on  'The  Kiss  of  Life  for 
Lips'  theme. 

A  counter  display  unit 
to  hold  all  four  products 
-Blistex  Lip  Cream  SPF 
6,  Blistex  Ultra 
Protection  Balm  SPF 30, 
Blistex  Lip  Conditioner 

SPF  15  and  Blistex 
Lip  Tone  SPF1  5- 
is  also  available  to 

Aimed  at  15-24- 
year-old  females, 
the  30-second 
commercial  will 
fortnightly  with 
the  Blisteze 
commercial  from 
I  ictobct  until 
March.  Advertising 
will  be  targeted  at 
the  same  magazines  as 
Blistex.  A  red  'X'  will  be 
used  on  the  counter 
display  unit  and 

Dendron  is  hacking  the 

product  manager 
Amanda  Byrne  says: 
"This  high-impact 
consumer  campaign  will 
increase  the  visibility  of 

Complete  across  the 
country.  We  believe 
many  soft  contact 
lens  wearers  still 
need  to  be  told 
about  the  benefits 
of  the  one-bottle 
system.  As 
Complete  is 
available  only 
from  opticians  or 
should  take  full 
advantage  of  the 
campaign  by  stocking  up 
now  and  ensuring 
Complete  is  highly 
visible  to  customers." 
Allergan  Ltd.  Tel:  01494 

Water  Gem  for  DIY  filtering 

Aqua  Cure,  one  of  the 
UK's  specialists  in  water 
purification,  has 
launched  a  unique  DIY 
home  water  filter  system 
in  response  to 
consumers'  health 
concerns  about  domestic 
water  quality  and  safety. 

Water  Gem  is  a  ready  to 
fit  water  filter  kit,  which 
can  be  easily  installed  to 
the  domestic  sink  to 
provide  clean,  filtered 
water  at  less  than  one 
penny  per  litre.  The  filter, 
approved  by  the  Water 
Research  Council,  is  said 
to  improve  the  taste  and 
smell  of  tap  water  by 
filtering  out  sediment,  dirt 
and  rust,  and  reducing 
levels  of  chlorine, 
chemicals,  herbicides 
and  pesticides,  as  well  as 

inhibiting  scale. 

Water  Gem  retails  at 
around  £49.95  with  a  12- 
month  supply  of  easy-fit 
replacement  filters  at 
£29.95  for  two.  The 
replacement  filters  are 
also  compatible  with 
most  other  makes  of 
domestic  filter  systems. 
The  Water  Gem  comes 
with  a  three-year 
guarantee  for  all  parts, 
excluding  the 
replaceable  filter  and  the 
company  also  provides  a 
free  helpline  number  for 
customers.  Further 
information  on  the 
product  can  be  obtained 
by  dialling  Freefone  0800 
627627  and  asking  for 
Water  Gem. 

Aqua  Cure  pic.  Tel:  01704 

publicity  package  with  a 
pharmacy  competition 
based  on  matching  lips 
to  famous  faces.  The  first 
correct  entry  opened  on 
October  1 1  will  win  a 

midi  hi-fi  with  48 
runners-up  receiving  £30 
Marks  &  Spencer 

Dendron  Ltd.  Tel:  01923 

(MUST  &  DRUGGIST  20  JULY  1991 

•  ©  «  •  9 

From  Practice 

i  ••••»•••«  ••••••••••••••••••••••• 

Win  a 
major  prize 

Is  the  professional  service  you  offer  from  your 
pharmacy  moving  with  the  times?  If  you  can  relate 
how  you  are  forging  links  with  other  healthcare 
workers,  the  Glaxo  ^JeWcome/ Chemist  &  Druggist 
Community  Pharmacy  Award  offers  you  an 
opportunity  to  win  a  major 

he  way  primary  care  is 
delivered  is  changing 
fast.  The  demarcation 
lines     between  the 
»sffe?o,    healt  h  professions  are 
breaking  down  and  community 
pharmacy  practice  is  adapting  to 
the  changes  local  purchasing  is 

With  this  in  mind,  we  want  you 
to  tell  us  how  you  are  forging 
links  with  other  health  profes- 
sionals to  the  benefit  of  patients, 
others  in  the  primary  care  team 
and  your  own  business. 

You  can  enter  the  award  if  you 
practise  as  a  community  pharm- 
acist anywhere  in  the  UK.  You 
should  explain,  in  an  essay  of 

The  closing  date  for  entries  is 
July  31,  1996. 

The  judges 

I  00(1  woids,  how  I  he  liaison  you 
have  forged  was  conceived,  how 
it  operates  and  the  benefits  it 

The  following  examples  may 
serve  as  a  guide  to  pharmacists 
wishing  to  enter: 
®  you  may  be  liaising  regularly 
with  your  local  GP  practice  to 
provide  prescribing  advice  or 
diagnostic  services 
•  you  may  be  co-operating  with 

hospital  pharmacists  over  med- 
ication for  patients  when  they 
are  discharged 

9  you  may  operate  clinics,  eg  for 
diabetics,  or  offer  services  in 
conjunction  with  other  health 

You  may  include  practice 
leaflets,  other  relevant  literature 
and  photographs  to  support  your 
entry  and  illustrate  an  aspect  of 
the  service  you  offer. 

Entries  will  be  judged  by  a  panel 
of  five  judges.  Glaxo  Wellcome's 
Dr  Maureen  Devlin  and  C&D's 
editor,  Patrick  Grice,  will  be 
joined  by: 

@  Ian  Carruthers,  chief  execut- 
ive of  Dorset  Health  Commission 

•  Georgina  Craig,  who  is  the 

head  of  professional  devel- 
opment at  the  National  Phar- 
maceutical Association 
@  Gill  Hawksworth,  a  comm- 
unity pharmacist  and  member  of 
the  Council  of  the  Royal  Pharm- 
aceutical Society. 

The  prizes 

The  opportunity  to  attend  one  of 
the  major  conferences  or  man- 
agement courses  listed  below 
will  be  offered  to  the  three 
winning  entries. 

•  FIP  1997 

•  Career  Management  Course 
( Raeburn  &  Keslake) 

•  Managing  Teams 

( Management  Centre  Europe) 

•  Managing  People  (Manage- 
ment Centre  Europe) 

•  Strategic  Decisions  (Ashridge 
Management  Centre) 

•  ASHP  Annual  Meeting  '96, 
San  Diego,  US. 

Please  complet  e  the  entry  form  below  and  attach  it  to  the  front  of  your  entry.  Send  the  complete 
entry  to  'From  Practice  to  People',  Chem  ist  &  Druggist,  Miller  Freeman  Professional,  Miller 
Freeman  House,  Sovereign  Way,  Tonbridge,  Kent  TN9  1RW. 


Registered  Address  

Pharmacy  Address  (if  different  from  above).. 

 Postcode  Telephone. 

Prizes  in  order  of  preference: 


1  Entry  is  open  to  any  pharmacist  on  the 
Register  of  the  Royal  Pharmaceutical 
Society  of  Great  Britain  or  the  Phar- 
maceutical Society  of  Northern  Ireland, 
and  who  practises  in  the  UK. 

2  The  winning  three  entries  as 
determined  by  the  judges  will  be  offered 
the  opportunity  to  attend  a  major 
conference  or  recognised  business 
management  course  with  all  expenses 
paid.  No  cash  alternative  will  be  offered. 

3  The  closing  date  for  entries  is  July  31, 
1996.  The  Award  winners  will  be 
announced  in  Chemist  &  Druggist  on 
November  9.  Individual  winners  will  be 
notified  by  post  by  October  10. 

4  The  entry  form  below  must 
accompany  an  essay  of  up  to  1,000 
words  setting  out  how  and  why  the 
entrant  considers  the  professional 
liaison  developed  by  her  or  his 
pharmacy  practice  has  improved 
healthcare  provision  to  patients; 
benefited  the  business;  and  improved 

;  Practice  leaflets,  patient  literature, 
photographs  •  and  other  supporting 
material Tnay  be  submitted  with  the  entry. 

5  Entries  should  be  typed  or  printed. 

6,  The  entry,  and  supporting  material 
may  be  used  editorially  within  Chemist 

6  Druggist,  G&D  cannot  give  an 
absolute  guarantee  that  entries  will  be 
returned  in  their  entirety,  although 
every  effort  will  be  made  to  do  so. 

7  Winning  entrants  should  be  prepared 
tn  write  an  article  for  publication  ol  up 
to  .1,000,  words  on  the  eortference/- 
j:bu§iness  course/study  tour  they  attend. 

8  The  decision  of  the  judges  is  final.  No 
correspondence  will  be  entered  uiu>. 



Eve  Taylor  claims 



Eve  Taylor  is  launching  its 
aromatherapy  retail  product  range  to 
over  14,000  pharmacies  on  August  1. 

Pure  and  blended  essential  oils 
will  be  made  available  to  the 
pharmacy  sector  under  the  label  of 
Face  Care,  Body  Care,  Specifics, 
Bath  Oil,  Hydrogels  and 
Environmental  Fragrance.  Prices 
range  from  £4.50  for  the  facial 
cleansing  brush  to  around  £15  for  the 
environmental  fragrancing  kit. 

Face  Care  will  incorporate  five 
products,  No1  to  No5,  designed  to 
help  dry,  sensitive,  spot-prone  and 
mature  skin. 

3ody  Care  will  consist  of  three 
products,  No10  to  No12,  blended  to 
stimulate  and  relax  skin 
imperfections  associated  with  fluid 

The  Specifics  range  includes  three 
products  (301  to  303)  designed  to 
assist  the  skin  in  its  regenerative 
cycle.  Specific  303  is  recommended 
for  scar  tissue  and  stretch  marks. 

Included  in  the  Bath  Oils  range  are 
six  different  oil-blends  labelled 
stimulating,  relaxing,  toning, 
balancing,  revitalising  and  soothing. 

Produced  specifically  for  the  retail 
market  is  the  Moisturising  Hydrogel 
range  -  Corelle,  Citrelle  and  Astrelle, 
a  facial  cleansing  brush  and  an 
Environmental  Fragrancing  range. 
The  range  consists  of  four  kits 
energising,  soothing,  revite  and 
refreshing  -  designed  to  release  the 
vapour  of  blended  oils  through  a  clay 

On-going  support  for  the  launch 
includes  package  brochures  with  an 
ingredient  listing  and  application/- 
usage  chart/guide,  a  sampling 
promotion  and  free  product  training. 
Pharmacies  will  be  able  to  contact  a 
helpline  to  obtain  information  for 
guidance  on  product  specification, 
skin  problems  and  ailments. 
Eve  Taylor  (London).  Tel:  01733 

Collection  2000 

Collection  2000  has  created  Shine 
Time  2000,  a  high-fashion  look  for 
autumn  '96,  combining  shades  of 
lilac,  mauve,  pearl,  blue  and  silver. 

Fashionable  combinations  includi 
the  Eyeshadow  Trio  No  97  (SI. 29), 
which  consists  of  Mauve  Sheen, 
Merlin  and  Flamingo  Pink;  or 
Quartet  Eyeshadow  No  7!).  leal  m  ini: 
Seahaze,  Diamond  IJlue,  Light  Blue 
and  Snowflake.  A  suitable  lipstick 
for  the  look  is  ( lollection  2000  Lip 
i  daze  in  <  )rchid  <  lem  (No  7)  (SI.  15). 

( lollection  2000  products  are  nol 
tested  on  animals. 
Collection  2000  Ltd.  Tel:  01695  50078. 

From  A  to  Zinc  with  Arkopharma 

Arkopharma,  the  herbal 
medicine  manufacturer, 
has  launched  a  new  multi- 
vitamin and  mineral 
product  -  Azinc  Complex 

The  sugar-free  product 
contains  the  recommended 
daily  allowance  of  a  range  of 
vitamins  and  minerals  from 
'A  to  Zinc'.  These  include 
beta-carotene  (a  precursor  of 
vitamin  A),  vitamin  C, 
vitamin  E,  vitamin  B6,  iron, 
magnesium,  zinc,  copper, 

folic  acid  and  others.  A  pack  of 
30  capsules  retails  at  S3. 65. 

The  new  product  has  multi- 
coloured and  white  packaging 
to  ensure  on-shelf  impact. 

Arkopharma  says  the 
supplement  is  "particularly 
effective  for  tired,  stressed, 
overworked  people;  those 
who  are  slimming  and  have  an 
unbalanced  diet;  or  those  who 
are  regularly  taking  part  in 
sporting  activities". 
Arkopharma  (UK)  Ltd.  Tel:  0181 
763  1414. 

*     5  c°™  Caps 


,,ls'an/  Reset 
\    \  r\  £'fectri/e 

t  savers 
for  Profit. 

Summer  Season  Sales 

History  shows  both  you  and  your  customer  alike 
can  trust  a  product  bearing  the  Carnation  name. 
With  this  proven  heritage  Carnation  Footcare 
.'ill  help  to  make  your  sales  grow. 

•  33V3%  Profit  on  return 

•  Full  consumer  advertising 
support  throughout  peak 
season  beginning  June  '96 

75  years  of  proven  pharmacy  sales 


Avail-able  in  packs  ol  5  01  10  tram  yon 
English  Circuns  representativi 

ABRIDGED  INFORMATION.  I  EGA1  CATEGI  IRY;  I  iSI   INI  Ml  ATI!  INS:  l-oi  the  ri'iiinvnl  «l  hard.  ■  ACTIVE  INGREDIENTS:  Sain  ylu  A,  id  BP  4.'". 

PRODUC1  LICENCE  HOLDER:  I  uxson  I  Icrrard  &  I   pany  I  imiU'd,  125  IWtwi-ll  R.»id, '  >l.ll.ury,  Warley,  VK-m  Midland*,  B6l)  4BI  li-l  0121  544  7117 





Strong  growth  in 
sun  care  sales 

The  growing  number  of 
people  taking  sun 
holidays,  and  the  hot 
summers  we  have 
experienced  in  recent 
years  here  in  Britain,  have 
contributed  to  strong 
growth  in  the  sun  care 
market,  thought  to  be 
worth  £136  million. 

A  new  market  report 
from  Datamonitor  reveals 
that  increased  growth  is 
coming  from  new  product 
developments,  particularly 
in  the  high-protection  area, 
and  that  high  sun  protec- 
tion factor  (SPF)  items 
have  increased  their  share 
of  the  sun  care  market.  Sun 
protectors  with  an  SPF  of  7 
and  above  now  account  for 
48  per  cent  of  the  sun 
protection  segment,  while 
the  share  of  SPF  0-3s  has 
almost  halved  from  15.5  per 
cent  in  1991  to  its  presents 
per  cent. 

L'Oreal's  Ambre  Solaire 
is  the  market  leader  with 
a  5  per  cent  lead  over 
Boots'  Soltan. 

UK  Skincare'  is 
available  at  a  price  of 
£495  from: 

Datamonitor  Europe.  Tel: 
0171  625  8548. 

Dazzling  campaign  for  Colgate  Platinum 

Colgate-Palmolive  is 
adopting  a  dazzling 
white  theme  for  its 
integrated  PR  and 
press  campaign  for 
Colgate  Platinum,  its 
whitening  toothpaste. 

All  the  activity  is 
being  targeted  at  women 
and  includes 
advertorials  in  high- 
profile  women's  titles, 
such  as  Vogue,  Marie 
Claire,  Cosmopol  ita  n 
and  Elle.  The 
advertorials  focus  on  the 

"whitening  benefits 
which  combine  with  the 
great  taste  to  promise  a 
pearly  white,  confident 

New  2  in  1  available  for  Synergie 

Synergie  is  building  on  its 
success  in  the  cleansing 
market  with  the  launch 
of  a  new  combination 
cleanser  and  toner. 

Synergie  Refreshing 
Gentle  Cleanser  Milk  + 
Toner  offers  the 
efficiency  of  a  milk  and 
the  benefits  of  a  toner 
in  a  one-step, 

The  active  ingredients 
inc  lude  mango  oil,  rich  in 
essential  fatty  acids, 
which  is  easily  absorbed 

by  the  skin  to  soften  it. 
Vitamin  E  is  added  for  its 
antioxidant  properties, 
which  the  company 
claims  helps  protect  the 
fatty  membranes  of  the 
cells,  delaying  the 
appearance  of  fine  lines 
and  wrinkles. 

Synergie  Refreshing 
Gentle  Cleanser  Milk  + 
Toner  is  available 
nationwide  from  August, 
retailing  at  S3. 19  for  a 
200ml  pack. 

Laboratoires  Gamier.  Tel: 
0171  937  5454. 

Rapping  with  Ricola:  going  Alpine  in  Atlanta 

Ricola,  the  medicated 
herbal  confectionery 
brand,  is  spending  £5 
million  on  marketing 
support,  which  kicks 
off  this  summer  with 
a  heavyweight  tele- 
vision campaign  set 
to  run  throughout 
Eurosport's  satellite 
coverage  of  the  forth- 
coming Olympics. 

Valued  at  SI. 6m, 
the  initial  Olympic 
campaign  will  be 
televised  daily  bet- 
ween July  20  and 

August  4,  and  is  expected 
to  reach  1.2  million 
adults  every  day.  The  ad, 
featuring  a  futuristic  rap 

group  who  solve  their 
vocal  problems  with 
sugar-free  Ricola,  is  a 
departure  from  the 
traditional  Alpine 

Ot  her  marketing 
support  includes 
public  relations 
activity,  point  of  sale 
material  and  space- 
saving  pre-packed 
counter  display  units, 
available  from 
leading  wholesalers. 
Cedar  Health  Ltd.  Tel: 
0161  483  1235. 

Braun  improves  comfort  factor  d  !!kpi!  system 

Next  month,  Braun  is 
launching  a  further- 
improved  Silk-epil  hair 
removal  system,  called 
Silk-epil  Comfort,  which 
combines  two  new 
product  features  for 
enhanced  comfort. 

Smaller  tweezers  are 
designed  to  provide 
gentler  epilation  by  only 
gripping  the  hair  to  be 
removed,  avoiding  the 
unnecessary  pulling  and 

dragging  of  the 
surrounding  hair  and 

Bigger  feed-in  combs 
smooth  a  larger  area  of 
the  skin  in  preparation  for 
the  treatment,  which  also 
enhances  comfort. 

Silk-epil  Comfort  EE110 
for  Legs  (£49.99)  offers  a 
choice  of  four  settings, 
adjustable  tweezer  grip 
for  normal  or  delicate 
hairs  and  Silk-epil  After 

Epilation  Moisturising 

The  Silk-epil  Comfort 
Body  System  (£49.99),  an 
extension  of  the  leg 
system,  is  an  epilator  with 
an  interchangeable  head. 
The  tweezers  can  be 
replaced  by  a  shaver  for 
use  on  more  sensitive 
areas,  such  as  the  bikini 
line  or  under  the  arms. 
Braun  (UK)  Ltd.  Tel:  01932 

smile  and  fresh 

Supporting  the 
advertorials,  press  ads  in 
the  same  premium  titles 

use  a  fashion  theme  to 
convey  the  'teeth  have 
never  been  so  white' 
message.  Models 
dressed  in  expensive 
white  designer  clothes 
wear  an  affordable  white 
smile  attributed  to 
Colgate  Platinum. 

To  ensure  the  'white' 
message  hits  home, 
cinema  and  video 
advertising  will  run 
through  July  and  August. 
Colgate-Palmolive  Ltd. 
Tel:  01 483  302222. 

Chocolate  selection  from  Bourjois 

The  autumn/winter  colour 
collection  from  Bourjois 
is  a  palette  of  chocolate- 
coloured  shades  for  eyes, 
cheeks,  lips  and  nails. 

Available  from 
September  4,  the  Bruns 
D'Automne  collection 
spans  the  spectrum  from 
Beige  Rose  Pastel 
Lumiere  Eyeshadow 
(£3.95),  a  light  iridescent 

beige,  to  Pastel  Naturel 
Matt  Eyeshadow  in  new 
Chocolat  (£3.95),  a  rich 
mocha  brown. 

New  shades  in  Pastel 
Joues  Blusher  (£4.75)  are 
Chatagne  Doree,  a 
shimmery  bronze  brown, 
and  Santal,  a  coco  brown 
with  a  hint  of  iridescence. 
Bourjois  Ltd.  Tel:  0171  436 


Alberto-Culver  V05:  STV,  C,  A,  HTV,  W,  C4  +  satellite 

Alka-Seltzer:  GMTV,  C4  +  satellite  

Andrews:  All  areas 
Aquafresh  toothpaste:  All  areas 
Centrum:  All  areas 

Colgate-Palmolive  Soft  &  Gentle:  All  areas 

Colpermin:  M 

Gentle  Touch:  All  areas 

Dettol  Antiseptic  spray:  All  areas,  except  CTV,  C4,  TSW 
Gentle  Touch:  All  areas 

Gillette  Natrel  Plus:  All  areas,  except  LWT  and  GMTV 
Hedex  Ibuprofen:  All  areas 

Macleans  Bicarbonate  of  Soda  toothpaste:  All  areas 

Nicotinell  gum  (trial  pack):  STV,  B,  G,  Y,  HTV,  LWT,  TT,  C4 

Nurofen:  All  areas  

Oil  of  Ulay:  All  areas  

Pantene:  All  areas,  except  GMTV 

Radox  Wheatgerm:  All  areas  

Rimmel:  All  areas,  except  U  

The  Wrigley  Company/Sugar  Free  Brands:  All  areas 

Total:  All  areas  

Wella  Experience:  All  areas,  except  CTV  

Wrigley's  Orbit  (Improved):  All  areas  

GTV  Grampian,  B  Border,  BSkyB  British  Sky  Broadcasting, 
C  Central,  CTV  Channel  Islands,  LWT  London  Weekend, 
C4  Channel  4,  U  Ulster,  G  Granada,  A  Anglia,  CAR  Carlton, 
GMTV  Breakfast  Television,  STV  Scotland  (central), 
Y  Yorkshire,  HTV  Wales  &  West,  M  Meridian,  TT  Tyne  Tees, 
W  Westcountry 



...In  fact,  a  massive  £1.7  million  in  only  six  months 

We're  investing  hugely  in  the  Blistex  brands 
throughout  the  6  months  from  September 
'96  with  a  lipsmackin'  campaign  including... 


ceptional  national  cinema  commercial  with  'The  Kiss  of  Life  for  Lips'  theme 

citing  heavyweight  press  campaign  in  the  young  female  magazines  with 
stunning  full  page,  high-visibility  ads. 

tremely  impactful  point-of-sale  including  eye-catching  window  displays. 

All  this  adds  up  to  a  major  Xtra  push  for  Blistex  -  giving  a  new 
Kiss  of  Life  to  your  profits! 

For  moisture,  protection  and  everyday  lipcare 


Drugs  in  sport 

How  some  formulations  can  be 
abused  to  enhance  performance 

Remember  the  1988 
Olympics  being 
overshadowed  by  the 
discovery  that  the 
world's  fastest  man,  Ben 
Johnson,  had  anabolic 
steroids  to  help  him 
across  the  finishing  line? 
Well,  in  this  Olympic 
year,  Glasgow 
community  pharmacist 
Stephen  Kayne  takes  a 
look  at  what  is  and  isn't 
banned  for  athletes 

The  use  of  performance 
enhancing  drugs  in  sport  is 
not  new.  In  1865,  canal 
swimmers  in  Amsterdam 
were  accused  of  taking  a 
mixture  of  heroin  and 
cocaine,  and  in  the  early 
years  of  this  century  alcohol 
and  strychnine  were  taken  by 
boxers  and  a  marathon 

Top  athletes  are  often  so 
caught  up  with  striving  for 
that  extra  margin  of  success 
that  they  may  resort  to  any 
method  that  seems  to  bring 
this  goal  nearer.  In  some 
countries,  drug  abuse  in  sport 
may  be  routinely 
incorporated  in  elite  training 

At  the  British 
Pharmaceutical  Conference  in 
London  two  years  ago,  the 
audience  sat  spellbound  as  an 
East  German  doctor 
systematically  catalogued  the 
programme  of  drug  abuse 
that  had  been  promoted  by 
the  authorities  in  his  country 
before  the  fall  of  communism. 
He  explained  the  practice  of 
'drug  holidays'  where  athletes 
ceased  to  take  drugs  at  set 
periods  before  competition  so 
that  the  risk  of  detection  was 

Much  of  the  initial  work  on 
drug  testing  in  sport  was 
accomplished  by  a 
pharmacist-run  laboratory  at 
King's  College,  London, 
where  an  International 
Olympic  Committee- 

^  Needle  exchange  ^  Research  digest 

Pharmacy-based  needle  exchange  (IffS      Predicting  incorrect  inhaler  te 

Pharmacy-based  needle  exchange 
schemes  come  under  scrutiny  IV 

Jicting  incorrect  inhaler  technique  to 
reduce  morbidity  and  mortality  VII 

accredited  drug  testing 
service  is  provided  for  many 
national  and  international 

Of  the  many  classes  of 
drugs  available  only  a  relative 
few  have  been  implicated  in 
enhancing  performance  or 
masking  the  use  of  banned 
drugs,  and  consequently 
placed  on  a  banned  or 
restricted  list  by  the  IOC.  Here 
are  some  of  the  more  widely- 
abused  drugs. 



Amphetamine  sprays  were 
originally  prescribed  for  the 
treatment  of  nasal  congestion 
(through  vasoconstriction). 
They  are  powerful  central 
nervous  system  stimulants 
and  have  been  taken  to 
increase  the  heart  rate  and 
allay  inhibition  before 
competition.  Amounts  of  14- 
21mg  of  amphetamine 
administered  two  to  three 

hours  before  an  event  have 
been  shown  to  improve 
performance  in  three-quarters 
of  a  sample  of  swimmers, 
runners  and  weight  throwers  . 

The  drug  causes  blood  to 
flow  from  the  skin  and  is 
particularly  dangerous  during 
intense  exercise  in  hot 
climates.  There  are  numerous 
reports  of  cyclists  suffering 
fatalities  after  taking 

Amphetamines  have  largely 
been  replaced  in  sport  by 
cocaine,  the  regular  use  of 
which  can  lead  to  anxiety, 
agitation,  insomnia  and, 
ultimately,  coronary  occlusion 
and  death. 

Adrenaline  and  the 
ephedrine  and  isoprenaline, 
are  also  considered  to  be 
stimulants  and  are  banned. 

These  compounds  have 
many  therapeutic 


This  course  (module  22),  in 
association  with  multiple 
choice  questions  being 
published  in  c&d  august 
10,  provides  1  hour  of 
continuing  education 


To  be  aware  of  the  problem 
of  drug  abuse  in  sport 

To  recognise  drugs  on  the 
banned  or  restricted  list 

To  understand  how  drugs  can 
enhance  performance  in  sport 

To  be  aware  of  OTC  banned' 
and  allowed'  drugs 

applications,  notably  in  the 
treatment  of  asthma,  and 
together  with  some  of  their 
derivatives  (for  example, 
pseudoephedrine  and 
phenylpropanolamine,  etc) 
are  often  present  in  the 
formulas  of  OTC  medicines, 
too  -  Aller-eze  Plus,  Lemsip 
Cold  Relief  and  Day  Nurse  all 
contain  banned  ingredients. 

Salbutamol  and  terbutaline 
are  permitted,  subject  to 
written  notification  by  the 
team  physician,  but  they  may 
only  be  administered  by 
aerosol.  Sodium 
cromoglycate,  used  mainly  to 
treat  allergic  asthma,  is  also 

Caffeine  produces  a  mild 
central  stimulation.  Maximum 
urinary  levels  of  12mg/ml  are 
set  by  the  IOC. 

The  drug  is  claimed  to 
counteract  the  reduction  in 
performance  caused  by 
fatigue  and  is  popular  in 
rallying,  particularly  at  night. 
It  is  thought  to  work  by 
enhancing  fat  utilisation,  thus 
sparing  glycogen  '.  As  few  as 

Continued  on  Pll 

CHEMIST  &  DRliWilST  20  JULY  1996 


Continued  from  PI 

four  cups  of  filter  coffee  or  six 
cans  of  a  famous  cola  drink 
may  cause  a  positive  dope 

Anabolic  steroids 

First  used  in  1954,  anabolic 
steroids  are  mainly 
alternatives  to  the  natural 
male  hormone  testosterone. 
They  are  designed  to  separate 
the  anabolic  and  androgenic 
features  of  the  hormone  and 
to  improve  its  availability. 

The  drugs  achieved 
spectacular  notoriety  at  the 
Seoul  Olympics  in  1988  when 
Ben  Johnson's  gold  medal 
was  withdrawn  after  he  tested 
positive  for  stanozolol. 

Anabolic  steroids  constitute 
nearly  half  of  all  positive 
samples  detected  by  IOC- 
accredited  laboratories.  They 
are  used  to  increase  muscle 
mass,  especially  in  the 
presence  of  high  protein 
intake,  as  well  as  improving 
power  and  speed  after 
intense  physical  training. 

There  is  some  discussion  as 
to  whether  they  act  directly 
on  muscle  tissue  or  whether 
they  encourage  muscle 
development  indirectly  by 
helping  prolonged  exercise. 
Performance  may  be 
enhanced  by  increased 
erythrocyte  formation 
allowing  an  increased  oxygen 

Side-effects  include  hepatic 
malfunction,  coronary  heart 
disease,  cancer,  sterility  and 
uncontrolled  aggressive 

An  increased  incidence  of 
tendon  damage  has  also 
been  noticed  among  athletes 
taking  anabolic  steroids  due 
in  part  to  competitors 
neglecting  accepted 
techniques  within  their 
chosen  sport. 

Clenbuterol  is  a  banned 
compound  related  to  the 
anabolic  steroids  that  was  'in 
fashion'  for  a  time.  It  has 
been  shown  to  stimulate  the 
deposition  of  body  protein  in 

However,  drug  testing  has 
not  proved  to  be  foolproof. 
British  athlete  Diane  Modhal, 
who  originally  tested  positive 
for  testosterone,  was  later 
cleared  because  of  possible 
false  results  due  to 
degradation  of  sample. 


These  drugs  are  used  to 
lower  blood  pressure  and 
slow  the  heart  rate.  Although 
they  reduce  the  ability  to 
perform  physical  exercise 
and  are  therefore  not  the 
subject  of  drug  testing  in 

endurance  events,  they  help 
allay  anxiety  and  steady  the 
nerves,  and  therefore  may 
help  competitors  in  archery, 
darts,  shooting,  bowls  and 
snooker.  Side-effects  include 
cold  extremities,  fatigue  and, 
in  extreme  cases,  heart 


Diuretics  are  sometimes  used 
where  a  specific  weight  is 
needed  -  for  example,  with 
jockeys  and  boxers.  Diuretics 
shed  weight  quickly  by 
excessive  water  loss  and  by 
acting  as  a  blocking  agent  to 
dilute  urine  and  therefore 
prevent  detection  of  drugs  in 
other  sports.  Compounds 
such  as  acetazolamide, 
amiloride  and  triamterene  are 

Narcotic  analgesics 

Included  in  this  class  are  a 
number  of  drugs  related  to 
morphine.  They  are  used  as 
moderate  to  severe 

The  IOC  Medical 
Commission  believes  there  is 
evidence  that  these 
compounds  have  been 
abused  in  sport  and,  as  there 
are  many  other  non-narcotic 
drugs  available,  they  should 
be  banned.  Over  the  counter 
products  containing  codeine 
should  not  be  offered  to 

Most  of  these  drugs  have 
major  side-effects,  including 
respiratory  depression  and 
Dextromethorphan  and 
pholcodine  are  not  banned 

and  can  be  used  as 

Peptide  hormones 

Human  growth  hormone 
(hGH)  is  naturally  produced 
by  the  body  to  invoke 
maturation  and  physical 
development.  It  is  now 
produced  synthetically  and 
may  be  used  to  increase  body 
mass.  Some  male  athletes 
use  hGH  to  stimulate 
testosterone  production, 
increasing  aggression  and 
competitiveness.  As  yet  it  is 

A  reverse  approach  is  to 
use  brake  drugs,  which  are 
generally  hormonal  and  are 
used  to  block  physical  and 
sexual  maturation.  They  are 
very  popular  with  female 

Other  banned  substances 
include  human  chorionic 
corticotrophin  (ACTH)  and 
erythropoietin  (EPO). 

The  latter,  a  genetically- 
engineered  substance, 
mimics  the  effects  of  training 
at  high  altitude  by  regulating 
the  synthesis  of  erythrocytes, 
but  in  excess  can  cause  fatal 
blood  clots.  Five  years  ago, 
the  drug  was  blamed  for  the 
death  of  18  German  cyclists 
from  circulation  problems. 

The  drug  disappears  rapidly 
from  the  body  and  detection 
has  proved  difficult  in  the 
past,  but  recently  a  new  test 
has  been  announced. 

Other  drugs  are  subject  to 
certain  restrictions.  For 
example,  alcohol  and 
marijuana  are  not  banned, 

Table  1:  an  example  of  a  homoeopathic  sports  first  aid  kit 

Abrasions-  superficial: 

Calendula  ointment/cream 

Anxiety,  excitement: 

Aconite  (terror),  Arrogant  nit  (anxiety) 

or  Gelsemium  (worry) 


Arnica  ointment 

Colds  and  flu: 

Gelsemium,  Nelson's  Coldenza, 

Weleda's  Infludo 


Bryonia  cough  linctus  (Nelson's) 


Argent  nit  (from  anxiety),  Arsen  alb 


Insect  bites: 

Apis  (stings)  or  Ledum  (bites)  tablets 

or  pyrethrum  spray 

Mental  and  physical  tiredness:  Arnica 

Motion  sickness: 

Cocculus  (or  Nelson's  travel  sickness 


Soft  tissue  injuries: 

Ruta  tablets  or  ointment 


Cantharis  tablets  (or  Nelson's  Burn 



Arnica  tablets 

but  the  presence  of  both  can 
be  tested.  There  are 
restrictions  on  the  use  of  local 
anaesthetics  and 

Pharmacy  advice 

Pharmacists  must  be  vigilant 
when  recommending  OTC 
remedies.  This  is  particularly 
important  for  elite  and  sub-elite 
athletes  who  may  be  subject  to 
drug  testing  during  training,  as 
well  as  competition. 

Sports  Councils  in  the  UK 
produce  handy  cards  listing 
the  banned  classes  of  drugs 
with  examples,  and  a  supply 
is  available  for  customers. 
There  is  also  a  compre- 
hensive guide  available, 
entitled  'Drugs  and  Sport'.  It 
details  all  the  banned  and 
permitted  products. 

Another  solution  is  to 
recommend  complementary 
remedies.  The  Sports  Council 
warns  that  some  herbal 
preparations  may  contain 
banned  substances  from 
naturally-occurring  plants.  For 
example,  ginseng  root  does 
not  contain  banned 
substances,  but  it  is  known 
that  marketed  tablets  (tablets, 
solutions,  teas,  etc)  bearing 
the  name  'ginseng'  may 
contain  other  undeclared 
ingredients,  such  as 
ephedrine.  The  Olympic 
sprinter  Linford  Christie  took 
ginseng  some  years  ago  and 
subsequently  tested  positive 
for  a  banned  substance. 

There  is  no  requirement  for 
a  comprehensive  listing  of 
ingredients  in  nutritional 
supplements  making  it 
difficult  to  determine  whether 
doping  regulations  are  liable 
to  be  breached. 

No  such  risk  is  involved  in 
recommending  homoeopathic 
remedies  and  they  are  not 
subject  to  any  IOC  controls. 
There  is  a  range  of  about  30 
generic  remedies  known  as 
'polychrests'  that  have  a  wide 
spectrum  of  activity  and  can 
be  administered  to 
sportspersons  safely  and 
effectively,  without  affecting 
any  concurrent  or  subsequent 
treatment.  Table  1  offers 
some  suggestions  for  treating 
common  problems. 

Discussions  are  in  progress 
with  the  British  Association  of 
Sports  Medicine  to  identify 
how  pharmacists' 
contribution  to  sports  care 
can  be  increased. 

References  available  on 

C&D  is  accredited  by  the 
College  of  Pharmacy  Practice 
as  a  provider  of  distance 
learning  material  until 
December  31,  1997. 


CHEMIST  ft  DRUGGIST  20  JULY  1996 

^  o  re  2  ^  5  7  ' 

j  ™  s  I  \ 

>  »  £  _  5  o  g1 

;  1 1  s  §  s  f 

I  Ifllfa 

l  s  ™  a  s  s  g  °  ' 

^J:  ^  c  II  c  j|  ] 

3  u 

a  ~»  Sc  E 

QJ  O  V  _  ^ 

?=  "s  ei  a ! 

:  1  3  5  2  ?  5 


i  If lif| ] 

!  S  c  8  I  „,  I 

!  i  E  £  5  5  S» 
!  a || 8  3  f  g 

v  *  E 


!  a-E  if>  -  o  T 


p  c  £  <u  ^  - 

■    '  D 

a ;  ? 

1=*? §1=11 i 

6  oj  ct11'  I 

^  -  i  s  ■ 

I  S  E  g 


Amiloride  HCl  Oral  Solution,  5mg/5ml,  Sugar  Free 

New  from  Rosemont! 


Potassium  Sparing  Oral  Liquid 

Now,  when  you  have  a  patient  who 
requires  a  potassium  sparing  diuretic,  hut 
finds  it  hard  to  swallow  tablets,  you  can 
offer  them  a  solution  ■  Ajtiilamont 

This  is  the  latest  addition  to  the 
Rosemont  range  of  oral  liquids,  and  is 
another  unique  product,  being  Britain's 
only  licenced,  single  ingredient, 
potassium  sparing  diuretic,  in  oral  liquid 

Like  many  of  Rosemont's  products, 
Amilamont™  is  sugar  free,  to  help 
protect  patients'  teeth,  it  is  suitable  for 

Rosemont's  Specials  Service 

Under  our  specials  licence  we  are  able 

to  offer  you  bespoke  oral  liquids, 
covering  a  wide  range  of  therapeutic 
areas  in  a  variety  of  strengths 
and  sizes. 

Naturally,  the  products  from  our 
Specials  Service  are  made  to  lull 
pharmaceutical  standards,  and  are 
analysed  and  tested  to  ensure  correct 
and  consistent  quality. 

These  products  can  be  supplied  in  as 
little  as  24  hours  upon  request. 

Just  call  us  on  our 

0800  919312 

diabetics  and  is  pleasantly  flavoured  to 
keep  patients  happy  as  well  as  healthy. 

Right  Strength,  Handy  Size 

Amilamont™  is  at  a  strength  of 
5mg/5ml,  making  if  easy  to  administer  a 
standard  dose*.  It  is  available  in  a  handy 
125ml,  tamper  evident  bottle,  from  all 
major  wholesalers 

With  Amilamont™  added  to  the 
licenced  liquid  range,  Rosemont 
continues  to  give  pharmacists  a  lop 
quality  way  to  treat  patients,  without 
taking  unnecessary  responsibility.. 

*BNF  March  IHflli 

Filled  with  confidence! 

As  Britain's  oral  liquid  ROSGITIOnt'S 

medicine  specialists,  Rosemont  -  ■    -  - 

are  keeping  at  Hie  forefront  of  HGW  rllCfll  Sp00O 
production  technology.  DrOdUCtiOII  line 

Rosemonl  has  installed  a  complete  new 
filling  line  as  part,  of  the  multi-million 
pound  improvement  to  their 
manufacturing  facilities.  High  speed 
bottle  filling  is  combined  with  optimal 
precision  to  volume,  ensuring  that  high 
quality  liquids  are  processed  into  ready 
to  use  products  with  the  latest 

Staff  are  sent,  to  Germany  and  Italy  for 
training  in  the  operation  and  servicing  of 
one  of  the  most  modern  filling  lines 
currently  in  use  in  the  UK. 

This  major  investment  is  part  of 
Rosemont's  ongoing  development, 
programme,  designed  to  ensure  that,  they 
will  continue  to  offer  pharmacists  and 
patients  the  very  finest  range  of  oral 
liquid  medicines  in  the  country. 

<  M  % . 

The  new  compounding  fj|jp| 
and  filling  line  at- 


Current  oral  liquid  medicines  in  the  Rosemont  range,  fully  licenced  and  prepared  to 
the  highest  quality  standards: 

•  Nuslamont™  Nystatin  Oral  Suspension,  100,000iu/ml,  Sugar  Free  -  PL  0427/0)01 

•  Temazepam  Oral  Solution  10mg/5ml,  Sugar  Free  -  PL  0427/00X9 
IBB '   IfE     •  Miihadose1"  Methadone  Oral  Concentrate,  lOmg/ml.  Sugar  Free  ■  PL  0427/0098  Ais         ,,  I:    ■  >  „         /  • 
WKtJ^^   '  Amilamonl'  '  Amitoritlv  IICI  Oral  Solitlioi,    inig/tiiul.  Sugar  Free  -  PL  0427/0091  //Of/    ((til    I' ('  I  If  (HI 

Rosemont  Pharmaceuticals  Ltd., 

Rosemont  House,  Yorkdale  Industrial  Park,  Braithwaite  Street,  Leeds  LSI  1'  9XE  Telephone:  (01 13)  244  1400  Fax:  (01 13)  246  071 


wop  shop 

Pharmacy  needle  exchange  schemes  are  now 
widespread  thanks  to  their  role  in  reducing  the 
transmission  of  HIV  among  injecting  drug  abusers. 
Dr  Rod  Tucker,  a  community  pharmacist  and  director 
of  the  Freelance  Needle  Exchange  scheme  in  North 
East  Lincolnshire,  investigates  how  pharmacists  can 
make  the  most  of  the  scheme 

N'eedle  and  syringe 
exchange  is  simply  a 
scheme  enabling  injecting 
drug  users  to  obtain  free 
sterile  needles  and  syringes 
in  exchange  for  their  used 

Exchange  schemes  were 
originally  established  in  1984 
in  Amsterdam,  not  in 
response  to  the  emerging 
AIDS  epidemic,  but  to  the 
growing  problem  of  hepatitis 
B  among  drug  injectors. 

Although  the  HIV  virus  had 
been  isolated  as  early  as 
1981,  little  was  known  about 
its  mode  of  transmission. 
However,  in  1983,  blood 
samples  taken  from  drug 
injectors  in  Edinburgh  were 
the  first  to  show  positive 
antibodies  to  the  HIV  virus' 
and  studies  of  drug  injectors 
have  since  found  that  the 
microtransfusion  of  blood 
which  occurs  when  drug 
injectors  share  syringes  poses 
a  significant  risk  for  the 
transmission  of  the  virus234. 

Moreover,  it  is  known  that 
injectors  will  share  spoons, 
filters  and  bowls  of  water,  and 
communal  use  of  such 
paraphernalia  is  thought  to 
pose  a  risk  in  the 
transmission  of  the  virus5. 

Government  policy 

The  UK  Government 
responded  quickly  to  the 
issue  of  HIV  prevention  and, 
in  1987,  exchange  schemes 
were  officially  launched.  The 
remit  of  these  exchange  sites 
was  to  issue  injecting  drug 
users  with  sterile  syringes,  on 
an  exchange  basis,  so  that 
used  injecting  equipment 
could  be  disposed  of  safely. 
Before  this  official  launch, 
schemes  to  supply  drug 
injectors  with  clean  syringes 
had  already  been  running 
through  various  drug 

In  Liverpool,  some 
pharmacists  were  distributing 
free  needles,  syringes  and 
condoms,  and  were  accepting 

back  used  syringes  for  safe 

The  sale  of  syringes  by 
pharmacists  to  known  or 
suspected  drug  misusers  was 
initially  denounced  by  the 
Royal  Pharmaceutical  Society 
which,  in  1982,  had  issued  a 
Council  statement  stipulating 
that  sales  of  syringes  should 
only  be  permitted  for  bona 
fide  customers  for  therapeutic 
purposes.  However,  by  1986 
the  Society  had  lifted  this 
restriction  and  issued 
guidelines  for  pharmacists 
wishing  to  become  involved 
in  exchange  schemes8. 

Aims  of  the  scheme 

In  response  to  the  growing 
AIDS  epidemic,  the  mid-1980s 
saw  a  wider  acceptance  of  the 
concept  of  harm 
minimisation.  This 
represented  a  pragmatic 
approach  to  drug  misuse  and 
involved  two  basic  tenets: 
reduce  the  risk  to  the 
individual  who  injects  drugs 
and  minimise  the  harm 
associated  with  the  misuse  of 

In  the  context  of  harm 
minimisation,  needle 
exchange  schemes  are 
considered  to  be  more  than 
simply  a  means  of  supplying 
clean  injection  equipment. 
They  are  a  strategic  response 
to  the  potential  rise  in  the 
prevalence  of  AIDS  and  a 
means  of  making  contact  with 
as  many  drug  injectors  as 
possible  in  an  effort  to 
change  their  AIDS-related  risk 
behaviour,  such  as  sharing 
syringes  and  filters,  for 

To  achieve  this  aim, 
exchange  schemes  need  to  be 
in  a  position  to  offer  a  wide 
range  of  drug  paraphernalia, 
such  as  medicated  swabs, 
tourniquets,  sterile  water  and 
filters.  During  the  past  ten 
years,  exchange  schemes 
have  become  accepted  as  an 
important  harm  reduction 


This  course  (module  23),  in 
association  with  multiple 
choice  questions  being 
published  in  c&d  august 
10,  provides  1  hour  of 
continuing  education 

Pharmacy-based  exchange 
schemes  are  designed  to  be 
complementary  to  the 
services  offered  by  drug 
agencies  and  should  be 
viewed  as  a  means  of  making 
contact  with  a  large  number 
of  clients  and,  if  necessary, 
referring  those  clients  to  drug 
agencies  where  there  is 
access  to  advice  and 
counselling  about  their  drug 

There  are  several  reasons 
why  pharmacies  should 
provide  needle  exchange 
services.  Accessibility  and 
anonymity  are  key 
advantages  of  community 
pharmacies.  Much  of  the 
early  needle  exchange 
research  found  that  drug 
injectors  would  not  travel  any 
great  distance  to  obtain  their 
syringes  or  'works'  and  many 
clients  still  feel  there  are 
barriers  to  using  agency- 
based  exchange  schemes. 

Pharmacies  also  tend  to 
have  longer  opening  hours 
and  many  are  open  on 
Sundays.  Moreover, 
pharmacists  are  available  to 
offer  advice  about  general 

O  To  understand  the  principles 
of  needle  exchange  schemes 

To  be  aware  of  Government 
support  for  such  schemes 
C  To  recognise  how  schemes 
can  be  put  into  practice 

To  recognise  the  aims  of  a 
pharmacy-based  scheme 

To  appreciate  the  associated 
moral  and  ethical  dilemmas 

health  matters  and,  provided 
they  respond  to  drug  injectors 
in  the  same  way  as  any  other 
customer,  a  degree  of  trust  is 
soon  built  up. 


Pharmacy  needle  exchange 
schemes  are  now  widespread 
in  the  UK  and  the 
Pharmaceutical  Services 
Negotiating  Committee  has 
information  about  schemes  in 
over  60  unitary  health 
authorities",  though  in  theory 
every  authority  has  funding 
available.  The  pharmacy 
schemes  are  often  co- 
ordinated by  a  local  drug 
agency,  but  in  some  areas  the 
health  authority  will  appoint  a 
needle  exchange  worker.  This 
is  sometimes  a  pharmacist 
who  can  visit  pharmacies 
with  training  and  advice. 

Alternatively,  as 
pharmacists  are  the  providers 
of  exchange  services,  it  would 
seem  logical  for  them  to 
amalgamate  and  co-ordinate 
the  needle  exchange  scheme 
themselves.  This  latter  option 
is  the  model  for  the  Freelance 
needle  exchange  scheme  in 
North  East  Lincolnshire.  The 
scheme  is  managed  by 

Continued  on  PVI  ► 


CHEMIST  &.  DRUGGIST  20  JULY  1996 

Excessive  perspiration  is 
deeply  embarrassing  and 

now  we're  telling 
everyone  about  it?9 

What    if   you    couldn't    find  an 

As  many  as  26%  of  all  women  asked 

antiperspiranl  that  worked?  What  if  were  interested  in  buying  a  product 

you  went  on  sweating  so  much  successfully  used  by  doctors'  -  if  it 

that  before  the  day  was  out  you  was  available  from  their  pharmacist, 

needed  a  change  of  clothing?  This  is  Clearly  the  market  is  there,  and 

the  reality  for  a  surprising  number  Driclor  Solution  is  ihe  brand  to 

of  people,  as  a  recent  Gallup  survey  reach  it      especially  once  our 

found.  In  fact,  11%  of  the  women 

edia  campaign  begins  this 

they  spoke  to  were  frequenth  forced      summer.  \s  a  c 


to  change  clothes  or  <o\er  up  ^ 

to  avoid  the  embarrassme 

Kcessive  perspiration. 
The  level  of  dissatisfaction 
with  existing  antiperspirants 
might  also  surprise  yon. 



(Ontmrc  Aluminium  Chloride  Htunhydiolo 

A  major 
advance  in 
the  treatment 
of  excessive 

Driclor  Solution  provides  long 
term  control  of  excessive 
perspiration,  and  even  works 
for  problem  sweaty  feet. 
Every  pharmacist  should 
stock  it.  Now  more  than  ever. 





Pharmacy  only  clinical  anli|>ci  s|>ii  ayS 

Presentation:  Solution  \ctlvc  ingredients:  Aluminium  Chloride  Hexahydrate  USP  areas  are  completely  «ir\  before  application   Do  noi  apply  Driclor  to  broken, 

20%  w/w  Uses:  Driclor  is  Indicated  for  the  treatment  of  hyperhldrosis  (excessive  Irritated,  or  recent l>  shaven  skin   Dru  inr  may  r.-msc  irritation  which  maj  be 

perspiration)  Dosage  and  administration:  Apply  Driclor  lasi  thing  al  night  after  alleviated  by  the  use  ol  a  weak,  corticosteroid  cream   \void  contact  with  the  eyes, 

drying  the  affected  areas  carefully  Wash  oil  in  the  morning.  Do  noi  re-applj  the  There  are  no  restrictions  on  1 1 ■  < -  use  ui  Driclor  during  pregnancy  or  lactation.  Avoid 

^1  product  during  the  day  Initially  the  product  may  be  applied  each  contact  with  clothing  and  polished  metal  surfaces.  Product  Licence  Number: 

5TIEFEL     rii^hl    until   sweating  slops  during  the   day.    Frequency   of  0174/004'!    Pack  si/e  and  Retail  Selling  Price:  30ml  bottle.  £4.75.  Legal 

\  application  may  then  be  reduced  to  twice  a  week  or  less  category:  P.  Date  ol  preparation:  March  1995  Stiefel  Laboratories  (I'M  Ltd., 

fterarch  in  Dermatology  Contra-indieations,  warnings  etc:  Ensure  that  the  affected  llollspur  Lane.  Wooburn  Green,  High  Wycombe,  Bucks,  11P10  0AU. 



J  Continued  from  PIV 

myself  and  another 
pharmacist  and  we  were 
successful  in  our  bid  for  the 
needle  exchange  services 
which  were  put  out  to  tender 
in  1993.  Today,  we  have 
ultimate  control  over 
providing  needle  exchange 
services  in  the  region,  liaising 
closely  with  the  local 
substance  misuse  agency  and 
providing  training  for 
pharmacists  and  information 
for  exchange  clients. 

The  range  of  possible 
equipment  that  can  be 
supplied  through  pharmacy 
exchange  schemes  is  listed  in 
Table  1.  Some  pharmacies 
supply  syringes  loose  while, 
in  other  areas,  equipment  is 
supplied  prepacked. 

Few  of  the  pharmacy 
schemes  will  supply  filters, 
tourniquets,  citric  acid  or 
sterile  water  since  the  supply 
of  such  paraphernalia  (other 
than  syringes  and  needles)  is 
an  offence  under  the  Misuse 
of  Drugs  Act.  In  practice,  it  is 
unlikely  that  the  police,  who 
are  generally  supportive  of 
exchange  schemes,  will  bring 
about  a  prosecution. 

Furthermore,  the  Code  of 
Ethics  cautions  pharmacists 
on  the  supply  of  substances 
"liable  to  misuse".  The  sale  of 
citric  acid  and  supply  of  filters 
or  tourniquets  could 
constitute  a  breach  of  the 

There  is  considerable 
variation  throughout  the 
country  in  both  the  allocation 
of  funding  for  exchange  and 
how  pharmacists  are 
remunerated.  As  a  broad 
generalisation,  pharmacists 
are  paid  a  fee  per  issue, 
whether  that  is  a  single 
syringe  or  a  pack,  and  an 
annual  retainer  fee  which  is 
paid  for  providing  the  service, 
irrespective  of  the  number  of 
exchanges  made.  The  fee  is 
sometimes  incremented  on  a 
sliding  scale  and  payments 
vary  between  a  maximum  of 
£6,000  per  annum  and  a 
minimum  of  £50  per  annum. 

Morals  and  ethics 

There  is  a  moral  dimension  to 
the  concept  of  supplying 
syringes  to  drug  injectors 
which  often  presents 
pharmacists  with  a  dilemma. 
To  supply  syringes  would 
appear  to  condone  drug 
misuse,  whereas  not  to 
supply  syringes  increases  the 
likelihood  that  drug  injectors 
will  share  syringes  and  hence 
expose  themselves  to  the  risk 
of  HIV  infection. 

While  this  might  be 
perceived  as  the  drug 
injector's  just  desserts,  the 

Table  1:  range  of  possible  equipment 
available  through  exchange 

Various  syringes  (eg  1,2,5  and  10ml) 

Medicated  swabs  


Intercobra  tubes  (to  return  used  syringes) 


Sterile  water 

Citric  acid 

Cotton  wool/filters 

major  route  of  transmission 
of  the  virus  is  through  sexual 
intercourse  and  drug  users 
are  known  to  be  sexually 
active  and  indulge  in 
unprotected  sex'1.  This  clearly 
has  implications  for  the 
spread  of  HIV  into  the  wider 
population  and  pharmacists 
should  bear  this  in  mind 
before  rejecting  the  idea  of  a 
needle  exchange  scheme. 

There  are  also  several 
practical  issues  to  be 
addressed  (see  Table  2)  and  it 
is  well  worth  doing  some 
research  into  the  drug 
problems  in  an  area  to  assess 
the  need  for  a  needle 
exchange  service.  Many  of 
these  concerns  can  be 
alleviated  by  talking  to  other 
pharmacists  who  are 
currently  involved  in 
exchange  schemes. 

Shoplifting  and  physical 
abuse  are  rarely  a  problem 
(although  they  may  occur) 
and  such  actions  are 
perpetrated  by  the  minority  of 
clients  as  most  exchange 
clients  value  the  service  and 
are  unlikely  to  act  in  such  a 
manner  as  to  jeopardise  it. 

Another  factor  which  poses 
a  problem  is  the  risk  of 
needle-stick  injuries.  Existing 
schemes  will  have  a  policy  on 
the  use  of  sharpsafe  boxes.  It 
is  sensible  to  store  such 
boxes  where  they  can  be 
easily  accessed,  but  not 
where  they  may  cause 
inconvenience  (or  risk)  to 
other  members  of  staff  or 
public.  Collection  of  the 
sharpsafe  boxes  is  normally 
arranged  by  the  local 

If  any  pharmacist 
does  sustain  an 
injury,  provided  that 
they  have  observed 
the  protocols 
already  in  place,  it  is 
unlikely  that  they 
would  be  held 
legally  liable  and 
hence  have  to  pay 
Furthermore,  if  a 
pharmacist  causes 
an  injury  to  a 
member  of  the 

public,  then  they 
would  be  covered 
by  their  insurance 
(for  example,  NPA 
Alternatively,  if  the 
pharmacist  causes 
injury  to  another 
member  of  staff, 
then  they  are 

  covered  by  the 


Pharmacists  are 
also  strongly 
advised  to  get 
themselves  and 
their  staff  vaccinated  against 
hepatitis  B. 

Despite  many  of  the 
reservations  that  pharmacists 
might  have  about  needle 
exchange  schemes,  the 
majority  who  are  already 
involved  find  it  is  a  satisfying 
part  of  the  extended  role  and 
that  it  has  not  adversely 
affected  their  business. 

While  the  direct  financial 
rewards  can  be  low  (though 
up  to  £6,000  per  year  is  not 
inconsiderable),  in  the  longer- 
term  many  of  the  exchange 
users  will  use  their  exchange 
pharmacy  to  collect  their 
prescriptions,  so  generating 
greater  revenue. 

Pharmacists  who  are 
interested  in  becoming 
involved  should  contact  their 
LPC  or  the  local  drug  agency 
which  will  be  able  to  advise 
them  on  the  availability  of 
services  in  their  particular 

Future  schemes 

In  the  future  it  is  conceivable 
that  pharmacists  will  become 
more  involved  in  the 
provision  of  services  to  drug 
misusers,  including  anabolic 
steroid  users.  There  are 
already  schemes  in  parts  of 
the  country  which  involve  the 
supervision  of  methadone 
and  it  is  possible  that 
pharmacists  could  play  an 
even  greater  role  in  the 
clinical  management  of  these 

The  recently  published  Task 
Force  review  on  services  to 
drug  misusers1'  foresees  a 
greater  role  for  pharmacists, 
and  with  the  Government 

Table  2:  possible  reservations  of 
pharmacists  before  starting  needle 

Increased  shoplifting 
Adverse  effect  on  business 
Staff  objections 
Risk  of  needle-stick  injury 
Threat  of  physical/verbal  abuse 
Level  of  remuneration 
More  needles  discarded  in  the  community 

prepared  to  allocate 
additional  money  for  projects 
related  to  substance  misuse, 
pharmacists  should  waste  no 
time  in  taking  the  initiative  to 
define  how  best  they  can 
extend  their  role  in  the  area  of 
service  provision. 


Mulleady  G.  A  review  of 
drug  abuse  and  HIV  infection. 
Psychology  and  Health 

2  Robertson  J  R,  et  al. 
Epidemic  of  AIDS-related 
virus  (HTLV  lll/LAV)  infection 
among  intravenous  drug 
abusers.  BMJ  1986;  292:  527- 

3  Wodak  A,  et  al.  Antibodies 
to  the  immunodeficiency 
virus  in  needles  and  syringes 
used  by  intravenous  drug 
abusers.  The  Medical 
Journal  of  Australia, 

4  Chitwood  D  D,  et  al.  HIV 
seropositivity  of  needles  from 
shooting  galleries  in  South 
Florida.  American  Journal  of 
Public  Health  1990,80(2):  150- 

5  Koester  S,  Booth  R,  Wiebel 
W.  The  risk  of  HIV 
transmission  from  sharing 
water,  drug  mixing  containers 
and  cotton  filters  among 
intravenous  drug  users.  The 
International  Journal  on  Drug 
Policy  1991;1(6):28-30. 

6  Lart  R,  Stimson  G  V. 
National  survey  of  syringe 
exchange  schemes  in 
England.  Br  J  Addiction 

7  Anonymous.  Liverpool 
pharmacists  supply  free 
needles  and  condoms.  Pharm 
J  1986;  237:  825. 

8  Council  Guidance. 
Guidelines  for  pharmacists 
involved  in  schemes  to 
supply  clean  syringes  and 
needles  to  addicts.  Pharm  J 
1987;238:  481. 

S  Advisory  Council  for  the 
Misuse  of  Drugs.  AIDS  and 
Drug  Misuse  Part  1.  HMSO, 
London  1988. 

10  Advisory  Council  for  the 
Misuse  of  Drugs.  AIDS  and 
Drug  Misuse  Update.  HMSO, 
London  1993. 

11  Horridge  G,  PSNC. 
Personal  communication, 
February,  1996. 

12  Quirk  A,  Rhodes  T, 
Condom  use  by  drug  users: 
whether,  why  not  and  how? 
Executive  summary  No41, 
CRDHB,  London;  10995. 

13  Task  force  on  the  services 
for  drug  misusers,  HMSO, 
London,  1996. 

C&D  is  accredited  by  the 
College  of  Pharmacy  Practice 
as  a  provider  of  distance 
learning  material  until 
December  31,  1997. 




Given  that  asthma  and 
chronic  obstructive 
airways  disease  cause 
significant  morbidity  and 
mortality,  and  that  metered 
dose  inhalers  are  the 
standard  means  of  delivering 
bronchodilator  therapy,  we 
ought  to  know  more  than  we 
do  about  the  ability  of 
individuals  to  use  the  devices 
correctly.  A  group  of  US 
pharmacists  have,  with  Glaxo, 
now  addressed  the  problem. 

They  studied  29  people 
attending  hospital  clinics  who 
were  prescribed  an  inhaler  for 
the  first  time  and  42  healthy 
volunteers  with  little  or  no 
previous  experience  of 
inhalers.  Their  average  age 
ranged  from  50  to  87  (mean 
70).  Each  was  given 
standardised  instruction  on 
inhaler  technique  using  a 
placebo  device.  Correct 
technique  was  defined  as 
activating  the  device  within 
the  first  half  of  inhalation; 
continuing  to  inhale  slowly 
and  deeply;  and  holding  the 
breath  at  full  inspiration. 

Assessment  of  inhaler 
technique  was  then  correlated 
with  variables  which  might 
influence  performance. 

Overall,  62  per  cent  of  all 
subjects  could  demonstrate 
the  correct  inhaler  technique 
after  instruction  and  56  per 
cent  could  still  do  so  one 
week  later.  There  was  no  link 
between  the  time  taken  to 
learn  the  technique  and 
ability  to  use  the  inhaler 
correctly,  with  half  the 
successful  users  needing  10 
20  minutes  and  one  in  eight 
needing  20  30  minutes  to 
master  the  device.  Variables 
that  were  significantly 
associated  with  incorrect 
technique  included  cognitive 

impairment,  male  gender  and 
lesser  hand  strength. 
Adjusting  for  hand  strength, 
those  with  cognitive 
impairment  were  3.7  times 
more  likely,  and  men  were 
five  times  more  likely  than 
women,  to  have  incorrect 
technique.  Factors  that  did 
not  predict  incorrect 
technique  included 
educational  status  and  being 
a  patient  or  volunteer:  those 
with  incorrect  technique 
tended  to  be  older  but  this 
was  not  significant. 

These  results  are 
informative:  advanced  age  is 
usually  assumed  to  be  one 
explanation  for  not  being  able 
to  use  an  inhaler  but,  in  itself, 

this  appears  not  be  so. 
Nonetheless,  many  of  the 
problems  sometimes 
associated  with  old  age  and 
drug  treatment  in  the  elderly 
-  cognitive  impairment,  weak 
hands  -  are  important.  It  is 
surprising  that  men  were  less 
able  to  use  inhalers  correctly; 
this  may  be  due  to  poorer 
manual  dexterity  compared 
with  women.  The  factors 
identified  in  this  study  are 
easy  to  use  clinically  as 
indications  that  some  patients 
may  need  extra  help  with 
their  inhaler  and  they  should 
be  borne  in  mind  when 
counselling  patients. 
Archives  of  Internal  Medicine 

Insight  into  schizophrenia  treatment 

For  many  people  with 
schizophrenia,  if  they  are 
to  live  in  the  community 
and  carry  on  a  near-normal 
life,  it  is  important  that  they 
are  encouraged  to  take  their 
medication.  Yet  discontin- 
uation seems  common, 
resulting  not  only  in  symptom 
recurrence  but  also  disrupting 
social  and  economic  support. 

One  reason  why  affected 
people  may  stop  taking 
antipsychotic  medication  - 
apart  from  the  adverse  effects 
-  is  that  they  may  not  believe 
they  need  it.  There  is  evidence 
that  only  one-quarter  of 
people  with  a  long  history  of 
psychiatric  illness  believe  they 
are  psychiatrically  ill 

In  particular,  people  with 
schizophrenia  may  not  be 
aware  that  they  are  ill,  that 
their  illness  causes 
symptoms,  or  that  they  need 
treatment.  Whether  this  lack 
of  insight  is  due  to 
schizophrenia  itself  is 
uncertain  but  it  has  been 
linked  with  a  belief  that 
treatment  is  unnecessary  and 
with  a  wish  to  stop 
medication.  Conversely, 
patients  with  insight  into  their 
problems  are  more  likely  to 
co-operate  with  treatment. 

Other  factors  which  might 
influence  the  decision  to  stop 
treatment  include  knowledge 
about  schizophrenia  and 
intellectual  functioning.  How 

they  interact  with  insight  has 
now  been  investigated  in  64 
people  with  schizophrenia. 

Their  keyworkers  (health 
professionals  designated  to 
co-ordinate  care  for 
individuals)  noted  that  nine 
actively  requested 
medication,  40  passively 
accepted  it  and  15  actively 
refused  treatment.  Insight 
was  strongly  correlated  with 
illness  severity  and  chronicity. 
Those  who  had  actively 
refused  medication  within  the 
previous  two  weeks  had 
significantly  less  insight  than 
those  who  had  accepted  it. 
Insight  correlated  with  years 
in  education  and  educational 
attainment  but  not  with  IQ; 

and  education  about 
schizophrenia  significantly 
increased  insight. 

Although  it  is  difficult  to 
define  insight  scientifically 
(one  definition  of  lack  of 
insight  is  disagreeing  with  the 
psychiatrist!),  it  appears  that 
initiatives  that  improve 
awareness  and  understanding 
of  schizophrenia  should 
improve  continuation  with 
medication.  Although 
intellectual  function  (as 
denoted  by  IQ  at  least)  does 
not  appear  to  be  relevant, 
these  initiatives  must  be 
modified  for  people  with 
poorer  education. 
British  Journal  of  Psychiatry 
7996,168:7 18-22 



"ash  incentives  for  prescribers 

A  cash  incentive  may  or  may 
1 1  not  encourage  GPs  to 
I  .^prescribe  more  cheaply 
but  it  is  only  one  of  several 
determinants  of  prescribing, 
say  researchers  in  Newcastle. 

They  surveyed  local 
practices  after  GPs  were 
offered  an  incentive  scheme 
to  cut  prescribing  costs  which 
would  have  earned  each  GP 
principal  £1,000-£2,500  to 
spend  on  approved 
development  projects. 

In  the  former  Northern 
Regional  Health  Authority, 
323  non-fundholding 
practices  completed  a 
questionnaire  on  the  factors 
that  affected  their  prescribing. 
Just  over  half  reported  that 
they  had  tried  to  achieve 
target  savings.  The  decision 
to  achieve  this  was  usually 
reached  within  the  practice, 
though  some  said  that 
professional  opinion  and  the 
size  of  the  financial  incentive 

were  also  important.  Of  these 
practices,  however,  two-thirds 
did  not  meet  their  target, 
saying  it  was  not  achievable, 
there  was  insufficient  time  or 
the  reward  did  not  justify  the 

Medical  and  pharmaceutical 
advisers  helped  40  per  cent  of 
practices  with  advice  about  the 
incentive  scheme.  Most 
practices  decided  to  achieve 
their  targets  by  increasing 
generic  prescribing,  but  a  third 
reconsidered  the  duration  of 
treatment  they  prescribed  and 
a  quarter  increased  recommen- 
dations for  self-medication. 

Only  31  per  cent  said  they 
had  a  formulary  or 
prescribing  policy,  though 
when  one  was  in  place 
adherence  to  it  was  high. 
Treatment  guidelines  were  in 
place  in  over  50  per  cent  of 
practices  for  asthma,  diabetes 
and  hypertension.  The  only 
guideline  that  was 

significantly  more  likely  to  be 
found  in  practices  which 
achieved  their  targets  was  for 
the  management  of  ischaemic 
heart  disease.  Guidelines 
were  more  often  followed 
'usually'  than  'always'. 

Hospital  practice  is  a 
potentially  important 
influence  on  GP  prescribing. 
Schizophrenia,  diabetes  and 
ischaemic  heart  disease  were 
identified  by  more  than  50  per 
cent  of  practices  as  conditions 
for  which  prescribing  was 
usually  or  always  hospital- 
led.  Around  40-50  per  cent  of 
practices  considered  the 
treatment  of  asthma,  peptic 
ulceration  and  hypertension 
as  predominately  hospital- 
led.  Conditions  least  often 
influenced  by  hospital 
practice  were  contraception, 
constipation,  osteoarthritis 
and  acute  infection. 
British  Journal  of  General 
Practice  1996,46:287-90 

Co-operation  for  a  formulary 

<n  Ps  who  develop  a 
|  ^-formulary  benefit 

U considerably  from  the 
exercise  -  not  only  through 
more  rational  and  often 
cheaper  prescribing  but  also 
by  revising  their  knowledge  of 
therapeutics.  However,  the 
process  is  very  time- 
consuming  and  often 
unwelcome.  Buying-in 
someone  else's  formulary 
avoids  the  work  but  leaves  GPs 
with  no  sense  of  participation 
and  little  interest  in  keeping  to 
the  recommendations. 

GPs  in  South  Bedfordshire 
have  investigated  whether 
these  problems  can  be 
overcome  by  sharing  the 
work  among  more  GPs  but 
keeping  the  initiative  local  by 
restricting  it  to  the  district. 
From  Bedfordshire's  350  GPs, 
50  agreed  to  work  together, 
taking  advice  from  specialists 
and  a  pharmacist.  They  based 
their  work  on  three  published 

formularies  and  met  once- 
monthly  to  review  products 
for  inclusion.  The  final 
formulary,  designed  to  meet 
80  per  cent  of  a  GP's  needs, 
contained  179  drugs  (72  per 
cent  generic)  and  delivery 
devices  from  12  therapeutic 

The  effect  of  the  formulary 
over  three  years  was 
evaluated  by  comparing 
prescribing  by  the  50 
participants  with  the  300  local 
GPs  who  did  not  take  part. 
Generic  prescribing  increased 
both  among  participants 
(from  44  to  51  per  cent)  and 
non-participants  (40  to  48  per 
cent).  Significant  changes 
among  formulary  users 
occurred  in  three  therapeutic 
categories:  cardiovascular, 
musculoskeletal  and  (for  one 
year  only)  obstetrics  and 
gynaecology.  The  number  of 
items  per  prescribing  unit 
increased  by  11.8  per  cent 

among  participants  compared 
with  14  per  cent  in  non- 
participants.  Before  the 
implementation  of  the 
formulary,  participating 
practices  spent  £1 1,000  less 
on  drugs  than  other  practices 
per  quarter;  afterwards,  the 
difference  increased  to 
£51,000.  The  cost  of 
developing  the  formulary  and 
auditing  its  effects  was 
estimated  at  £70,000.  It  would 
break  even  after  six  months. 

It  is  difficult  to  identify 
trends  in  prescribing  practice 
in  that  context  but  the 
formulary  appears  to  have 
had  a  positive  impact  on 
prescribing.  The  50  GPs 
involved  spent  £1.3  million  on 
drugs  in  the  first  quarter  of 
1994  and  the  authors  note 
that  even  small  changes  in 
practice  have  a  significant 
impact  on  costs. 
British  Journal  of  General 
Practice  1996;46:271-5 

in  hospitals 

/^Vver-use  of  antibiotics  is  one 

|of  the  biggest  problems 
\J pharmacists  tackle.  It 
wastes  money;  increases  the 
risk  of  antimicrobial 
resistance;  and  increases  the 
risk  of  adverse  reactions. 
However,  a  seven-year  study 
from  a  Utah  hospital  shows 
that,  with  effective 
intervention,  substantial 
improvements  in  antibiotic 
use  can  be  achieved. 

Activity  data  is  routinely 
recorded  at  the  hospital, 
providing  clinical  and  financial 
data  which  can  be  fed  back  to 
prescribers  via  a 
computerised  information 
system.  The  computer 
software  supports  an  expert 
system  which  provides 
computer-assisted  decision 
support  and  this  was  used  to 
develop  consensus  guidelines 
on  antibiotic  prescribing. 
Prescribers  used  the  computer 
model  to  rationalise  their 
treatment  decisions.  Each 
received  feedback  on 
prescribing  decisions  and  this 
was  found  to  be  critical  to  the 
system's  success. 

Of  the  162,000  patients 
discharged  from  hospital  64,000 
received  antibiotic  therapy. 
There  were  significant 
improvements  in  the  quality  of 
surgical  prophylaxis:  the 
proportion  of  patients  receiving 
their  pre-operative  dose  within 
two  hours  of  surgery  increased 
from  40  per  cent  to  99  per  cent 
and  the  mean  number  of 
prophylactic  doses  given  per 
patient  decreased  from  19  to  5.3. 
Throughout  this  period, 
prophylaxis  was  provided  with 
only  three  cephalosporins  - 
cefazolin,  cefoxitin  and 

In  1986,  prescribers'  choice 
and  the  computer  guidelines 
conflicted  an  average  of  2.67 
times  per  day  and  treatment 
was  changed  in  30  per  cent  of 
cases.  By  1994,  there  was  an 
average  of  1.32  conflicts  daily 
and  99.9  per  cent  were 
changed  to  match  the 
computer's  recommendation. 
Annals  of  Internal  Medicine 

PHARMACYupdate:  distance  learning  for  pharmacists 

Pharmacists  using  Pharmacy 
Update  for  continuing  education 
are  reminded  of  the  need  to  test. 
With  the  support  of  Johnson  & 
Johnson  MSD,  C&D's  readers 
can  self-test  their  progress  by 
using  the  multiple  choice 
question  (MCQ)  paper  to  be 

inserted  in  the  August  10  issue, 
which  will  cover  this  week's 
modules,  together  with  those  in 
the  July  6  issue.  In  other  words: 
«  Malaria  (20) 
®  Headaches  (21) 
•  Drugs  in  sport  (22) 
®  Needle  exchange  (23) 

A  faxback  service  for  these 
modules  and  associated  MCQs 
operates  on  0891  444791 
(premium  rates  apply).  A 
telephone  marking  service  offers 
independent  verification  of 
results  -  details  are  given  on  the 
monthly  MCQ  papers. 

C&D  in  association  with 
^  o$wwn   (Amen  °  MSD 
Consumer  Pharmaceuticals 



See  what  the 

market  leader 

can  do  for  you 

Complete"  is  the  market  leader  in  the  fastest  growing  contact  lens 
care  segment. 1 

Complete'  is  exclusively  available  to  opticians  and  pharmacists 
August  national  press  campaign 

Reference  I  Soft  lens  cold  chemical  Independent  Market  Research 


There  is  only  one  solution 

Optometrists,  like 
pharmacists,  are 
m  pallidal  it  lie  if  no  lie  ami 
taking  on  the 
management  of  minor 
c.-fr  coiiiidittions. 
CfiristopSio  Kerr,  an 
optometrist  in  south 
London  and  consultant 
ilo  y,lie  1  yecaire 
Information  Service, 
explains  how  guidelines 
are  being  seu  imgii  io  help., 
"  ''--Acs,  aii  trends 
in  contact  lens  wear 

As  with  pharmacists,  the 
expertise  of  optomet- 
rists has  perhaps  been 
under  used  until  re- 
cently. Poor  communi- 
cation between  optometrists  and 
their  medical  colleagues  has 
blighted  the  development  of  the 
Optometrie  services  in  the  t'K. 
But  times  are  changing. 

In  theory,  the  Opticians  Act 
and  subsequent  legislation  re- 
quires optometrists  to  refer  all 
patients  with  abnormal  condi- 
tions to  their  GP,  without  diagno- 
sis. The  OP  then  eithei  treats  the 

patient  or  refers  them  for  spe- 
cialist or  emergency  help.  The 
optometrists'  NHS  Terms  of  Ser  - 
vice further  reinforce  these 
responsibilities.  It  is,  however, 
some  years  since  these  protocols 
were  established  and  the  quality 
of  optometiic  education  and 
clinical  ability  have  improved 
considerably  over  the  years. 

It  is  now  more  widely  accepted 
that  the  optometrist  is  probably 
best  suited  to  treat  a  range  of 
common  ophthalmic  conditions 
that  do  not  require  urgent  refer- 
ral to  hospital.  These  conditions 
demand  a  level  of  specialist 
knowledge  and  instruments  that 
most  GPs  do  not  -  nor  wish  to  - 
possess.  In  the  interests  of  con- 
venience to  the  patient  and  econ- 
omy to  the  health  service,  many 
'unofficial'  arrangements  have 
evolved  locally  over  the  years. 

Many  optometrists  have  been 
safely  and  effectively  treating  a 
range  of  relatively  minor  and 
often  chronic  conditions  which 
do  not  require  acute  manage- 
ment. They  are  now  keen  to 
advance  their  profession  by 
expanding  their  range  of  practice 
in  such  areas. 

With  this  in  mind,  Lambeth, 
Southwark  &  Lewisham  Health 
Authority  drew  up  'Referral 
guidelines  for  abnormal  ocular 
conditions',  after  extensive  con- 
sultation with  optometrists  and 

GPs.  Copies  were  distributed  to 
all  optometrists  contracted  with 
the  health  authority. 

The  guidelines  list  the  main 
eye  conditions  likely  to  be  seen 
in  community  practice  and  rate 
(hem  according  to  how  quickly 
they  should  be  referred  else- 
where or  whether  the  opto- 
metrist could  treat  them.  In  gen- 
eral we  would  take  those  listed 
'urgent'  as  needing  a  specialist 
opinion  that  day;  'soon'  as  need- 
ing referral  within  a  few  days; 
and  'in  turn'  implying  that  a  'new 
patient'  waiting  time  would  be 
appropriate.  We  arrived  at  the 
range  of  conditions  and  referral 
priorities  after  extensive  discus- 
sion and  consensus. 

Some  examples  are  given  on 
page  91,  in  the  hope  that  they 
may  help  pharmacists  decide  on 
the  urgency  with  which  patients 
should  be  referred. 

The  document  is  for  guidance 
only  and  does  not  in  any  way 
remove  the  rights  of  practition- 
ers to  make  individual  decisions 
on  individual  cases.  GPs  were 
fully  briefed  to  ensure  that  the 
introduction  of  the  guidelines 
received  a  harmonious  welcome. 

The  cost  of  an  ophthalmic  out- 
patient visit  in  the  Lambeth, 
Southwark  and  Lewisham  area  is 
£70  a  consultation.  Any  means  by 
which  these  expensive  resources 
can  be  more  effectively  used  is 

obviously  in  the  interests  of  both 
purchasers  and  providers,  and, 
most  of  all,  the  patients.  The 
guidelines  are  such  a  stratagem 
and  seek  to  give  some  consis- 
tency in  referral  policy,  in  line 
with  the  Patients'  Charter 

The  scheme  is  now  being 
audited  at  the  end  of  its  first  year. 
Opinions  of  both  optometrists 
and  doctors  (GPs  and  ophthal- 
mologists) are  now  being  sought 
as  to  its  effectiveness  in  improv- 
ing inter-professional  communi- 
cation and  the  more  appropriate 
use  of  ophthalmic  resources.  The 
initiative  has  been  enthusiasti- 
cally welcomed  and  supported 
by  many  concerned  for  the  ulti- 
mate benefit  of  the  professions 
and  our  service  to  patients. 

Changing  contacts 

Contact  lens  research  has  led  to 
an  entirely  new  concept  -  the  dis- 
posable lens. 

As  modern  lens  materials  have 
developed  they  have  become 
more  and  mor  e  like  body  tissues 
or  biocompatible,  allowing  the 
wearer's  eye  to  breathe  naturally 
beneath  the  lens.  These  delicate 
materials  are  so  well  accepted  by 
the  body  that  they  eventually 
wear  and  become  contaminated 
by  cell  products  and,  like  the  tis- 
sues themselves,  need  regular 
replacement.  The  contact  lens 
industry  thus  faced  a  problem:  as 




Some  examples 
of  the  guidelines 

Urgent  referral 

Acute  glaucoma 
Chemical  injuries 
Penetrating  injuries 
Retinal  breaks  and  tears 
Retinal  detachment 
Sight-threatening  keratitis 
Suspected  temporal  arteritis 



Diabetic  retinopathy 
In  turn 

Ectropion  (eversion  of  the  eyelid 

Entropion  (inversion  of  the 
eyelid  margins) 
Hayfever  conjunctivitis  in 

Persistent  blepharitis  or 
Severe  dry  eye 

Optometrist  managed 

Chronic  blepharitis 
Chronic  dry  eye 

Contact  lens  problems  not  invol- 
ving serious  corneal  infection 
Hayfever  and  allergic 
conjunctivitis  in  adults 
Sub-conjunctival  haemorrhage 
with  normal  blood  pressure 
Superficial  foreign  bodies  and 
ingrowing  lashes 

contact  lenses  became  more  and 
more  perfect  they  lasted  for 
shorter'  and  shorter  periods! 

However,  the  development  of 
sophisticated  moulding  technol- 
ogy has  reduced  the  costs  of  con- 
tact lenses  and  made  disposable 
or  frequent  replacement  lenses  a 
practical  proposition.  By  fre- 
quently changing  their  lenses, 
wearers  can  avoid  many  of  the 
complications  sometimes  associ- 
ated with  contact  lens  use  such 
as  infections  and  allergic  reac- 
tions. Disposable  lenses  are  of 
varying  types  which  are  dis- 
carded after  one  day,  one  week, 
two  weeks  or  one  month. 

Success  with  all  types  of 
lenses  pr  obably  depends  mostly 
on  the  choice  of  practitioner,  and 
price  is  rrot  always  the  best 
guide.  Anyone  thinking  of  trying 
contact  lenses  should  ask  friends 
who  wear  lenses  or  their  GP  for 
advice  in  selecting  a  competent 
and  conscientious  practitioner 
who  will  give  ongoing  care. 

Fees  are  usually  fairly  low  for 
disposables;  about  £30  should 
cover  initial  examination  and  fit- 
ting, tuition,  supply  of  die  first 
lenses  and  follow-up  checks. 
When  t  he  practitioner  is  satisfied 
that  the  lenses  arc  a  success,  the 
client  registers  with  the  practice 
and  receives  further  supplies  of 
lenses  for  the  next  three  or  six 
months.  Monthly  payments  of 
around  £15-20  ensure  a  constant 
supply.  This  fee  should  include 

lens  warranty  or  insurance,  as 
well  as  aftercare  at  regular  inter- 
vals, typically  every  six  months. 
These  aftercare  visits  are  vital. 

Disposable  contact  lenses,  if 
properly  maintained,  have  the 
best  safety  record  of  any  contact, 
lenses  yet  developed  Studies 
have  shown  that  they  are  about 
four  times  safer  than  conven- 
tional lenses  in  terms  of  compli- 
cation rates.  People  who  discard 
their  lenses  daily  need  no  lens 
care  solutions  at.  all.  Those  who 
change  their  lenses  less  often 
should  still  clean  them  every 
night  and  store  them  in  a  disin- 
fecting solution.  But  there  is  no 
need  for  other  time-consuming 
cleaning  routines  such  as  protein 

The  contact  lens  practitioner 
will  recommend  the  most  suit- 
able solutions  for'  the  lens  mater- 
ial prescribed.  These  will  lie 
products  designed  for  soft  rather 
than  gas  permeable  lenses.  The 
solutions  must  not  be  changed 
without  consulting  the  practi- 
tioner. As  well  as  the  widely-pub- 
licised risks  of  using  products  for 
gas  permeable  lenses  with  soft 
lenses,  some  soft  lens  materials 
must  be  used  only  with  specified 

( Irdinary  soft  lenses  have  an 
average  lifespan  of  one  to  one 
and  a  half  year  s  and  cost  about 
£150.  ( )vei  this  tune,  frequent 
replacement  lenses  usually  work 
out  less  expensive  because  the 

higher  cost  of  the  lenses  is  bal- 
anced by  the  reduced  cost  of 

Disposables  also  give  specta- 
cle wearers  a  chance  to  try  con- 
tact lenses  cheaply  for  the  first 
time.  No  wonder  eye  care  practi- 
tioners are  encouraging  their 
patients  to  throw  away  then- 

National  Eye 
Week  1996 

This  year's  National  Eye  Week 
will  be  September  23-29.  Once 
again  the  Eyecare  Information 
Service  will  create 
opportunities  for  those  who 
wish  to  capitalise  on  the  central 

The  organisers  say  the  week 
will  generate  plenty  of  media 
interest,  so  why  not  organise 
your  own  in-store  promotion, 
providing  customers  with 
information  on  eye  care  and 
optical  products,  or  featuring 
Eye  Week  in  a  special  window 
display?  Many  manufacturers 
will  be  supporting  the  event  and 
may  be  offering  promotions  or 

The  EIS  can  supply  leaflets  on 
a  range  of  subjects.  Tel:  0171 
357  7730. 

This  year  the  focus  of  Eye 
Week  will  be  on  image  and 

NEW  H  ffl 


Liquid  and  cream  shampoo,  with  malatflion 


DO3070  MAY  1996 

Legal  category:  P  Product  licence  holder:  Ultra  Chemical,  Tubiton  House,  Oldham  0L1  3HS.  Quellada  is  a  registered  trade  mark.  Further  information  is  available  from  the  distributor: 

Stafford-Miller  Ltd,  Broadwater  Road,  Welwyn  Garden  City,  Herts.  AL7  3SP. 

CHEMIST  &  DRUGGIST  20  JULY  1 996 



Keeping  in  contact 

The  increase  in  professional  only'  contact  lews  care  products  is  likely  to  be  of  benefit  to  the  pharmacist. 
Adrienne  de  Mont  looks  at  changing  trends  and  the  products  which  have  evolved  to  meet  them 

■  l  is  vital  for  pharmacies  to 
I  offer  a  full  range  of  products 
I  if  they  wish  to  maximise  their 
I  contact  lens  care  business, 
I  says  Allergan.  Customers  can 
then  buy  everything  they  need 
from  the  same  place. 

"It  is  also  important  that  phar- 
macies continue  to  make  lens 
care  products  prominently  visi- 
ble and  accessible  to  customers," 
says  Amanda  Byrne,  senior  prod- 
uct manager. 

The  total  contact  lens  care 
market  is  worth  about  ii  118  mil- 
lion and  is  growing  by  10  per  cent 
year  on  year.  The  optical  sector  is 
increasing  its  share,  estimated  at 
57  per  cent  ( up  from  53  per  cent 
last  year),  while  pharmacies  are 
declining  slightly  with  33  per 
cent  (from  37  per  cent).  Grocers 
account  for  about  10  per  cent.  A 
rapid  initial  growth  in  this  sector 
has  stabilised  at  about  1  per  cent 
year  on  year. 

Allergan  says  that  the  increase 
in  'professional  only'  products  is 
likely  to  help  pharmacies.  The 
company's    latest  disinfecting 

products  -  Complete  and  Total 
Care  -  are  available  only  through 
pharmacies  and  opticians. 

According  to  Allergan,  the  seg- 
ments are  as  follows: 

•  soft  lens  disinfection  52  per 
cent  (oxidative  led  by  Oxysept, 
soft  lens  cold  chemical  led  by 

•  surfactants  1 1  per  cent  (led  by 

•  general  lens  care  10  per  cent 
(led  by  Total  ) 

•  salines  12  percent  (led  by  Ciba 

•  protein  removers  7  per  cent 
(led  by  Ultrazyme/Hydrocare) 

•  wetting  drops  1  per  cent  (led 
by  Lensfresh). 

Peroxide  systems  dominate 
the  pharmacy  market,  but  there 
is  a  growing  demand  for  one-bot- 
tle systems  for  soft  lens  wearers. 
These  systems  are  by  far  the 
fastest-growing  segment,  with  a 
70  per  cent  year  on  year  growth. 
They  have  had  a  big  impact  in 
opticians  but  have  yet  to  realise 
their  full  potential  in  pharmacies. 

"One-bottle  systems  now  meet 


OINTMENT  (0  1 5%  w/w  dibromopropamidine  isethionate  BP)       I  p  I 
DROPS  (0  1  %  w/w  propamidine  isethionate)  l_E_l 

"A  sight  for  sore  eyes" 

New  formulation  as  an  ointment  and  new  eye  drops 
Treats  conjunctivitis,  blepharitis  and  minor  eye  infections 
<M>  50%  on  cost  profit  plus  w/s  discount 
:  Pharmacy  Only  guaranteed 
Available  from  your  wholesaler 

^'ifSffLDEN EYE  * 


Typhaim  Limited  14,  Parkstone  Road,  Poole  Dorset  BH5  2PG 
Telephone  (01202)666626  Fax  (0t202)666909 

a  real  need  by  lens  wearers  for 
simple  and  convenient  lens 
care,"  says  Ms  Byrne.  "Our  Com- 
plete solution  has  seen  rapid 
growth  in  pharmacy  and  has 
been  instrumental  in  increasing 
the  Allergan  leadership  position, 
which  now  stands  at  51  per  cent 
of  the  market.  By  stocking  these 
simpler  to  use  systems,  pharma- 
cies can  help  to  expand  their 
business  opportunities." 

The  company  is  supporting  the 
Association  of  Contact  Lens  Man- 
ufacturers in  its  bid  to  swell  the 
ranks  of  lens  wearers.  Only  about 
4  per  cent  of  the  UK  population 
(2.5  million  people)  wear  lenses, 
but  the  market  is  gr  owing  due  to 
competitively-priced  lenses,  easy 
to  use  care  systems  and 
increased  advertising.  It  is  hoped 
the  number  of  wearers  could 
reach  similar  levels  to  the  IIS, 
which  is  around  15  per  cent. 

Trends  in  contact  lens  use 
obviously  impact  on  the  lens  care 

market.  Soft  lenses  are  showing 
strong  growth  and  disposables 
have  doubled  their  market  share 
in  the  past  12  months.  Hard  and 
rigid  gas  permeable  lenses  are 
declining  in  popularity. 

The  latest  Target  Group  Index 
Data  shows  that  contact  lens 
wearers  are  predominantly 
females  aged  15-44  years.  They 
are  most  likely  to  be  ABC  1  and  in 
full-time  employment.  There  is  a 
strong  regional  bias  towards  Lon- 
don and  the  South,  although  all 
regions  are  expanding. 

Consumer  profiles  have  found 
that  contact  lens  wearers  tend  to 
be  outgoing,  experimental,  ad- 
venturous and  career-orientated. 
The  average  user  fits  into  one  of 
two  groups:  urban  venturers  who 
are  young  adults  with  a  high  dis- 
posable income  living  in  major 
cities,  and  affluent  achievers 
who  are  high  income  families  liv- 
ing in  the  suburbs  and  who  own 
two  or  more  cars,  eat  out  regu- 

Easier  to  use  systems  have  helped  grow  the  contact  lens  care  market 



Read  the  market 

The  OTC  reading  glasses  market  has  changed  since  its  introduction  in  1989.  But 
rather  than  stocking  large  numbers  of  designs  in  all  the  powers,  the  advice  is  to 
have  a  selection  of  good  designs  in  a  range  of  about  six  powers 

Lil  ly,  go  to  the  theatre  and  follow 
investments  closely.  The  former 
lend  to  lie  (luiuilimi  and  Inde- 
pendent leaders,  while  the  latter 
opt  tor  The  Times,  Financial 
Times  and  The  Daily  Telegraph. 
•  Revive,  Allergan's  new  comfort 
drops  for  soft  lens  wearers,  is 
hem"  supported  by  lull-colour 
advertisements  m  The  Times, 
Evening  Standard  and  the  Daily 
Mail.  The  preservative-free  for- 
mula is  based  on  carboxymethyl- 
cellulose.  A  recent  Gallup  survey 
reported  that  a  thud  o1  people 
who  give  up  wearing  lenses  each 
year  do  so  because  of  comfort 

Another  new  product  from 
AUergan  is  Lens  Plus  Purite  saline, 
a  rinsing  solution  for  soft  lenses. 
The  company  says  its  telesales  ini- 
tiatives have  encouraged  bettei 
merchandising  and  sell-selection. 
This  month's  offer  is  a  mixed  case 
of  Oxysepl  and  Complete,  with 
POS  material.  Complete  is  being 
supported  by  a  S150,000  press 
campaign  in  August . 

Educational  mater  ial,  including 
the  guide  'You  and  your  contact 
lenses',  is  available  to  pharmacy 
staff  to  help  them  understand  the 
lens  care  products  available 

Rorer  has 
produced  an 
eye  care 
pack,  which 
leaflets  and 
a  poster 

Avoid  weird  styles  and  do 
not  be  tempted  to  stock 
too  many  strengths  of 
reading  glasses,  com- 
ments Direct  Percep- 
tion's Peter  Philips. 

Some  frame  designs  will  never 
sell  at  any  price,  he  says,  as  the 
over-50s  are  unlikely  to  be  happy 
with  anything  too  startling. 

"We  are  selling  to  a  more 
mature  inai  kel  and  the  designs 
should  be  to  their  taste,"  he  says 
"Unfortunately,  there  are  suppli- 
ers with  no  optical  background 
who  seem  to  import  whatevei 
they  are  offered  providing  the 
price  is  right.  That  is  why  we  see 
so  many  weird-shaped  frames 
that  might  suit  the  US  oi  the  Far 
East  but  not  the  I  IK. 

"Some  designs  sell  better  than 
others  simply  because  they  are 

specifically  designed  for  the  UK 
market.  ( )ur  search  starts  with  an 
analysis  of  optical  sales  arrd,  with 
t  he  help  i  if  our  panel  i  >f  i  >|  it  lcians, 
we  plan  the  shape  and  colour 
very  carefully  on  the  basis  of 
these  findings." 

The  better  the  designs,  the 
more  facial  types  they  fit.  And  the 
smaller  the  stockholding,  the 
greatei  the  profitability  from  the 
capital  involved. 

"No  one  can  display  50  differ- 
ent designs  in  all  the  powers. 
This  only  produces  confusion 
and  irritation  for  stockist  and 
customer  alike,"  continues  Mr 
Philips.  A  range  of  six  powers  is 
enough.  Ranges  with  nine  pow- 
ers mean  a  50  per  cent  larger 
stockholding  for  the  same  sales 

"What  you  need  is  a  selection 
from  some  good  designs,  well 
made  frames  and  lenses,  in  a  well 
thought-out  range.  You  need  lull 
frames,  half  frames,  metal  and 
plastic,  economy  ones  and 
smarter  designs. 

"Regularity  of  supply  is  also 
important  Do  not  get  palmed  ofl 
with  inferior  substitutes  that  hap- 
pen to  be  left  on  your  suppliers' 

The  (  )T( '  reading  glasses  mai 
kel  has  changed  considerably 
since  il  began  in  IMS!).  Many  opto- 
metrists offer  budget  ranges  of 
spectacles,  after  being  motivated 
by  NHS  changes  arrd  the  intro 
duction  o1  readymades.  This  has 
shown  up  some  of  the  expensive 
ranges  as  overpriced  and  has 
damaged  then  sales,  says  Mr 

He  calculates  that  the  iead\ 

made  market  could  be  worth 
about  £53  million,  based  on  an 
estimate  of  22  million  people 
aged  45  years  and  over.  Although 
not  everyone  uses  readymades, 

others  make  multiple  purchases 
at  an  average  price  of  So'  a  pair. 
About  6  per  cent  of  sales  go 
through  non-optical  outlets. 

Eyecare  Products  estimates 
that  the  self-selection  reading 
glasses  market  is  nearer  S22m. 
About  one-third  of  sales  are 
Boots  own-label,  one-third  goes 
through  other  pharmacies  and 
the  remainder  through  supermar- 
kets, department  stores  and 
other  independent  outlets,  in- 
chiding  opticians 

There  are  about  24.5m  people 
in  the  UK  with  presbyopia,  the 
company  says.  ( )nce  someone 
has  started  using  reading  glasses, 
he  or  she  will  change  them  for  a 
stronger  magnification  every  two 
to  three  years.  So  the  market  is 
growing  rapidly  with  the  ageing 

In  Japan  and  the  US  -  the 
world's  most  developed  self- 
selection  readers  markets  -  it  is 
not  uncommon  for  consumers  to 
have  six  or  more  pairs  in  various 
locations  (home,  office,  car,  etc), 
so  they  are  never'  far  away  from 
their  glasses. 

Consumer  buying  patterns  are 
spin  between  considered  pur- 
chases and  emergency/impulse 
buys  which  are  needed  when  the 
usual,  often  prescription,  glasses 
have  been  left  behind. 

The  latter  often  triggers  further 
purchases  as  consumer  satisfac- 
tion w  ith  self-selection  readers  is 
high,  particularly  as  they  start  at 
prices  well  below  the  eye-test 

"Independent  phai  mai  ies  are 
in  a  strong  position  to  increase 
market  share  as  consumers  have 
the  reassurance  that  the  product 
is  slocked  in  an  ethical  environ- 

Continued  on  P95  ► 


with  Counterpart! 

you  have  retained  all  your  counterpart  modules  the 
cost  to  you  will  be  only  £20  (+  VAT)  per  assistant! 
To  re  order  all  the  modules  at  £15  (+VAT)  and  register  one 
assistant  at  £20  (+VAT)  still  works  out  at  only  £35  (+VAT) 
per  assistant.  For  four  assistants  the  price  reduces 
even  further  to  £23.75  (+VAT)  per 

J  -J  J  J  J 




i—i r-i person!  r- 1 


The  RPSGB  deadline  of  July  1,  by  which  all  pharmacies  in 
England,  Scotland  and  Wales  should  have  registered  their  counter 
assistants  for  an  accredited  training  course,  has  now  passed! 

If  you  have  not  already  complied  with  the  RPSGB  requirements 
don't  worry...there's  still  time.  BUT  YOU  MUST  HURRY! 

Register  your  staff  now 

with  the  Chemist  &  Druggist  Cambridge 
Counterpart  Pharmacy  Assistant  Development  Programme  -  the  most 
cost-effective  course  available  to  Chemist  &  Druggist  subscribers! 

#  Cambridge  Counterpart  has  been  accredited  by  the  College  of 
Pharmacy  Practice  as  satisfying  the  RPSGB's  requirements. 

#  Counterpart  has  been  generously  co-sponsored  by  Whitehall 
Laboratories  for  the  benefit  of  Chemist  &  Druggist  subscribers. 

#  Since  the  course  began  in  July  1995,  subscribers  will  have 
received  a  total  of  13  Counterpart  modules. 

#  The  training  modules  are  packs  designed  to  be  shared  by  four 
assistants,  but  include  separate  questionnaires  and  case  studies 
for  each  individual.  An  associated  Pharmacist's  Briefing  comes 
with  each  module. 

#  To  qualify  for  accreditation,  assistants  must  not  only  follow  the 
course  set  out  in  the  modules  but  also  answer  the  questionnaires, 
participate  in  the  case  studies  and  have  their  questionnaires 
independently  mar  ked  thr  ough  C&D's  unique  telephone  marking 

Sign  up  now! 

Here's  what  you  do... 

1.  If  your  assistants  are  already  following  Counterpart 
and  are  registered  for  telephone  marking. ..continue 
with  the  course.  Once  it  is  completed,  you  will  receive 
the  results  and  documentation  for  CPP  certification  for  a 
payment  of  £8.81  including  VAT. 

2.  If  your  assistants  are  following  Counterpart,  but  are 
not  yet  registered  for  telephone  marking...  use  the 

form  below  to  register  today! 

When  your  assistants  receive  their  personal  identity 
numbers  (PINs),  they  should  enter  their  multiple  choice 
questionnaire  responses  up  to  date,  then  follow  the 
course  to  the  end.  CPP  certification  will  be  available  as 
above  for  £23.50  including  VAT. 

3.  If  your  assistants  are  not  yet  following 
Counterpart.. .use  the  form  below  now  to  register  them 
today.  If  you  have  retained  the  free  modules,  start  your 
assistants  on  the  course  at  once  and  mark  the 
questionnaires  as  soon  as  PINs  are  received. 

If  you  do  not  still  have  the  free  modules  available,  use 
the  order  form  to  obtain  complete  packs  of  the  full 
course  (training  modules,  questionnaires  and 
Pharmacist's  Briefings)  for  just  £17.63,  including  VAT. 
Remember,  each  pack  will  cover  four  assistants! 

PIN  registration  and  CPP  certification  fees  are  still 
payable  as  in  section  2  above.  Subscribers  who  have 
mislaid  just  one  or  two  modules  only  should  contact 
Tracy  Matthews  on  0181  747  8797 

Remember:  if  your  counter  assistants  have  not  already  completed  an  approved  course  or  are  not 
currently  following  an  accredited  course,  they  may  no  longer  serve  medicines  to  the  public! 

Priority  Order  Form 

YES!  My  counter  assistants  are  following 
Counterpart  but  are  not  registered  to  use  the 
interactive  telephone  marking  system.  Please 
register  them  now  @  £23.50  each  including  VAT. 








@£23.50  =  subtotal  £ 

YES!  I  subscribe  to  C&D  at  the  pharmacy  address 
below  but  need  (    )  complete  sets  of  all 
Counterpart  modules  to  enable  my  assistants  to 
complete  the  course.  (Remember  to  register  each 

Please  send  me  (     )  complete  sets  of  modules 
1  -1 3  at  the  special  price  of  just  £1 7.63  inc  VAT 

If  you  do  not  already  subscribe  to  C&D,  or  your 
subscription  has  lapsed,  your  cheque  must  include 
an  additional  £115  for  the  full  annual  subscription. 

Sub  total  £  

Total  payable  £  

Method  of  payment:  □  I  enclose  a  cheque 
payable  to  Chemist  &  Druggist 




Post  code 



Post  now  in  an  envelope  (no  stamp  required)  with 
payment  to  Sue  Cheeseman,  Pharmacy  Group  Special 
Projects,  Miller  Freeman  Professional  Ltd,  Chemist  & 
Druggist,  FREEP0ST,  Sovereign  Way,  Tonbridge,  TN9  1YZ. 




In  the  public  eye 

Customers  looking  for  eye  care  products  usually  visit  the  pharmacy  first. 
Research  shows  that  as  86  per  cent  of  products  are  sold  here,  good 
merchandising  is  essential  as  customers  are  more  aware  of  their  needs 

l-Doc:  supported  by  consumer  advertising  this  summer 

<  Continued  from  P93 

ment  and  can  seek  assistance 
from  the  staff  it  necessary," 
says  Eyecare  Products,  whose 
25  per  cent  market  share 
includes  the  Readi  Read,  Foster 
Grant  and  Magnivision  brands. 
I  lisplay  is  the  key  factor  in  good 

What  to  choose 

•  Eyecare  Products'  29  styles 
conform  to  British  Standards 
(European  standards  pending) 
and  carry  a  12-month  guarantee. 
All  lenses  are  aspheric,  so  they 
aie  thinnei  and  flatlet  than  con- 
ventional spherical  lenses.  A 
range  of  Sun-readers  pr<  ivides  1  A' 

The  company's  service  in- 
cludes next  day  delivery  on 
repeat  orders,  low  minimum 
repeal  orders  (three  pans 
mixed),  opening  deals,  free  dis- 
play stands  to  suit  all  si/.es  of 
outlet,  and  a  lelesales  service  or 

regular  merchandising  for  largei 
outlets  All  displays  include  an 
ophthalmically-appn  >ved  sight- 
tesl  inn  chart  f<  ir  selecting  I  he  <•<  >r- 
recl  strength. 

Future  plans  for  this  year 
include  public  relations,  further 
stand  developments,  promotional 

oilers  to  the  retailei   and  con 

sumer,  and  a  constanl  updating  of 


•  Direct  Perception's  prices 
range  from  £2.98  to  £10.98,  w  hich 
Mr  Philips  believes  should  cover 
the  needs  of  everyone,  from  the 
person  who  wants  a  basic  pan  to 
the  one  who  w  ishes  to  enhance 
his  appearance  with  a  better 
design.  Stockists  can  experiment 
with  new  mi  idels,  which  I  he  c<  >m- 
pany  is  quite  happy  to  exchange  if 

"This  way,  a  stockist  of  a  bud- 
get range  may  gradually  test  the 
market  out  with  better  models," 
says  Mr  Philips.  Several  promo- 
tions will  i  mi  over  the  next  few 
mi  ml  lis. 

Modern  lifestyles  are  good  for 
the  eye  care  market.  Pollution, 
air  conditioning  and  staring  at 
computer  screens  all  put  strain 
on  i  he  eyes. 

Research  by  <  )rookes  Health- 
care shows  that  the  number  of 
people  suffering  from  minor  eye 
complaints  is  on  the  increase, 
with  the  result  that  the  <  »T< '  eye 
care  market  is  growing  steadily 
and  is  now  worth  .S 18  million. 
About  ten  million  people  -  over 
one-fifth  of  adults  -  use  <  iptrex 
and  the  brand  accounts  for  71 
per  cent  of  the  market. 

The  introduction  of  <  Iptrex 
Dry  Eye  Therapy  eye  drops  in 
April  was  an  attempt  to  expand 
the  market  as  a  whole  and  to 
offer  an  <  iptrex  product  in  an 
area  with  no  other  promoted 
brands  A  survey  in  1994  found 
i  hat  ( ivei  half  i  he  3.3  millii  in  dry 
eye  sufferers  were  unaware  that 
remedies  existed.  Promotion  will 
be  targeted  both  at  these  people 
and  current  users  of  dry  eye 
I  real  inents. 

This  year  sees  the  highest-ever 
promotional  spend  on  the<  >ptrex 
brand  Explains  product  man- 
ager Pisa  Miller:  "By  educating 
the  consumer  and  increasing 

awareness  of  eye  care  through 
both  educat  ional  i  >ublic  relatii  ms 
and  high-profile  advertising,  we 
are  Stimulating  demand  for  eye 
care  products  and  making  the 
category  more  accessible  to  the 
ci  msumer " 

Research  shows  that  86  per 
cent  of  eye  care  products  are 

bought  m  pharmacies,  so 
Crookes  Healthcare  believes  that 

g  I  merchandising  is  essential 

as  customers  become  more 
aware  of  their  eye  care  needs  and 
the  role  of  '  >T< '  medicatii  m 
ii  h  i  eases  in  general. 

New  display  units  and  shell' 
managers  form  pari  of  this  year's 
&3m  support  programme.  A  two- 
tiei  countei  unit  provides  space 
for  12  packs  of  the  dry  eye  drops, 
as  well  as  a  new  customei  infor- 
mation leaflet  A  flexible  modu- 
lar shelf  management  system  for 
use  behind  the  counter  can 
house  all  ( iptrex  products, 
including  Hayfever  Allergy.  A 
new  shell  manager  for  use  in  the 
<  1S1>  atea  houses  the  lotion  and 
eye  masks, 

Rhone-Poulenc  Rorer  com- 
ments that  over  the  past  year 
Brolene's  share  has  lumped  to  22 
per  cent  of  the  ,S7  (ini  eye  c  are 
market  through  pharmacy 
(excluding  Boots)  and  accounts 
for  90  per  cent  of  the  anti-infec- 
I  ive  segment 

OTC  marketing  manager 
kevan  (iill  explains:  "Consumers 
are  very  reluctant  to  self-diag- 
nose where  eye  problems  are 
concerned,  and  need  the  reassui 
ance  and  recommendation  of 
then  local  community  pharma- 
cist who  can  offer  them  a  per- 
s< dial  service." 

The  c<  impany  has  produced  an 
eye  care  counselling  pack  for 
pharmacists  and  their  assistants. 
It  contains  leaflets  OI1  the  lour 

most    common  complaints 
allergic  seasonal  conjunctivitis, 
infective  conjunctivitis,  blephar- 
itis and  styes  -  to  pass  on  to  cus- 
tomers, after  consultation. 

An  illustrated  poster  for  use 
in  the  pharmacy  helps  identify 
eye  problems  and  gives  guidance 
on  their  treatment.  Both  are 
available  tree  from  the  com- 
pany's representatives. 

•  Golden  Eye  drops  and  oint- 
ment are  being  advertised 
nationally  on  radio,  and 
Typharm  is  sponsoring  pollen 
count  bulletins.  Advertising  is 
appealing  in  the  Daily  Mail 
health  pages  and  women's  maga- 
zines, as  well  as  some  medical 
journals.  A  new  range  of  POS 
materials  and  leaflets  is  avail- 
able from  the  company.  There 
are  special  offers  from  whole- 
salers throughout  the  summer 
and  a  compel  if  ion  for  pharmacy 
staff,  with  prizes  of  the  '( iolden- 
eye'  James  Bond  video,  runs 
until  the  end  i  if  August. 

•  A  public  relations  campaign  is 
in  progress  for  new  l-Doc  preser- 
vative-free eye  lotion.  There  are 
advertorials  in  the  women's 
press  and  sampling  through  the 
national  Sunday  supplements 
ami  women's  interest  piess. 
Advertising  is  appearing  in  the 
.luly  and  August  issues  of 
Options,  Mm  ir  <  'laire  and  Zcsl. 
Containing  distilled  witch  hazel, 
l-Doc  is  packaged  in  single  dose 
ampoules  w  hich  contain  enough 
lotion  lo  bathe  both  eyes. 



o  RPM  -  no  pharmacy' 

On  another  positive  note,  65 
per  cent  intend  to  expand  their 
businesses  by  adopting  new  ser- 
vices, such  as  consultancies  'in 

The  increasing  power  of  gen- 
eral practitioner  fundholders 
brought  mixed  reactions.  While 

Ninety-one  per  cent  of  pharma- 
cists believe  their  businesses 
would   be   threatened   by  the 
removal  of  Resale  Price  Mainte- 
nance, according  to  a  Glaxo  Well- 
come survey.  Eighty-eight  per 
cent  also  feel  threatened  by 
changes  in  Government  remu- 
neration I  lispensing 
doctors,  meanwhile, 
are  regarded  as  pot- 
entially harmful  by 
81  per  cent  of  the 
pharmacists.  Slightly 
lower     down  the 
scale  of  threats  are 
outlets,  which  alarm 
75  per  cent  . 

However,  most  of 
the  pharmacists  are 
keen  to  fight  on.  Sixty 
per  cent  say  they  are  Ian  Millar,  a  community  pharmacist  at  Seres 
not  seriously  consid-  Road  Pharmacy  in  Glasgow,  won  a  Toshiba 
ering  getting  out  of  Pentium-powered  laptop  for  taking  part  in  Glaxo 
retail   pharmacy,   24  Wellcome's  questionnaire.  He  is  flanked,  from 
per  cent  appear  to  lie  the  left,  by  Doug  McLean,  account  manager  at 
giving    the    notion  Glaxo;  Rose-Marie  Parr,  director  of  the  Scottish 
some  thought,  and  14  Centre  For  Pharmacy  Postgraduate  Education; 
per  cent  are  seriously  and  Maureen  Devlin,  Glaxo's  customer  manager 
considering  quitting,  (pharmacy) 

48  per  cent  of  the  pharmacists 
say  the  trend  is  a  threat,  22  per 
cent  see  it  as  an  opportunity. 

Forty  per  cent  believe  patient 
pack  dispensing  is  an  opportu- 
nity for  their  business,  as 
opposed  to  20  per  cent  who  see  it 
as  a  threat. 

The  development  of  primary 
care  teams  is  considered  good  by 
60  per  cent  of  the  pharmacists, 
while  48  per  cent  see  the  nurse 
prescribing  pilot  as  an  opportu- 
nity for  their  businesses. 

Glaxo  sent  out  more  than  8,000 
questionnaires  to  community 
pharmacists  around  the  UK  in 
April.  The  company  says  it  will 
use  the  information  as  a  base  to 
build  a  better  relationship  with 

The  questions  ranged  from  the 
respondent's  purchasing  respon- 
sibility to  general  attitudes 
towards  key  issues.  Glaxo  says 
the  response  was  excellent. 
Those  who  completed  the  ques- 
tionnaire were  eligible  to  win  a 
laptop  computer,  software  and 
modem  worth  £3,000.  Ian  Millar, 
of  Glasgow  was  the  winner. 

Co-op  Health  Care 
acquires  more  stores 

Co-op  Health  Care,  the  pharmacy 
chain  operated  by  United  Nor- 
west  Co-op,  has  acquired  five 
pharmacies  in  the  North  Mid- 
lands and  north  west  of  England. 

The  chain,  which  now  has  49 
stores,  plans  to  acquire  at  least 
another  six  by  the  end  of  the  year 
and  will  again  be  looking  in  these 
two  regions. 

A  spokesman  for  Co-op  Health 
Care  says  the  latest  acquisitions 
are  in  line  with  its  plans  to 
expand  in  the  North  West.  More 
stores  also  improve  the  chain's 
buying  power,  he  adds. 

The  c  hain  has 
been  strengthen- 
ing its  manage- 
ment team  over 
the  past  year  to 
cope  with  its 
expansion.  New- 
comers include 
a  professional 
d  e  v  e  1  o  p  m  e  n  t 
manager  to  help  with  recruit- 
ment and  to  maintain  profes- 
sional standards,  and  an  integra- 
tion manager,  whose  brief  is  to 
aid  new  branches  in  assimilating 
into  the  organisation. 

Geoff  Flint,  right,  controller  of  Co- 
op Health  Care,  and  Philip 
Broadhurst  seal  the  Co-op's 
acquisition  of  Mr  Broadhurst's 
pharmacy,  Stoke-on-Trent-based 

Astra  fights  Losec  copies 

Astra,  the  Swedish 
pharmaceuticals  group,  has 
lodged  a  complaint  with  the 
European  Commission  against 
Portugal  for  approving  13  pirate' 
copies  of  its  anti-ulcer  agent, 
Losec,  according  to  the  Financial 
Times.  Astra  estimates  that  it  is 
losing  S12  million  annually  to 
Losec  imitations. 

Proteus  reduces  losses 

Revenues  earned  from  licensing 
agreements  and  a  cost-cutting 
programme  helped  Proteus 
International,  the  Macclesfield- 
based  biotechnology  company,  to 
reduce  its  pre-tax  losses  by  £2.5 
million  to  £5.4m  for  the  year  to 
March  31. 

Alberto-Culver  expands 

Hair  care  and  toiletries 
manufacturer  Alberto-Culver  is 
investing  £3.15  million  in  a  new 
50,000ft2  manufacturing  site  at  its 
base  on  the  Swansea  Enterprise 
Park  in  South  Wales.  The 
expansion  will  create  100  new 

Sun  worshippers 

Balmy  weather  in  June  brought 
very  good  sales  of  sun 
preparations  in  pharmacies  and 
department  stores,  while  demand 
fell  for  cough  and  cold  products, 
according  to  the  British  Retail 
Consortium.  The  weather  also 
lifted  sales  of  hay  fever  remedies. 
Demand  was  mixed  for 

Therapeutic  flotation 

Therapeutic  Antibodies,  which 
produces  polyclonal  antibodies 
to  treat  diseases,  has  fallen  prey 
to  the  rapid  decline  of 
biotechnology  shares.  The 
company  expects  a  placing  price 
of  525p  per  share,  valuing  it  at 
£112  million,  when  it  is  floated  on 
the  Stock  Exchange  next  week. 
The  company  had  originally  been 
hoping  to  price  its  shares  at  700- 

Chiro  founder  reaps  reward 

Bearish  market  bites  into  Alizyme  flotation 

Chris  Evans,  founder  of  Chiro- 
science,  the  biotechnology  com- 
pany, has  turned  816,000  share 
options  into  shares. 

Mr  Evans,  now  a  non-executive 
director  of  the  company,  bought 
600,000  shares  at  25p  and  216,000 
at  16.67p.  Having  paid  £186,007 
for  them  all,  Mr  Evans  would 
make  a  profit  of  more  than  S2.6 
million  if  he  sold  them  at  their 
market  price  of  346p  [share  price 
quoted  on  July  12).  However,  he  is 
said  lo  have  no  immediate  plans 
to  sell. 

Alizyme,  a  biopharmaceutical 
company  based  in  Cambridge, 
expec  ts  a  relatively  poor  recep- 
tion when  it  is  floated  this  week 
because  of  the  current  bear  mar- 
ket for  biotechnology  shares. 

It  expects  to  raise  about  £4.5 
million  net  when  it  joins  the 
Alternative  Investment  Market. 
By  contrast,  three  weeks  ago, 
Alizyme  said  it  was  expecting  to 
raise  between  £12-  13m  through 
the  flotation. 

This  week's  placing  price  will 

be  60p,  valuing  the  company  at 
about  £10.4m,  although  it  had 
originally  been  hoped  to  place 
shares  at  150p. 

Alizyme  will  issue  8.33  million 
shares  that  represent  48  per  cent 
of  the  enlarged  shar  e  capital. 

It  will  use  the  money  raised  to 
fund  product  development  The 
company  is  developing  drugs  to 
combat  obesity  and  gastro- 
intestinal disorders.  Such  drugs 
are  developed  from  a  late  stage 
of  their  research  and  supervised 

through  pre-c  linical  testing  to  the 
end  of  Phase  II  trials.  The  prod- 
ucts are  then  licensed  out  to 
other  companies  for  late  stage 
trials,  commercial  manufacturer 
and  marketing. 

The  company  is  collaborating 
with  Oxford  Molecular  and  the 
Institute  of  Food  Research  to 
develop  lipase  inhibitors  for  use 
in  obesity  and  atherosclerosis, 
and  with  BTG  on  drugs  for 
inflammatory  bowel  disease, 
diarrhoea  and  flatulence. 


HHRMIST  &  DRITfifilST  20  JULY  19 


Appointments  £25P.S.C.C.  +  VAT  minimum  3x1 
General  Classified  123  P.S.C.C.  +  VAT  minimum  3x2 
Box  Numbers  £  1  2.00  extra.  Available  on  request. 
Copy  date  4pm  Tuesday  prior  to  Saturday  publication. 
Cancellation  deadline  1 0am  Friday;  one  week  prior  to  insertion  date 
All  cancellations  must  be  in  writing 

Contact  Lucy  Reynolds  Chemist  and  Druggist  (Classified) 

Miller  Freeman  PLC,  Sovereign  Way,  Tonbridge,  Kent  TN9  IRW 
Tel:  01732  377222  Internet: 


Nr  Cross  Keys,  Gwent 

EnchusiasiK  Pharmacist  required  to  manage 

pleasant  village  pharmacy  \  xccllcnt 
supporting  stafi  Pleasant  disposition  and  a 
liking  tor  pjucm  contact  essential-  Hours 
and  salary  negotiable 
rdephone  Alan  Peterson  on 
01495  244227  (daytime)  or 
0149S  244226  (evenings). 

Full  &  Part-time 

Bournemouth  Area 
Competitive  salary, 
holidays  &  excellent 
team  of  staff, 
/t/'/'/t/  Mrs  Cough 
Tel:  01202  749397 
01202  523481 

Multi  Pharmacy  chain  require 
evening  locnms  to  work  in  t ho 

following  stores. 
Rygate  Surrey  01737  244132 

Hadleigh,  Essex  01702  555321 
Felixstow,  Suffolk  01394  276297 
(until  Xpm) 
Upper  Norwood,  S.  London 
01X1  7717639 
(until  Hpm) 



Dispensing/Medical  Counter 
Assistant  required  lull  time  (part 
time  considered).  Newly  extended 
and  refitted  pharmacy. 

References  required 

Please  phone  The  Manager 
0171-226  3645 


Superintendent  Pharmacist 

required  immediately  for  high 

street  pharmacy. 
Please  contact  Mr  O.  Dede 
on  0181  692  5807  9am-7pm 
or  Miss  McCarthy  on 
0181  692  3725  9am-7pm 


Burghfield  Common,  nr.  Reading 

Experienced  dispensing  assistant 

required  part  time  for  a  busy 
community  pharmacy  Good  rate  of 

Phone  Mrs  Thomas  on  01734 
831145  (daytime) 
or  01734  845740  (eves  &  w/ends) 


Pharmacist  manager  required  for 
easily  run  branch  of  small  friendly 
group.  No  paperwork.  Very  few 

Apply  to  P.  Henderson,  95  Park 
View,  Whitley  Bay,  TVne  and 
Wear  NK26  3RJ  or  telephone 
0191  252  0253 


Enthusiastic  Pharmacist 
Manager  required  fur  an  easily 
run  pharmacy  Recently 
qualified  considered 
Please  contact:  H.C.  Patel 
0171  476  0243  (daytimel 
0181  464  4812  (evening) 



from  5th  August  for  6 
Contact  Kirit  on 
0171  249  2441  (day) 
0181  881  3977  (eve) 


Manager  required  for  easily  run 
branch  pharmacy,  good  supporting 
staff,  attractive  salary  with  profit 
sharing  incentive.  Newly 
registered  considered. 

Apply  P.  Lappin  0151  236  0618, 
0151  722  3926  (eve). 

Friendly  family  pharmacy 
group  require  a 
for  village  pharmacy  near 
Eastbourne.  Interested9 
Phone  Paul  Houston 
01323  411047  or  647420 



We  have  over  5,000  pharmacists 
registered  PLUS  experience  of 
handling  over  250,000  booking 

'  Provided  by  experienced  staff. 
1  Locum  bone-fides  checked. 
'  A  mobile  &  motivated  locum 

•  Pharmacist  staff  to  deal  with 
technical  issues. 


Plena  eM 

Bvmitqlum  0121-233  0233 
NwcaitU  0191-2330506 
MmdutU  0161-766  4013 
SUffull  0114-2699  937 
Edbthwyk  0131-229  0900 
Cardiff  01222  549174 
London  01892  515963 
Exit&t  01392422244 

London  SW4 

Regular  lotum  pharmacist  required 

to  cover  late  night  dispensing 
in  Clapham,  for  Thursdays  &  Fridays 
b-9pm.  knowing  Mediphase  is 
desirable.  Salary  by  negotiation. 
Telephone  Dr.  Gharib 
0171  622  3147 


+  Are  you  familiar  with  'self- 
assessment'  rules  starting  from 
April  1996? 

*  Qualified  Accountant  provides 
a  full  accountancy/tax  service 
for  reasonable  rates. 

Tel:  0181  908  5006 

Seaton,  Devon 

Locum  required  on  a 
regular  basis.  Also  for 
another  local  pharmacy. 
Telephone  W.  Gaine  on 
(01297)  20414  or  (01297) 


Urgently  required  in 
South  Waits  &  Bristoi  area 
•  Competitive  rates  oi  pay 



Capital  Support  Services 

Tel:  01222  540940 
Fax:  01222  54'M«5 

CHEMIST  ADRI'MilST  20  JULY  1996 





Run  your  own  business  without  any  capital  investment. 
Unique  opportunity  has  arisen  for  a  Pharmacist  with 
business  acumen  to  operate  this  branch  on  a  profit  share 

For  further  details  contact  H.  Modi,  Jardines  (UK)  Ltd. 
Telephone  01908  506828. 



(01423)  508172 

Retirement  sale  of  unopposed  pharmacy  in 
delightful  coastal  village.  T/O  FYE  April  95 
£426,807.  CP  27.4%.  NHS  items  average 
3,460  per  month  Immaculately  presented 
premises  available  on  new  lease  or  freehold 
with  attractive  four  bed  living  accom  if 
required  Offers  invited  around  £225,000  for 
GW/Fix  plusSAV. 

Long  established  suburban  pharmacy.  T/O 
FYE  April  95  £642,656.  NHS  items  average 
5,500  per  month.  Prominent  corner  premises 
available  on  new  lease  at  £5,000pa.  An 
extremely  profitable  concern.  Offers  invited 
around  £400,000  for  GW/Fix  plus  SAV 
(approx  £55.000) 




'Simply  the  besf 




6  Vulcan  St,  Liverpool  L3  7BG 
Fax:  0151-298  1689 

'Subject  to  Park's  standard  terms  and  conditions 


A  FREE  Service  for  Chemist  &  Druggist  Subscribers 

35,  Dansac  unique  2-55  ref  502-55. 
Trade  less  20%+ VAT+ Postage  - 
Paroven  caps  250mg,  Loron  520 
tabs,  Cardura  tabs  4mg.  Tel:  01923 


6  Pergonal  7587  inj+solvent  (exp 
10/97),  10  DepLxol  inj  40mg/2ml  (exp 
2/98),  4  Fortral  30mg/ml  inj  (exp 
1 1/97),  1x5  5ml  Suprefact  S/C  inj  (exp 
11/97),  3  Deca-Durabolin  50mg/ml 
(exp  3/97),  2  Sustanon  250  1ml  inj 
(exp  12/97)  and  many  others.  Tel: 
0181422  2563. 
TRADE  LESS  20%  +  VAT  + 
POSTAGE-  Opsite  10cmxl2cm 
4630.  Trade  less  1 5%+ VAT+ Postage 

-  Coloplast  Assura  2471,  Comfeel 
iOcmxlOcm  3213,  Mepore  9x10cm. 
Tel:  0171  620  0429. 


-  456  Loron  400mg  caps,  Farlutal 
lOOmg  tabs,  Provera  400mg  Tabs, 

Danol  200mg  caps,  Calcitare  vials, 
Duocal  cans  2x400g,  Desferal  iiu  1 
box.  Tel:  0181  672  6116. 

TRADE  LESS  30%+VAT  -  38  Dutonin 
200mg,  53  Cedocard  Retard  400mg, 
90  Hydergine  1.5mg,  3  Lentaron 
Depot  250mg,  5  Inj  Kemadrin.  Tel: 
0181  904  4197. 

TRADE  LESS  30%+VAT  -  1 1x30x3118 
Hollister,  2x30  Hollister  7164.  Tel: 
0171-730  1080. 

TRADE  LESS  25%+VAT  -  2x30  Neoral 
50mg  (exp  7/97),  4x30  Neoral  +vat 
(exp  9/97),  trade  less  40%  -  Norplant 
(exp  9/96).  Tel:  01793  495499. 

TRADE  LESS  20%+ VAT  -  33  Celectol 
200mg,  28  Climesse  2mg,  100  Flur- 
biprofen 50mg,  84  Ketoprofen  LOOmg, 
42  Foradil  12mcg,  28  Monocor  lOmg, 
80  Volmax  4mg,  plus  others.  Tel: 
01827  262488. 

TRADE  LESS  40%  -  Suprefact  spray, 
Cyproterone  50mg £20/56  tablets.  Tel: 

Increase  Profitability 
Enhance  Customer  Care 
Increase  Staff  Motivation         j>  - , 

Improve  Communication  m  rVOjCSSlOtlM 

improve  Efficiency        I  .j   Dispensing  Systems  for 

Provide  Profes^nTpractfce  Image  II  Professional  PhatWadStS 
Increase  Flexibility  II  FOR  DETAILS 


Tel:  0161  9417011 


IBM  computers  are  amongst  the  most  highly 
respected  in  the  industry  .  They  have  unequalled 
reliabilty,  are  manufactured  in  the  UK  and  have  a 
reputation  second  to  none.  It  is  only  fitting  they 
should  run  software  of  equal  standing.  That 
software  is  JRC. 

IBM  &  JRC,  forward  thinking ,  here  for 
the  future. 

Call  John  Richardson  Computers 

(a  division  of  Taylor  Nelson  AGB  pic) 

ON  FREEPHONE:  0500  947116 

*91%  of  Community 
Pharmacists  have  read  four 
out  of  the  last  four  issues 
of  Chemist  &  Druggist. 

('source  Martin  Hamblin  Pharmacist  Readership  Survey) 

01582  21760. 

TRADE  LESS  30%+VAT  -  Celance 
0.25mg  x  0.05mg,  Dalacin  150nig, 
Axid  300nig,  Sandimmun  25mg,  Lam- 
ictal  50mg,  Zydol  SR,  Cipramil  20mg, 
Becodisk  150,  Berstec  200,  Aerobec 
Forte.  Tel:  01623  643801. 

TRADE  LESS  30%+VAT  -  300  Lopid 
300mg  (exp  10/96),  100ml  Bactrim 
Paed  syrup  (exp  9/96),  2x56  DMC 
90mg  (exp  8/96),  trade  less  40%+vat, 
100  Kinidin  duniles  (exp  9/96).  Tel: 
01438  312228. 

TRADE  LESS  20%  +  VAT  + 
POSTAGE  -  6x30  Convatec  Com- 
bihesive  pouches  45mm  S265,  4x10 
Stomahesive  flange  45mm  S241 
Tel:  01792  458883. 

TRADE  LESS  30%+VAT  -  15  Vagifem 
(exp  2/97),  56  Lederfen  450  (exp 
8/99),  50  Lodine  200mg  (  exp  6/97),  56 
Ludiomil  25mg,  100  Tegretol  retard 
400mg  (exp  6/97),  3x28  Climagest 
(exp  1 1/96),  3x28  Climagest  lgm  (exp 
6/97),  30  Voltaren  lOOmg  (exp  3/97). 
Tel:  01 16-283  2140. 

TRADE  LESS  30%+VAT  -  1x250  Hex- 
opal  forte  dispensing  pack  (exp  7/00). 
Tel:  01667  462617. 

TRADE  LESS  25%+VAT  -  10x28  Nys- 

tan  pessaries  (exp  1/97),  10x150 
Atarax  syrup  (exp  5/00),  36x42  Para- 
max  tabs  (exp  11/98),  6x30  ManerLx 
(.exp  9/99).  Tel:  01274  593274. 
TRADE  LESS  60%  + VAT  -  7  Oxygen 
stands,  unused,  5.5  inch,  new  price 
S16.16+vat.  Tel:  0181-684  1352. 


than  three  years  old,  four  perfume 
cabinets,  two  counters,  gondola, 
shelves,  dispensary  fittings,  conti- 
nental drawers,  light  fittings,  safe 
and  Mediphase  computer.  Tel: 
01494  520685. 

new,  hardly  used  £40.  Tel:  0181-684 

7,  Packard  Bell  486  Multimedia  8MB 
RAM,  Star  colour  printer,  complete 
system,  ready  to  run  £800.  Tel:  01474 

MINI  LAB  Oriental  mini  2,  complete 
system  which  prints  up  to  8x12,  100 
films  a  day,  ideal  for  busy  phar- 
macy, one  year  old  Tel:  01703 




+  CAMRx  + 


Alchemist  3000  PMR 

dispensary  system 
NEW  VERSION  !!!!!! 

Prophet  2000  EPOS 
Intelligent  till  system 
Transform  your  business 



We  use  our 

We  deliver  & 
install  FREE 

Police  Station 

'i>l  ffl  I  77  7\  f,7 


CLEARWAY  INHALER  is  now  established  as  the 
preferred  way  of  inhaling  steam  and  aromatics  in  the 
treatment  of  catarrh,  sinusitis,  coughs  and  colds. 
We  now  require  distributors  willing  and  able  to 
promote  and  sell  to  community  pharmacies.  Please 
reply  to  Clearway  Products  Ltd.,  Kiln  House, 
Station  Road,  Wisbech  St.  Mary,  Cambs.  PE13 
4RW  or  telephone  01945  410466  for  further 

their  PROFITS  by  £££££'s 

1.  A  vital  invc 
base  will  p 

ridable  negotiati 

2.  Group  31      o  ^jMj)  adds  pounds  to 

3.  Our  negotiating  skills,  contacts  and  know 
how  will  bring  you  extra  savings  from 
numerous  companies. 


54/62  Silver  Street,  Whitwick,  Leicestershire  LE67  3ET 
TEL:  01530  510520  FAX:  01530  811590 

FREEPHONE  0800  526074 

23/07/96  -  CALL  01732  377  222 


A  FREE  Service  for  Chemist  &  Druggist  Subscribers 


S25.00  +  VAT  +  POSTAGE  -  10  x 

Cusilyn  eye  drops  13.5m]  (soil  cro- 
moglycate  2%)  exp  1/97.  Tel:  01223 

TRADE  LESS  50%  +  VAT  + 
POSTAGE  -  Coloplast  -  1285  4x10, 
12705x50,  1200  2x30,  12507x5,  Sur- 
gicare  SI 00  2x5,  S351  1x5,  S240 
1x10,  SI  1x4,  Conveen  S125  2x30, 
S120  1x10,  S172  1x10,  S236  1x10, 
S272  2x10,  S313  1x10,  Dansac  226- 
60  4x30,  226-40  1x30,  226-45  2x30. 
Tel:  01202  262486. 

TRADE  LESS  50%+VAT  -  63  Dol- 
matil  200mg  (exp  10/96),  66  Neu- 
rontin  lOOmg  (exp  8/97).  Tel:  01269 

TRADE  LESS  30%+VAT  -  2x42  Val- 
trex  tabs  (exp  10/96),  3  boxes  Corn- 
fell  over  dressing  20cm  2  Tel:  0171 

485  1251. 

TRADE+VAT  -  190  Pentasa  M/R  500mg 

(long  expiry)  Tel:  0121  477  0123. 

260  Megace  tabs  40mg  (exp  11/98), 
5x100  Hormonin  tabs  (exp  2/08), 
1x120  Alu-cap  caps  (exp  3/07)  Tel: 
0181  651  6062 
TRADE  LESS  50%+VAT  -  4  boxes 
Predfoam  enemas  (exp  8/96  &  12/06), 
3x5Cytamen  inj  1000mg(exp  11/96), 
3  Zofran  inj  2mg/ml  (exp  0/07),  60 
Loron  520  tabs  (exp  1/98),  12x4ml 
Uromitexan  inj  (exp  11/98),  1  I)e-Nol 

labs  (exp  11/98),  100  Parlodel  lmg 

(exp  1 1/96)  plus  others.  Tel:  0161  480 

TRADE  LESS  50%+VAT  -  10  vials 
Genotropin  16iu,  Kabivial  multidose 
(exp  10/96)  guaranteed  fridge  stored, 
buyer  to  arrange  colleciioti  Tel 
01382  611227. 

TRADE  LESS  25%  + VAT  -  Duphalac 

dry  sachet,  Alrheunial  caps, 
Alphoditl)  (team,  Kersanial  labs, 
1000  Triludan  OTC  packs.  Trade  less 
20%+ VAT  -  Zofran  8mg.  Tel:  0181  520 

TRADE  LESS  50%+VAT  -  2x10 
Normegon  150iu  (exp  10/06)  Tel 
01227  457830. 

TRADE  LESS  50%+VAT  -  Provera 
400mg,  Nicotinic  acid  50nig,  Rocal- 
tro!0.5mcg,  Importal  Danazol  lOOmg, 
Targocid  400mg,  Cesamet  lmg, 
Litarex  Minodiab  2.5mg,  Loniten 
5mg.  Tel:  0181  874  1405. 

1  Predfoam,  120  Anturan  200mg,  60 
Coracten  lOmg,  80  Mexitil  50mg,  408  200mg,30  Provera  400mg,  Tri- 
nordiol,  .84  Gamanil.  Tel:  01963 


Cardene  SR  45  x  56  (exp  10/96),  Cor- 
win200mgx  186  (exp  11/97"),  Retrovir 
250mg  x  37  (exp  7/97).  Tel:  0191  528 

TRADE  LESS  40%+VAT+P&P  -  80 

Aspav  (exp  12/96),  16  Coloplast 
a.ssuia  uro  bags  2550,  25  Voltarol 
50mg  suppositories  (exp  11/96),  32 
white  Tenoretic  (exp  2/97),  4x28 
Sinequan  25mg  (exp  8/98),  2  packs 
Napratec  (exp  11/96),  25  Adizem  SR 
90mg  (exp  11/96)  and  many  others 
Tel:  01693  8:30261. 

TRADE  LESS  30%+VAT  -  6  Lentaron 
t.m  depot  250mg  (1  ampoule 
250mg/l  ampoule  of  2ml)  in  each 
box.  Tel:  Blackpool  301522. 

30%+VAT+POSTAGE  -  Zinamide 
500mg,  Dansac  unique  2-55  ref  555- 
35,  Dansac  unique  light  35  ref  255- 

Pharmacists  are  responsible  for  the  quality,  safety  and  efficacy  of 
medicines  they  supply.  In  purchasing  from  sources  other  than 
manufacturers  or  licensed  wholesalers,  they  must  satisfy  them- 
selves about  product  history,  conditions  of  storage  and  so  on. 



medieltte  pic 

Tel  0181  841  4144  Fax:  0181  841  H  i  ■% 




The  Power 
of  Multiples . . . 
...the  Privilege 
if  Independence 

UK's  fastest  growing 
buying  network  of  800 



*  join  us  now  * 

Wish  to  become  a  member?     Nucare  pic 

Please  contact  us  Today.  447  Keruon  Road 


Middlesex  HA3  OXY 
Tel:  0181-732  2772 
Fax:  0181-732  2774 

CHEMIST  &   ^ers  ^e  mos^  comPre^ens^ve  selection  of  products 

TppTCT&  services  of  in  any  Pharmaceutical  Publication. 
VMmm.  call  Lucy  on  01732  377222 

To  pit  your  Products  &  Services  in  front  of  our  unique  readership 

Free  entries  in 
"Business  Link" 
(maximum  30 
words) are 
restricted  to 
subscribers  to 
Chemist  & 
Druggist.  No  trade 
advertisements  will 
be  permitted. 
Acceptance  is  at  the 
discretion  of  the 
Publishers  and 
depends  upon  space 
being  available. 
Send  proposed 
wording  to 
"Business  Link" 
using  the  form 
printed  alongside. 

To:  Business  Link,  CHEMIST  &  DRUGGIST,  Miller  Freeman  House, 
Sovereign  Way,  Tonbridge,  Kent  TN9  1RW. 


Surname  .  .  . 
First  names . 



Personal  RPSGB  Registration  number  

Telephone  Number  

Proposed  advertisement  copy  (maximum  30  words) 













Edison  Road,  St  Ives  Industrial  Estate,  St  Ives 

Huntingdon,  Cambs  PE17  4LF 
Telephone:  01480  494262  Fax:  01480  495826 


TEL:  01392  491920 
TEL:  01392  49HH22 

the  key  to 

solve  your  pharmacy 

diofijjitiuuf.  problems  ^^r-^y — ^ 

•  comprehensive  service    •  part  or  full  refits        "  N^n-*^ 

•  competitive  quotations     •  free  advice  'budgets 

write/telephone:  fredenck  moore,  39  cooks  meadow 
edlesborough,  beds  Iu6  2rp  a  01525  222526 

name  &  address   


Manufacturers  of  Special         . Pharmaceutical  Products 

Bespoked  Tailors  of  Pharmaceuticals  offering 


for  that  "specials"  patient  cared  for  by  that  special 

Where  confidence  in  quality  and  price  is  a  must  and  where  the 
minimum  order  value  is  ONE. 

Contact  Karol  Pazik,  Director,  on  01296  394142. 
Mandeville  Medicines,  The  Specialists  in  Specials. 
For  sterile,  non-sterile  and  assembled  specials,  clinical  trials 
supplies  and  a  free  help  line 


5  x  60  MST  lOOmg  50%  off  trade. 
500  x  60  SELEGILINE  5mg  42%  off  trade. 
60  x  28  ZESTRIL  5mg  48%  off  trade. 
130  x  28  ISOSORBIDE  MONONITRATE  60SR  35%  off  trade. 
15  x  25  ZOVIRAX  400mg  40%  off  trade. 
1000  x  24  exp  own  brand  films  35mm  80  pence  each. 

Contact:  Kasumba  Chemist 
261  Chesterfield  Road,  Sheffield,  S.  Yorks.  S8  0RT 
Tel:  0114  255  4361 



Old  chemist  shop  fittings,  drug  runs,  bow 

cabinets  etc. 
Complete  shop  interiors  purchased.  We  try 
hardest,  travel  furthest,  pay  more. 

Telephone  01327  349249  days. 
01327  341192  Eves.  Fax:  01327  349397 


Surplus  Coloured  Glass  Bottles  and  Jars  Wanted. 
Black  Glass  Jars.  Drug  Jars  -  Blue  or  Green. 
Blue  Castor  Oils.  Coloured  Soda  Syphons. 
"Admiralty"  Square  Blue  Poisons.  Spare  Stoppers. 
Common  Blue  "Not  to  be  taken"  Poisons  -  All  shapes. 
Mixed  Assortments  of  Surplus  Bottles  as  above. 
Contact:  Eric  Padfield, 
18  Mulberry  Gardens,  Sherborne,  Dorset. 
Tel:  01935  816073  Fax:  01935  814181 







Dental  aid  delivery  to  Bihac 

A  pharmacist  has  been  involved 
in  a  live-day  trek  across  Europe 
to  deliver  essential  dental  sup- 
plies to  Bihac  in  the  north  west  of 

Stephen  Beasley,  a  pharmacy 
manager  at  R  A  Hopkins  in 
Luton,  Bedfordshire,  made  the 
journey  last  month  to  deliver 
54,500  of  dental  supplies  as  part 
of  the  work  of  local  charity 
Balkan  Relief.  Bihac,  with  a  pop- 
ulation of  180,000,  has  not  seen 
real  dental  care  for  over  four 

Mr  Beasley  has  been  involved 
with  fund-raising  for  the  charity 
and  organised  a  sponsored  swim 
in  April.  Septodont  UK  donated 
2,000  local  anaesthetic  vials  and 
sterile  needles,  and  gave  sub- 
stantial discounts  on  other  prod- 
ucts. Luton  dentist  Donald 
Cousin  helped  arrange  the  dona- 
tion of  other  supplies. 

The  delivery,  which  also  in- 
cluded new  drills  and  materials 

to  make  dentures  and  fillings, 
was  made  to  Bihac  hospital.  "It 
should  enable  routine  dentistry 
to  be  carried  out  for  several 
months,"  says  Mr  Beasley.  "Imag- 
ine having  your  tooth  filled  with 
a  blunt  drill  and  no  anaesthetic." 

Food,  clothing,  bicycles  and 
toys  were  also  taken  in  the  truck 
that  was  co-driven  by  Philip 
Waters,  a  director  of  the  stock- 
taking company  Take-Stock.  The 
brewer,  Bass,  supplied  funds  to 
pay  for  the  truck's  fuel. 

Stephen  Beasley  (centre)  meets  Adem  Yusufagic,  a  dentist  at  the  Bihac 
hospital  dental  clinic,  whose  relatives  are  refugees  in  the  Luton  area. 
Mr  Beasley  delivered  news  from  them  to  Mr  Yusufagic  and  his  mother 

usmess  news 

There  is  another  new  face  at 
Chemist  &  Druggist. 

The  recent  restructuring  of  the 
editorial  team  has  seen  Guy 
L'Aimable  (above)  appointed  as 
business  editor 

Guy,  who  has  ten  years  of 
reporting  experience,  joins  C&D 
from  World  Tobacco  where  he 
was  assistant  editor  for  four  and  a 
half  years.  His  previous  experi- 
ence includes  four  years  spent 
with  Reed  Business  Publishing. 

Feeling  a  little  bit  under  the  weather? 

The  two  main  topics  of  interest  to 
the  British  are  their  health  and  the 
weather.  What  was  on  television 
last  night  also  ranks  highly  as  a  con- 
versation topic. 

Now  the  British  public  can  have 
their  fill  of  all  three  with  the  launch 
of  the  24-hour  cable  television 
channel  'The  Weather  Network'. 

Not  only  will  the  station  pro- 

vide updated  weather  reports 
round  the  clock,  it  is  also  going  to 
feature  health  tips  presented  by 
pharmacist  Sharon  Buckle. 

Ms  Buckle  works  as  group  pub- 
lic relations  manager  for  Boots  the 
Chemists,  and  was  approached  by 
the  TV  company  to  provide  short, 
educational  health  promotion 
inserts  for  broadcasting. 

Stars  in  his  eyes ... 

A  face  that  may  become  more 
familiar  to  you  on  television  is 
getting  a  second  airing  on  this 

Ortis  Deley  recently  hosted  his 
own  television  programme,  but 
he  appeared  on  this  page  in  Octo- 
ber 1994  when  he  was  still  a  Sun- 
derland pharmacy  student. 

Back  then,  he  was  taking  part 
in  'Blind  Date'  on  ITV.  When  he 
sang  for  presenter  Cilia  Black,  his 
talent  was  spotted  and  he  was 
signed  up  by  an  agent. 

His  new  show,  'Passport  to  Pas- 
sion', was  shown  two  weeks  ago 
in  the  Friday  night  post -pub  slot 
on  ITV.  The  pilot  programme  had 
Ortis  and  co-presenter  Sarah 
Matravers  setting  out  "to  discover 
whether  Copenhagen  is  really  a 
place  to  find  tare  romance". 

"I  was  over  the  moon  when  I 
was  asked  to  present  'Passport  to 
Passion'  -  and  I  really  enjoyed 
doing  it,"  he  says. 

Although  he  graduated,  Ortis 
has  yet  to  qualify  as  a  pharmacist. 
It  seems  the  bright  lights  hold 
more  attraction  and  he  is  now 
poised  to  sign  a  record  deal. 

CPP  exam  success 

The  College  of  Pharmacy  Prac- 
tice has  announced  that  it  has 
seven  new  full  members. 

The  candidates  who  have  suc- 
cessfully completed  the  Col- 
lege's membership  examination 
are  Alison  Archer,  Barend 
Arrthon,  Raymond  Atkinson, 
Nickos  Efthynriou,  Elizabeth 
Hardman,  Alisorr  MacRobbie  and 
Lesley  Webster. 

The  closing  date  for  registra- 
tion to  the  College's  Assessments 
D,  E  and  F  examinations  is 
August  9.  Reports  for  Assess- 
ments D  and  F  should  be  submit- 
ted by  August  23. 

Further  details  can  be  ob- 
tained from  Michelle  Chaplin  at 
the  College  by  telephoning  01203 

The  former  president  of  the  Royal  Pharmaceutical  Society  has  been 
presented  with  the  College  of  Pharmacy  Practice's  Schering  Award. 
The  presentation  was  made  at  the  College's  award  dinner  last  month  in 
Stratford-upon-Avon.  Pictured  are  (standing,  from  left)  Professor 
Graham  Calder,  speaker  Clive  Jackson,  Brian  Riley,  Norman  Morrow, 
Schering  Health  Care  managing  director  Mike  Wallace  and  College 
chairman  Dr  David  Anderson;  (seated,  from  left)  Mary  Tompkins,  Ann 
Lewis,  Joan  Greenleaf  and  Elizabeth  Roddick 

All  rights  reserved.  No  part,  of  this  publication  may  be  reproduced  or  transmitted  in  any  form  or  by  any  means,  electronic  or  mechanical  including  photocopying,  recording  or  any  information  storage 
or  retrieval  system  without  the  express  prior  written  consent  of  the  publisher.  The  contents  of  Chemist.  &  Druggist  are  subject  to  reproduction  in  information  storage  and  retrieval  systems.  Miller 
Freeman  Professional  Ltd  may  pass  suitable  reader  addresses  to  other  relevant  suppliers.  If  you  do  not  wish  to  receive  sales  information  from  oi  lier  companies  please  write  to  Ben  Martin  at  Miller 
Freeman  Professional  Ltd.  Origination  by  London  Scanning,  24a  Shore  Rd, London.  Printed  by  St  Ives  (Gillingham)  Ltd,  Gillingham,  Kent.  Registered  at  the  Post  Office  as  a  Newspaper  22/19/24S 



:  H  E  M  E  X   '  9  6  COLY  M  PIaT)  1  -  2   SEPTEMBER  19 

New  look 
New  home... 
id  a  New  era 

emex  '96  is  a  bigger  better 
dw.  Two  floors  of  Olympia 
dedicated  to  pharmacy 
□ducts,  to  beauty  and 
althcare,  to  current  topics 
d  to  help  you  maximise 
ur    business  potential.. 
10     floors     which  will 
3vide  you  with: 

ie  New  NPA  Village 

i  arena  where  existing  and 
tential  members,  may  see  and 
ar  what  their  trade  association 
Joing.  A  place  where  you  can 
ve  your  say  and  to  seek  advice 
current  issues. 

ie  New  International 

ijor  international  companies  will 
showing  you  what  is  new  and 
lat  will  be  arriving  on  the  domes- 
market  in  the  near  future. 

ie  New  Demonstration 

new  concept  to  provide  all 
itors  with  an  opportunity  to  see 
citing  new  products  and  services 
action  and  a  chance  for  you  to 
.t  the  best  before  you  buy. 

;w  Seminars  and  Workshops 

rpose  built  theatres  will  be  the 
itform  for  a  series  of  provoking 
d  serious  discussions  which  relate  to 
jr  business,  your  profits,  and  how  to 
nerate  new  growth  without  com- 
3mise.  What  to  do,  how  to  do  it,  and 
w  to  monitor  the  results.  Subjects  on 
s  draft  programme  include; 

Original  Pack  Dispensing 
Alternative  Therapies 
)avid  and  Goliath...  how  to  work  in 
larmony  in  the  face  of  competition 
rom  the  multiples 

Vill  IT  work7  ..  Computing  and  its 
ole  in  the  pharmacy 

No  hard  drive 
to  Chemex. . . 

Vhat's  new 
nake  profit 

and  will  what's  new 


but  you  could  win 
a  2Gb  hard  drive  at 
Chemex  this  year \ 

15mb  EDO  RAM,./-gnt^peakers  and  Windows  95, 

keyboard,  sound  ca 

The  New  Visitors  Voucher  Book 

An  exciting  new  concept.  Every  registered 
visitor  to  Chemex  '96  will  receive  a  voucher 
book  bursting  with  special  offers  and 
promotions.  So  you  know  where  the  best 
deals  and  the  best  incentives  are  before 
you  even  enter  the  exhibition  hall. 

Stunning  New  Promotions 

Early  indications  show  that  a  number  of 
companies  are  supporting  the  biggest 
and  most  spectacular  prizes  ever  seen 
at  Chemex...  so  if  you  wish  to  increase 
your  chances  of  winning...  register  now. 

The  New  Trade  Show 

Every  floor  will  be  bustling  with  activity 
and  this  year's  exhibition  bookings 
would  indicate  that  the  recession  is 
dead.  Hundreds  of  exhibitors  all  eager 
to  keep  you  abreast  of  the  latest  devel- 
opments... and  gossip!  Special  offers, 
exclusive  to  Chemex  '96,  will  be  the 
common  theme. 

New  Venue 

Olympia  2  welcomes  Chemex  '96  to  its 
new  improved  facilities.  Olympia  2  has 
all  the  advantages  you  would  expect 
from  an  international  exhibition 
centre,  convenient  to  all  mainline 
railway  stations  as  well  as  having  its 
own  tube  station.  Olympia  2  also 
features  parking  for  up  to  2100 
cars,  so  you  will  be  assured  of 
easy  and  convenient  access. 

New  Registration 
Competition  -  win  a 
Multimedia  Pro  120  PC 

When  you  pre-register  you  will  receive  the 
opportunity  to  win,  for  your  business,  a  state 
of  the  art  Pentium  120  Multimedia  PC  com- 
plete with  16mb  EDO  RAM,  2  Gb  hard  drive, 
Eight  speed  CD  ROM,  IS"  SVGA  colour  monitor, 
keyboard,  sound  card  with  speakers  and 
Windows  "95,  to  boot1  Every  pre-registered 
visitor  will  be  entered  inio  our  tree  to  enter 
draw  The  winner  will  be  advised  of  their  suc- 
cess at  Chemex  '96  In  addition  all  visitors 
who  pre-register  will  receive  a  compliment- 
ary free  gift  pack  of  TRU-ALO,  with  a  retail 
value  of  £23  25  Your  gift  pack  will  include 
Soothing  Gel,  Moisturiser,  Moisturiser  with 
Vitamin  E,  Antiseptic  Cream  and  Liniment. 


WORTH  OVER  £1*00 

Sponsored  by 


Supported  t 

MEMEX  '96 

he  UK  show  for  pharmacists/ 
pharmacy  buyers. 

141  M;ll-r  I  :  .  •:  i; 

Miller  Freeman  Exhibitions  Ltd. 
Marlowe  House,  109  Station  Road 
Sidcup,  Kent  DA15  7ET 
Internet:  UK 

For  the  treatment  ^ 
of  verrucas,  warts,  V<** 
corns  and  calluses 

■  Uniquely  formulated,  clinically  proven  treatment 

■  Dries  to  form  a  water-resistant,  protective  barrier 

■  Designed  to  inhibit  spread  of  the  verruca/wart  infection 

■  No  plasters  necessary  ■  Simple,  once-daily  application 


A  bullseye  for  Bazuka! 

Bazuka  Gel  has  taken  the  verruca/wart 
market  by  storm,  soaring  to  brand  leadership 
within  months  of  its  launch. 

With  its  clinically  proven  prescription 
heritage  Bazuka  offers  simple,  effective 
treatment  for  verrucas,  warts,  corns  and 
calluses.  It  dries  to  form  a  unique,  water- 
resistant  protective  barrier  designed  to 
help  inhibit  the  spread  of  the  verruca/wart 
infection,  without  the  need  for  plasters. 

And  wtfith  continued  heavyweight  national 
press,  radio  and  TV  support,  Bazuka  sales 
will  go  from  strength  to  strength.  Be  sure 
to  keep  up  with  demand! 

lor  the  treatment  of  verrucas,  warts,  corns  and  calluses 

salicylic  acid,  lactic  acid 


BAZUKA  Trademark  and  Product  Licence  held  by  Diomed  Developments  Ltd ,  Hitchin,  SG4  7QR,  UK  Distributed  by  DDD  Ltd ,  94  Rickmansworth  Road.  Wattord.  Herts.  WD1  7JJ.  UK  Active  Ingredients: 
Salicylic  Acid  BP  12  0%  w/w,  Lactic  Acid  BP  4  0%  w/w  Also  contains  Camphor  BP,  Pyroxylin  BP,  Ethanol  (96%)  BP,  Ethyl  Acetate  Indications:  For  the  treatment  ot  verrucas,  warts,  corns  and  calluses 
Directions  lor  adults,  including  the  elderly,  and  children:  Apply  one  or  two  drops  to  the  lesion  and  allow  to  dry  to  form  a  small  white  patch  The  following  day.  carefully  peel  or  pick  oft  the  dried  patch, 
and  apply  fiesh  gel  Once  every  week,  before  applying  Iresh  gel,  gently  rub  the  treated  surface  with  the  emery  board  provided  Continue  treatment  until  the  condition  has  resolved  This  may  take  up  to  12 
weeks  for  certain  vemicas  and  warts  Contra-indications:  Not  to  be  used  on  the  face  or  anogenital  regions,  or  by  diabetics  or  individuals  with  poor  blood  circulation  Not  to  be  used  on  moles,  birth  marks, 
hairy  warts,  oi  any  othei  lesion  loi  which  the  gel  is  not  indicated  Not  to  be  used  in  cases  of  sensitivity  to  any  ot  the  ingredients  Precautions  and  Warnings:  Keep  away  from  the  eyes,  mucous  membrane 
and  from  cuts  and  grazes  Avoid  spreading  onto  surrounding  normal  skin  Do  not  use  excessively  Some  mild,  transient  irritation  may  be  expected,  but  in  cases  of  more  severe  irritation,  treatment  should  be 
discontinued  Avoid  inhaling  vapour,  and  keep  cap  firmly  closed  when  not  in  use  Avoid  contact  with  clothing,  fabrics,  plastics  and  other  materials  as  it  may  cause  damage  Keep  all  medicines  out  of  the  reach 
ill  i  hildren  HIGHLY  FLAMMABLE  Keep  away  from  flames  Store  at  room  temperature  (not  exceeding  25°C),  with  the  cap  replaced  tightly  jFOR  EXTERNAL  USE  ONLY  [Legal  Category:  [T]  (PL  0173/0161) 
Packs:  5g,  RSP  E4  35  (£3  70  exc  VAT)  5/95